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My interest in soft tissue (non-articular) rheumatism was stimulated by my 
appointment as an Arthritis and Rheumatism Council (ARC) research fellow 
and honorary senior registrar in rheumatology attached to Dr Brian 
Hazleman's unit in Cambridge, England. Soft tissue lesions are common in 
clinical practice and an interest in the frozen shoulder had been present 
in Cambridge for many years. 
The paucity of consistent data on the frozen shoulder led me to examine the 
pathogenesis, natural history and the response to treatment. I also sought 
to ascertain the value of clinical and laboratory features in the 
differentiation of sub-groups presenting with a painful stiff shoulder. 
As the geniune frozen shoulder is relatively uncommon, I expanded the study 
to include rotator cuff tendinitis of the shoulder and lateral 
epicondylitis of the elbow which it seemed might share a common pathology 
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PART I 
GENERAL CONCEPTS AND A REVIEW OF THE LITERATURE 
CHAPTER 1 
SOFT TISSUE RHEUMATISM 
Lesions of tendons and their sheaths, fasciae, bursae, ligaments, joint 
capsules and the teno-periosteal junction (the enthesis) cause much 
morbidity. As biopsy and surgery are rarely employed for diagnosis and 
treatment, histological data is scanty and their pathologies are poorly 
understood. 
While these lesions may occur in association with overt systemic disease as 
for example, inflammatory arthritis or infection, most occur in the absence 
of other features and are included under the term of 'Soft Tissue 
(Non-articular) Rheumatism'. 
CLASSIFICATION 
There is no universally accepted classification. For practical purpose the 
conditions can be divided into (A) generalised (Table 1:1) and (B) localised 
soft tissue lesions. Generalised soft tissue lesions will not be considered 
further. 
The major structures involved in the localised soft tissue lesions (Table 
1:2) and many of the commoner conditions (Figure 1:1) are shown. Some of 
the soft tissue lesions affecting the shoulder and elbow have been chosen 
for detailed study. 
EPIDEMIOLOGY 
The lack of an accepted classification and the differences in nomenclature 
of the soft tissue lesions has resulted in a paucity of information 
regarding the epidemiological and economic importance of these conditions. 
Wood et al (288) used the International Classification of Diseases, eighth 
revision (ICD, WHO 1967) (277) to assess the incidence of soft tissue 
lesions in the community and noted that over one third of the 
rheumatological consultations in general practice were for soft tissue 
lesions, making over 4 million visits in Britain each year. A new ICD 
introduced in 1977 (278) has not yet been used to study these lesions. The 
association between occupation and specific soft tissue lesions (16, 116, 
212) may also produce regional variation in the incidence of some of these 
conditions. 
ASSOCIATION OF SOFT TISSUE LESIONS 
While many lesions result from activities related to specific occupations, 
sport or hobbies, their occurence is often unexplained and may result from 
individual susceptibility. This predisposition in supported by the 
documented associations of a variety of these lesions in the same patients. 
Rotator cuff tendinitis, frozen shoulder, tennis and golfer's elbow, carpal 
tunnel syndrome, Dupuytren's contracture and de Quervain's tenosynovitis 
have been found to occur more frequently in the same patients (22, 61, 102, 
127, 195, 204, 216). 
Niepal and Sitaj (203) proposed enthesopathy as a unifying concept for many 
of the soft tissue lesions including those affecting the shoulder and elbow. 
They did not however, offer any explanation for the susceptibility of the 
enthesis in these patients. The 'fibrositis syndrome' (252) which is 
characterised by musculoskeletal ache and tender sites at the entheses has 
been suggested as a pain amplification syndrome. Its pathogenesis is 
unexplained and the association between this syndrome and a variety of soft 
tissue lesions in the same patient is uncertain. Cervical spine disease 
particularly cervical spondylosis can result in severe pain in the shoulder 
and elbow (102, 247) and may be confused with localised soft tissue lesions 
in the upper limb. Murray-Leslie and Wright (195) felt that the symptoms 
can be indistinguishable. A hereditary predisposition was suggested by 
Bulgen et al (30) who reported an increased incidence of HLA-B27 antigens in 
painful stiff shoulder patients. However, this association has not been 
confirmed (206, 234, 243) or reported in other soft tissue lesions. 
TABLE 1:1 
GENERALISED SOFT TISSUE LESIONS 
A. WITH EVIDENCE OF INFLAMMATION 
i. Polymyalgia rheumatica and cranial arteritis 
ii. Prodrome of inflammatory arthropathies and connective tissue 
diseases 
iii. Viral and bacterial infections 
B. WITHOUT INFLAMMATION 
i. Hypothyroidism 
ii. Drug related painful states associated with steroid 
withdrawal, chronic barbiturate abuse and the contraceptive 
pill 
iii. Dyskinetic phase of Parkinson's disease 
iv. Chronic Brucellosis, Bornholm's disease 
v. Associated with malignancy e.g. myeloma, carcinoma 
vi. Osteomalacia 
vii. 'Fibrositis', 'lumbago' 
C. ASSOCIATED WITH WEAKNESS 
i. Prodrome of polymyositis or dermatomyositis 
ii. Carcinomatous neuromyopathy (some forms) 
iii. Hypokalemic states 
D. 'PSYCHOGENIC' RHEUMATISM 
TABLE 1:2 










Rupture, degeneration, tendinitis 
Peritendinitis, tenosynovitis, ganglion 
Bursitis - acute or chronic 
Enthesopathy, apophysitis 
Fasciitis, Dupuytren's contracture 
Sprain, strain, tear 





carpal tunnel compression---.-. r---.,...__:~v;--- lsct,ial bursitis 
Dupuytren's contracture--"'""",..,, -----Meralgia paraesthetica 
\ I 
F I G U R E I I. Common sites of soft tissue lesions. 
CHAPTER 2 
THE NORMAL TENDON, JOINT CAPSULE AND ROTATOR CUFF AND THE EFFECT 
OF AGING; FUNCTIONAL ANATOMY OF SHOULDER 
THE NORMAL TENDON 
EMBRYOLOGY: Tendons begin as mesenchymal condensations of fibroblasts which 
secrete parallel orientated collagen fibres (281). As these fibres increase 
in number, the cellularity of the structure reduces and the remaining 
fibroblast nuclei come to lie in parallel between the bundles of collagenous 
fibres. Tendons can usually be recognised in the embryo by the end of the 
second month. 
The tendon develops independently of its muscle and is later linked by 
connective tissue which comes predominantly from the perimysium (108). This 
area remains vulnerable to rupture throughout childhood. Once muscle and 
tendon have been united, the force and the direction of stress affecting the 
unit, controls the further orientation of collagen fibres and the extent of 
its proliferation (230, 281). While most collagen fibres remain in 
parallel, some interweaving does occur (98) to provide additional stability 
to the structure. The wavy nature of the collagen bundles and the presence 
of scanty elastin fibres within the tendon (98, 107, 230), provide further 
longitudinal flexibility. Once the tendon has been fully developed, the 
remaining fibroblasts within the structure lose their ability to divide 
(107). If damage occurs, fibroblasts migrate from the surrounding loose 
connective tissue to the area of damage and are responsible for new collagen 
production and eventual tendon repair (29, 218). 
HISTOLOGY: The parallel but wavy bundles of collagen fibres are grouped in 
fascicles separated from each other by small amounts of loose connective 
tissue (endotendineum) containing scanty blood vessels, nerves and elastin 
fibres. The fascicles are held together by loose connective tissue 
(peritendineum) which is continuous with the endotendineum. The fibrous 
sheath (epitendineum) merges with the surrounding loose connective tissue. 
A high elastin content in this region permits some tendon movement, but 
where greater movement is necessary, a double layered synovial-lined sheath 
is present. The cellular component of adult tendon is scanty with 
fibroblasts lying in parallel and between the collagen bundles. The lateral 
limits of these cells are indistinct. The nuclei are spindle shaped and 
heterochromic with axes parallel to the collagen fibres. In cross-section, 
the nuclei are stellate shaped, lying between the collagen bundles. 
Occasional macrophages may also be identified. 
ULTRASTRUCTURE: Electron microscopy of normal adult tendon (51) shows 
collagen fibrils ranging from 250 - 1400 angstrom which in cross-section are 
grouped in bundles separated by granular and filamentous precipitates. 
Longitudinal sections of the individual fibrils shows monotonously regular 
periodicity characteristic of the native type macro-molecular aggregated 
collagen. Scanty elastin fibres are also noted. The fibroblasts 
('tenocytes) appear to be metabolically active cells (136) with well 
developed rough endoplasmic reticulum, Golgi apparatus, mitochondria and 
large cytoplasmic ribosomes. Lysosomes and lipid vacuoles are also evident. 
The cell membranes show indentations caused by the surrounding collagen 
fibres. 
HISTOCHEMISTRY: Tendons have traditionally been considered as metabolically 
inert structures (98, 214). Holloszy (1971) (126) reported very low levels 
of oxidative enzyme in rat tendon even after exercise. However, Tipton et 
al (1975) (264) showed experimentally that tendons were metabolically active 
and that the activity increased with exercise, although it remained 60 - 70% 
lower than the attached muscle. Heikkinen et al (1975) (114) demonstrated 
that chronic exercise could increase collagen turnover and selectively 
activate Kreb cycle enzymes in rat tendon. Suominen and Heikkinen (1975) 
(261) found similar effects in tendon biopsy specimens from older men 
engaged in a long standing exercise program. Jozsa et al (1979) (136) 
studied fresh human postmortem tendons and identified enzymes for oxidative 
and anaerobic metabolism which correlated with the ultrastructural evidence 
of the metabolic potential of adult tenocytes. 
THE ENTHESIS: The point of attachment of tendons to bone (the enthesis) has 
long been recognised to be the site of maximum stress and an area which 
differed histologically from the rest of the tendon. Havers (1691) (112) 
and Kolliker (1853) (144) observed that some tendon fibres penetrated the 
cartilage and attached directly to bone. Sharpey and Ellis (1856) (244) 
stressed the importance of these perforating (Sharpey) fibres to the tensile 
strength of the enthesis. I 
Dolgu-Saburoff (1929) (70) described the 4 traditional zones of tendon, 
fibrocartilage, mi neralised fibrocartilage and bone which constitute the 
enthesis. A distinct "blue-line" was attributed to the zone of mineralised 
fibrocartilage. Cooper and Misol (1970) (51) confirmed the presence of 
these zones and added ultrastructural detail of this region. Smooth 
endoplasmic reticulum and intracellular lipids and lysosomes increased and 
the Golgi apparatus became more prominent. An electron-dense line 
(corresponding to the blue-line) was noted in the mineralised fibrocartilage 
zone with granular deposits becoming increasingly evident within the matrix. 
These deposits clumped and eventually merged with bone. This study 
suggested that the cells were both viable and metabolically active, but no 
histochemical studies have been performed to confirm this. 
BLOOD SUPPLY TO THE TENDON: While early anatomists (119, 144) regarded the 
adult tendon as an avascular structure, Mayer (1916) (174) used an injection 
technique to demonstrate a vascular supply arising from muscle, bone and the 
surrounding connective tissues. Edwards (1946) (77) found a scanty 
superficial longitudinally orientated vascular network to sustain the 
tenocytes and Peacock (1959) (214), using a dog tendon model and 
32 radio-active phosphorus ( p), showed that blood vessels from the muscle 
supplied the proximal third and vessels from the bone the distal quarter of 
the tendon. The rest of the tendon was supplied by vessels from he 
paratenon - these anastomosing segmentally with vessels from muscle and 
14 bone. Heiple et al (1967) (115) showed that C - labelled collagen could 
be used to estimate the tendon blood flow in animal models and Piaggi and 
Mingione (1981) (217) that 133 Xenon could be used in a similar manner in 
clinical practice. Davies and Young (1954) (60) injected labelled sulphate 
into innnature rats and found maximum radioactivity at the enthesis of 
tendons and ligaments. Similar observations were made by Ball (1971) (9) 
who used radioactive calcium. Peacock (1959) (214) and Rathbun and Macnab 
(1970) (225) also suggested that this region has a rich blood supply. 
THE ROTATOR CUFF: Codman (1934) (45) described a musculo-tendinous cuff 
formed when the shoulder joint capsule fused with parts of the tendons of 
teres minor, infraspinatus, supraspinatus and subscapularis muscles. Palmer 
(1939) (211), Lindblom and Palmer (1939) (161) and Pettersson (1942) (215) 
called this structure the tendon aponeurosis of the shoulder joint. Moseley 
(1947) (188) introduced the term the "rotator cuff" which referred to the 
aforementioned muscles and their tendons. In the literature, the terms 
musculo-tendinous and rotator cuff are used to include both above concepts. 
Skinner (1937) (251) and Withers (1949) (286) suggested that the tendinous 
component of the cuff was short and not fused with the joint capsule in the 
newborn. With growth, the tendons increased in length and eventually fused 
with each other and with the joint capsule. Olsson (1953) (208) dissected a 
large series of shoulders and found the mean length of the tendinous portion 
of the cuff to be 19rrun for the supraspinatus and 13mm for the infraspinatus 
and subscapularis tendons. He could not confirm any age related changes in 
the cuff. The rotator cuff lies between the glenohumeral joint and 
subacromial bursa, with no communication between the joint and bursa unless 
rupture of the cuff has occurred. 
The supraspinatus muscle is the most important of the rotator cuff muscles. 
It arises from the supraspinatus fossa of the scapula and inserts into the 
greater tuberosity of the humerus, merging with the superior aspect of the 
capsule and forming part of the floor of the subacromial bursa. Its 
principal action is to assist abduction of the arm by fixing the head of the 
humerus against the glenoid. This is especially important in the initial 15 
- 20° of abduction after which the deltoid muscle plays a more important 
role. 
The infraspinatus muscle arises from the infraspinatus fossa on the 
posterior aspect of the scapula and inserts into the postero-superior aspect 
of the greater tuberosity. It acts as an important lateral rotator of the 
humerus. 
Teres minor arises from the axillary border of the scapula and inserts into 
the postero-inferior aspect of the greater tuberosity. It strengthens the 
capsule at this site. Its functions are similar to infraspinatus with which 
it is intimately structurally associated. 
The subscapularis muscle arises from the subscapular fossa and inserts into 
the lesser tuberosity of the humerus just lateral to the glenoid rim. It is 
separated from the rest of the cuff by the bicipital groove containing the 
tendon from the long head of biceps which inserts into the supraglenoid 
tubercle. A transverse ligament often covers the gap between the two 
tuberosities and when present also gives attachment to the rotator cuff. 
The subscapularis plays an important role in medial rotation of the humerus. 
The tendinous portion of the rotator cuff and the interrelated capsule is 
attached to all except the inferior aspect of the anatomical neck of the 
humerus. In this area where the cuff is deficient, only the capsule gains 
attachment. 
VASCULAR SUPPLY TO THE ROTATOR CUFF: Hitzrot (1901) (119) and other early 
anatomists described the blood supply to the shoulder region, but as they 
regarded the tendons to be avascular, they made no attempt to study their 
vasculature. Mayer (1916) (174) showed that the rotator cuff does have a 
vascular supply and Lindblom (1939) (160) studying postmortem shoulder 
specimens described a hypovascular area ('the critical zone') in the 
supraspinatus tendon, close to its insertion. With aging, he noted 
progressive degeneration and fibrosis in this area. Olsson (1953) (208) 
also noted a hypovascular area which he attributed to pressure from the 
humeral head on the rotator cuff. He felt this pressure caused local tendon 
ischaemia with resultant degeneration. Laing (1956) (150) used a dye 
injection technique to study the arterial supply to the humeral head and 
demonstrated that some osseous vessels did enter the rotator cuff through 
its attachment. Moseley and Goldie (1963) (187) used a similar method and 
showed that the rotator cuff received vessels from osseous, tendinous and 
muscular sources. They found no reduction in th~ rich blood supply with 
increasing age and regarded the 'critical zone' as an area of muscular and 
osseous vessel anastomoses and not a hypovascular area. Rothman and Parke 
(1965) (237) further defined the macrocirculation to the shoulder, 
demonstrating that 6 vessels contributed blood to the rotator cuff. They 
noted profuse anastamoses between the different vessels, but also reported a 
hypovascular zone in 63% of supraspinatus tendons and a similar area in 37% 
of infraspinatus and 7% of subscapularis tendons. They felt that tendon 
degeneration began at this site and increased with age. They used an animal 
model to demonstrate the progressive reduction in the capillary bed of 
tendons with age. Reeves (1968) (227) showed a similar reduction in the 
vascular bed of the rotator cuff in men of increasing age. Rathbun and 
Macnab (1970) (225) studied the microcirculation of the rotator cuff and 
demonstrated a marked difference in the vascular pattern of the 
supraspinatus when compared to the other rotator cuff tendons. Irrespective 
of age, a hypovascular zone was noted in most supraspinatus and some 
infraspinatus tendons close to the insertion. Like Olsson (208) they felt 
that pressure from the humeral head caused "wringing out" of vessels in this 
region. Macnab (1973) (170) extended this work by experimentally 
demonstrating that pressure such as that applied by the humeral head on the 
rotator cuff, could cause a partial interruption of the blood supply to the 
tendon. The resulting ischaemia caused degenerative changes in the centre 
of the tendon and not at the site of pressure. 
GLENOHUMERAL JOINT CAPSULE: The capsule of the glenohumeral joint is a 
loose redundant synovial-lined fibrous structure with an intra-articular 
volume of 20-50 ml. It attaches proximally to the labrum and surrounding 
bone and distally to the anatomical neck and shaft of the humerus. It is 
strengthened both by the rotator cuff tendons and by variable thickened 
areas which form superior, middle and inferior glenohumeral ligaments. 
Inferiorly there is no additional support and the capsule forms a lax 
redundant inferior recess. A number of other synovial-lined recesses may be 
present. The most constant are the bicipital tendon sheath recess and a 
recess at the upper end of the subscapularis tendon. In the region of the 
rotator cuff, the capsule fuses with the tendons and the two structures 
cannot be separated. Lundberg (1970) (167) analysed the glycosaminoglycan 
characteristics of the capsule in both normal and frozen shoulders. 
NERVE SUPPLY TO THE SHOULDER: The two sensory nerves to the shoulder 
region, are the axillary (or circumflex) nerve which supplies the anterior 
aspect of the capsule and joint and the suprascapular nerve to the superior 
and posterior parts of the joint and capsule, most of the tendon sheath and 
the acromioclavicular joint (ACJ). The long thoracic nerve also sends a 
branch to the coracoid process and ACJ. 
With the exception of the ACJ (derived from C4 sclerotome), all structures 
of the shoulder are derived entirely or partially from the CS sclerotome and 
thus shoulder pain from whatever deep structure is perceived in the 
distribution of the CS dermatome. Pain is therefore felt at the point of 
insertion of deltoid or down the outer aspect of the arm but not involving 
the hand or the superior aspect of shoulder. Pain from the ACJ is felt on 
the superior aspect of the shoulder and cannot radiate to the arm. 
TENSILE STRENGTH OF TENDONS (WITH EMPHASIS ON THE ROTATOR CUFF) AND CHANGE 
WITH AGE: 
The remarkable tensile strength of normal adult tendon has been recognised 
for many decades. McMaster (1933) (177) used an animal model to demonstrate 
that normal tendon could resist rupture even when severed halfway through 
its bulk. However, if the blood supply to the tendon was partially 
interrupted, the tensile strength decreased in 3 - 5 weeks. He also noted 
that if a normal tendon was stressed, the muscle would tear or the tendon be 
avulsed from the bone at a lower level of strain than that required to 
rupture the tendon. Cronkite (1936) (56) confirmed the remarkable tensile 
strength of human tendons. 
Cadman and Akerson (1931) (44) dissected postmortem shoulders and recognised 
that the supraspinatus tendon was the site of primary pathology with 
subacromial bursitis merely being a secondary phenomenon. They noted that 
rupture of the tendon was common and attributed this to a traumatic episode. 
King and Holmes (1927) (142) accepted the tendon as the site of pathology, 
but regarded wear and tear (attrition) as the probable cause. Meyer (1924, 
1931) (180, 181) believed that the tendon to the long head of biceps and to 
a greater or lesser extent all other tendons were subject to increasing 
attrition with age. Fowler (1933) (85) studied surgical and postmortem 
specimens and noted a high incidence of unsuspected rupture of the 
supraspinatus tendon. He regarded this as the major predisposing factor to 
shoulder pain. Keyes (1935) (141) examined the autopsy specimens of 
shoulders from an elderly population and found that 20% had unsuspected 
rupture of the supraspinatus tendon. Skinner (1937) (251) who extended 
autopsy study of the supraspinatus tendon to include all age groups, 
regarded degenerative changes in the tendons as a normal occurrence 
dependent on aging, occupation and attrition. Lindblom (1939) (160), 
Simmonds (1949) (248) and Wilson and Duff (1943) (282) also reported 
progressive degeneration in the supraspinatus tendon associated with age and 
use. Olsson (1953) (208) in an extensive histological study of shoulder 
tendons found an increasing incidence of degenerative changes with age, but 
no clear association between tendon degeneration and shoulder pain. He 
observed that the degeneration first affected the centre of the tendon and 
was therefore unlikely to have resulted simply from attrition. He 
postulated that pressure from the humeral head on the supraspinatus tendon 
resulted in partial obstruction of the vascular supply to the tendon and 
eventually central tendon degeneration. This stimulated interest in the 
vascular supply to the rotator cuff, which led Macnab (1973) (170) to 
construct an animal model to show that pressure such as that applied by the 
humeral head on the rotator cuff, could cause partial interruption of the 
blood supply and central tendon degeneration, which rendered the tendon 
liable to tear when subjected to trivial often unrecognised trauma. This 
concept remains the basis for current beliefs with regard to the pathology 
of many of the soft tissue lesions of the shoulder. 
FUNCTIONAL ANATOMY OF THE SHOULDER: 
The complex and intricate activities of the upper limbs in man require a 
high degree of precision of muscle synergism and an extraordinary range of 
shoulder movement. This versatility comes at the cost of potential 
instability. Unlike the hip joint which has exact congruity of joint 
surfaces, the shoulder is characterised by a complex system of soft tissue 
structures (muscles, tendons and ligaments) which connect the bony 
components of the shoulder girdle to each other. This permits smooth 
rhythmic and coordinated shoulder movement in almost every direction. The 
glenohumeral joint is the main articulation of the shoulder, but movement 
also occurs at 4 other sites. The acromioclavicular and sternoclavicular 
joints are true plane joints. Their anatomy has been described by De Palma 
(1963) (64). Movement also occurs between the scapula and the thoracic wall 
and in the subacromial region where a large bursa separates the 
acromioclavicular arch from the head of the humerus and its tuberosities and 
facilitates smooth movement. The subacromial bursa is intimately associated 
with the tendons of the rotator cuff, the acromioclavicular joint and other 
neighbouring structures (Figure 2:1) and often becomes secondarily involved 







Supraspinatus and other rotator cuff lesions 
FIGURE 2 : I. Diagram of the shoulder showing the relationship 
between the shoulder joint, rotator cuff, subacromial bursa and the 
acromioclavicular joint. Common sites of pathology and common lesions 
are indicated. 
CHAPTER 3 
THE PAINFUL STIFF SHOULDER A REVIEW OF THE LITERATURE 
Duplay (1872) (73) described the clinical features of 'scapula-humeral 
periarthritis' which included pain and limitation of shoulder range, but its 
significance was not recognised until Cadman (1934) (45) published his 
authoritative work which attempted to differentiate various clinical 
shoulder disorders. 
Neviaser (1945) (199) surgically explored the shoulders of ten patients with 
painful stiff shoulder and reported capsular thickening and chronic 
inflammatory changes with adhesive bands which caused the rotator cuff and 
capsule to adhere firmly to the humeral head. He suggested 'adhesive 
capsulitis' as a more suitable name. Simmonds (1949) (248) also operated 
on painful stiff shoulders but saw no adhesions. He felt that a 
degenerative lesion in the supraspinatus tendon set up a foreign body 
reaction with a spread of the inflammatory process to contiguous structures 
leading to a 'frozen shoulder'. McLaughlin (1961) (176) found true 
inflammatory changes in the capsule and rotator cuff of only 10% of frozen 
shoulders explored from 1938 to 1961. The rest showed a marked reduction in 
joint volume and a shrunken rotator cuff with no inflammatory changes or 
adhesions. He felt that frozen shoulder constituted a primary disorder of 
collagen. Bloch and Fisher (1961) (18) analysed over 2000 patients with 
frozen shoulder and concluded that the condition constituted the final stage 
of inflammation of the shoulder capsule and periarticular connective 
tissues. Macnab (1973) (170) postulated a type IV auto-immune reaction to 
degenerate collagen as the mechanism of development of a frozen shoulder 
from a localised tendinitis lesion. Lundberg (1969) (168) found marked 
periarticular inflammation and capsular thickening in 14 surgical specimens 
from patients with frozen shoulder. Electron microscopy confirmed the 
increase in fibroblasts and fibrous tissue. He also examined capsular 
material from the frozen shoulder specimens and found considerable 
differences in the glycosaminoglycan content when compared to normal 
capsular material. There was an increase in heparin, chondroitin and 
dermatan sulphate and a reduction in hyaluronic acid, reflecting the 
transformation from normal capsule to fibrosis and granulation tissue. He 
also documented a larger than 50% reduction in the mineralisation of the 
humeral head and arthrographic evidence of a shrunken capsule; the volume of 
the joint correlating with the degree of restriction in range. He concluded 
that the main abnormality in the frozen shoulder was capsular retraction. 
Dickson and Crosby (1932) (66), Meulengracht and Schwartz (1952) (179) and 
Wright and Haq (1976) (291) noted an association between painful stiff 
shoulders (PSS) and the occurrence of diabetes mellitus and thyroid disease. 
Bridgman (1972) (24), Gray and Gottlieb (1976) (97) and Lequesne et al 
(1977) (157) also found an association with diabetes. Simmonds (1949) (248) 
recognised the importance of disuse and irrnnobilisation in the precipitation 
of PSS and also considered cardiovascular disease to be important. De Palma 
(1952) (62), Quigley (1956) (221) and Haggart et al (1956) (105) stressed 
disuse and immobilisation in the aetiology of the PSS. Bruckner and Nye 
(1981) (26) also showed a significant increase in the risk of frozen 
shoulder in patients with hemiplegia or following periods of 
unconsciousness. 
Franklin and Nemeik (1954) (86), Johnson (1959) (133) and Fisher et al 
(1963) (81) noted an increased frequency of PSS lesions in patients 
suffering from pulmonary tuberculosis. 
debility to be the important factors. 
They considered immobility and 
Good et al (1965) (96) felt 
antituberculous therapy was the more likely cause. However, Saha (1966) 
(240) also documented a high incidence of PSS in patients with chronic 
obstructive airways disease. 
Lorenz and Musser (1952) (165) felt that personality disorder and an 
abnormal emotional state were essential elements in the development of a 
PSS. Coventry (1953) (53) stressed both the 'periarthritic personality' and 
disuse as the triggering factors for patients with shoulder pain to develop 
a frozen shoulder. Fleming et al (1976) (84) and Wright and Haq (1976) 
(291) reviewed the concept of a 'periarthritis personality' and found 
increased anxiety and neurotic symptoms but no obvious personality disorder. 
The association between the PSS and other soft tissue lesions (22, 61, 205, 
216), cervical spine disease (195, 247) and enthesopathies (203) has been 
mentioned. Wright and Haq (1976) (292) noted the frequent occurrence of 
cervical spondylosis in PSS patients, but felt this was only a reflection of 
age and not of any other significance. Kopell and Thompson (1959) (145) 
postulated suprascapular nerve entrapment as an explanation for the severity 
of pain in the PSS, but no supporting evidence for this concept has been 
forthcoming. 
A review of radiology, blood tests, other investigations and a consideration 
of conservative therapy and the natural history of PSS will be given in the 
relevant chapters. 
PART II 
THE SHOULDER CLINIC AND SHOULDER CONTROLS 
CHAPTER 4 
THE SHOULDER CLINIC 
Shoulder problems are common in the general rheumatology clinics in 
Cambridge, England. To facilitate study of such patients a special clinic 
was set up and local practitioners were asked to refer patients with 
shoulder pain to the clinic as soon as possible after their presentation and 
before instituting therapy. All the patients referred to the clinic were 
examined by the same physician. 
CLASSIFICATION 
Patients with shoulder pain were included in 3 groups (Table 4:1). 
SHOULDER GROUP: Pain modified by shoulder movement and not felt proximal to 
the shoulder unless the acromioclavicular joint (ACJ) was affected. 
Neurological deficit in the upper limbs excluded patients from this group. 
REFERRED PAIN GROUP: Pain referred from the cervical spine or other 
structures outside the shoulder with the primary source of the symptoms 
being identified. The pain was not markedly exacerbated by shoulder 
movement and was usually felt proximal to the shoulder. 
UNDETERMINED GROUP: Patients in whom the site of pathology could not be 
accurately determined or where the findings were suggestive of a combination 
of lesions. 
CLINICAL ASSESSMENT 
All the patients seen at the shoulder clinic were assessed according to the 
method suggested by Cyriax (58). 
General history: Patients were asked about the duration of symptoms, 
whether they arose spontaneously or followed trauma and if the onset was 
sudden or gradual. Previous or concomitant pain in the other shoulder, 
other illnesses and therapy was recorded. 
Pain: The exact location of initial pain, its behaviour from onset, the 
relationship to time of day or night and the effect of active and passive 
movements and other aggravating and relieving factors on the pain were 
documented. 
Limitation of range: If the patients had noted any restriction in the range 
of movement, its timing in relation to the pain, its course and severity was 
noted. 
Cervical spine: Specific enquiries were made with regard to pain and 
limitation of range of the cervical spine. Neurological symptoms in the 
upper limbs were also sought. 
General examination: In addition to a full general systematic and 
musculoskeletal examination, particular emphasis was placed on a detailed 
assessment of the cervical spine and neurological system of the upper limbs. 
Attempts were made to reproduce the presenting pain by movement of the 
cervical spine to the extremes of its range. 
Shoulder examination: Both shoulders were assessed in an identical manner 
so the unaffected shoulder acted as a control. The shoulders were inspected 
for muscle wasting, swelling or deformity and palpated for tenderness around 
the shoulder or in the region of the ACJ. Patients were instructed to move 
the shoulder to the extremes of range (active range) and the movement was 
then continued by the observer (passive range). Four movements were 
routinely assessed - total forward flexion, total abduction, internal and 
external rotation. If the passive range was markedly reduced, the 
glenohumeral component of abduction and flexion was also recorded. The 
character and rhythm of shoulder movement and presence of a painful arc on 
active abduction was noted. Exacerbation of the pain on resisted 
abduction, external and internal rotation was assessed to determine 
involvement of the supraspinatus, infraspinatus and subscapularis tendons 
respectively. Shoulder pain on resisted forearm flexion was accepted as an 
indication of bicipital tendon involvement. Local anaesthetic infiltration 
at different sites around the shoulder was used to confirm or exclude 
suspected rotator cuff lesions (58). 
All the patients had rheumatoid factor and erythrocyte sedimentation rates 
estimated and most had X-rays of the shoulders and where indicated the 
ACJ's. 
SHOULDER CLINIC PATIENTS 
During a 2 year period, 438 patients were referred to the shoulder clinic. 
Three hundred and twenty-eight had primary shoulder disease and 64 pain 
referred to the shoulder. In 46 patients the cause of the symptoms could 
not be clearly determined (Table 4:2). Only 118 of the patients (27%) had 
the diagnosis at referral confirmed at the clinic. 
SHOULDER GROUP 
Rotator cuff lesions: Rotator cuff tendinitis was the commonest shoulder 
condition referred to the clinic, constituting 41% of the 'Shoulder Group'. 
The supraspinatus tendon was most frequently affected, although this was 
sometimes in association with infraspinatus involvement. All these lesions 
caused a painful arc on abduction. Subscapularis tendinitis was less common 
and only rarely presented with a painful arc on abduction. Thirty patients 
had mild symptoms which resolved without treatment and 6 patients refused 
local corticosteroid injections due to the pain produced by previous 
injections. The other 98 patients were treated with one or more local 
steroid injections to the subacromial bursa. Detailed follow-up was not 
carried out on all these patients, but they were offered the opportunity of 
returning to the clinic if symptoms recurred. Twenty-three patients with 
symptoms which persisted for 3 months despite therapy were included in a 
prospective therapeutic study which is discussed in detail below. 
Four patients who presented with pain and severe restriction of range of 
sudden onset were found on X-ray of the shoulder, to have extensive 
calcification of the supraspinatus tendon. A diagnosis of acute calcific 
tendinitis was made. A further 10% of patients with rotator cuff tendinitis 
had some calcification in the rotator cuff on the affected and 6% on the 
unaffected side. Complete rupture of the rotator cuff (10 patients) was 
diagnosed in those patients who were unable to initiate active abduction, 
but had a full range of passive movement. Six of the 10 patients had 
arthrography of the shoulder which confirmed the diagnosis in all cases. It 
was not possible to differentiate partial tears of the cuff from tendinitis 
and all the patients were included in the tendinitis group. Complete 
rupture of the cuff failed to respond to local steroid injections and 1 
patient required a surgical repair. The others learnt to live with the 
disability. 
Bicipital tendinitis: This lesion was difficult to diagnose clinically. 
Pain induced by flexion of the forearm against resistance was considered to 
be the only reliable sign. Tenderness over the bicipital groove was not a 
consistent finding. Rupture of the long head of the biceps tendon occurred 
spontaneously in 2 patient and followed steroid injection in a further 4 
cases. 
Frozen shoulder: Of the 78 patients (24% of the 'Shoulder Group') with a 
painful stiff shoulder (PSS), only 10 were related to trivial traumatic 
incidents. The PSS which followed severe trauma was not included in this 
group. Six PSS patients had diabetes mellitus, 3 thyroid disease, 6 angina 
pectoris and 12 systemic hypertension. In 1 patient the PSS followed 6 
weeks after a cerebrovascular accident and in another case it followed 
herpes zoster involvement of the TS dermatome on the affected side. Many of 
the frozen shoulder patients were included in the detailed studies of this 
condition and will be considered below. 
Hand-shoulder syndrome: A PSS in association with pain, stiffness and 
swelling of the hand was found in 4 patients. Three followed acute 
myocardial infarction and 1 arose spontaneously. 
Arthritis: 
pathology. 
The acromioclavicular joint (ACJ) was a common site of 
Twenty lesions followed trauma and 30 arose spontaneously - 18 
being in manual workers. The clinical diagnosis of this lesion was usually 
easy and X-ray confirmation of ACJ arthritis was obtained in 87% of cases. 
Local steroid injections into the ACJ improved 30 of he 41 patients who 
received this therapy, but symptoms recurred within 2 months in at least 16 
cases (11 manual workers), who had severe and prolonged disability. 
Glenohumeral arthritis was an uncommon cause of localised shoulder pain. 
Osteoarthritis was noted on X-ray in 6 patients, 4 having Heberden's nodes 
or involvement of other peripheral joints. Only 3 patients had an 
inflammatory polyarthropathy, 2 with a positive rheumatoid factor. Two 
patients had a rapidly progressive destructive arthritis of both 
glenohumeral joints fitting the syndrome of 'Milwaukee Shoulder' (175). All 
these joints had tense blood-stained effusions containing hydroxyapatite 
crystals. 
Traumatic lesions: Patients with serious traumatic lesions usually present 
to casualty or orthopaedic departments. Only 4 patients with chronic pain 
and restriction of range following severe trauma presented to the shoulder 
clinic. Fracture through the humeral head or neck was noted in all 4 cases. 
It was not possible to identify any specific lesion in three other patients 
who complained of pain following less severe trauma and symptoms resolved 
without treatment. 
Periscapular myalgia: A constant ache in the periscapular muscles 
associated with mild kyphosis of the thoracic spine and forward drooping of 
the shoulders was noted in 15 patients. Tenderness could be elicited at the 
lateral edge of the scapula with exacerbation of the pain by abduction of 
the shoulder. Local corticosteroid injection under the scapula usually 
resolved the lesion, but postural retraining was important in preventing 
recurrence of symptoms. 
Miscellaneous: Uncommon causes of shoulder pain seen at the clinic included 
subscapularis nerve palsy, infection, humeral cyst, tumour and avascular 
necrosis. X-ray of the shoulder was diagnostic in most cases. 
REFERRED PAIN GROUP 
Sixty-four patients (15% of all the cases) had shoulder pain of a referred 
nature, 53 (83%) being due to cervical spondylosis with or without 
neurological abnormalities in the upper limb. Pain could usually be induced 
or exacerbated by moving the neck to the limits of its range. Nearly 50% of 
these patients had failed to recognise any pain or limitation of neck 
movement. X-ray of the cervical spine was sometimes helpful in confirming 
the diagnosis. 
Secondary deposits of tumour in the cervical spine and visceral malignancy 
with shoulder tip pain was diagnosed in 4 patients. Polymyalgia rheumatica 
and the fibrositis syndrome also occasionally presented at the clinic. 
UNDETERMINED GROUP 
In 46 patients it was impossible to determine the source of the pain. Eight 
were obese females with pain in the line of the brassiere straps. Weight 
reduction, postural retraining and alteration in the brassiere strap tension 
resulted in improvement in the symptoms. In 32 cases the lesion was complex 
with both features of rotator cuff and cervical spine disease being present. 
The exact contribution of each lesion could not be determined. In the other 
6 patients no signs of pathology were detected and no explanation for the 
shoulder pain was uncovered. 
DISCUSSION 
This brief survey of patients seen at the shoulder clinic is not intended to 
be an exhaustive study of shoulder lesions and their therapy and may not 
reflect the incidence of different shoulder conditions in the orthopaedic or 
general rheumatology clinics. The value of the clinic was to confirm (58) 
that most shoulder lesions can be diagnosed by careful clinical assessment. 
Many shoulder lesions resolved spontaneously or with local steroid 
injections and did not pose a major clinical problem. However, lesions 
which persisted for at least 3 months despite therapy resulted in serious 
disability and were therefore selected for detailed study. 
TABLE 4: 1 
CAUSES OF SHOULDER PAIN 
A. SHOULDER GROUP 
INTRACAPSULAR 
EXTRACAPSULAR 







2. Frozen shoulder 
3. Trauma 
1. Rotator cuff tendinitis 
2. Rotator cuff rupture 
3. Acromioclavicular arthritis 
4. Periscapular myalgia 
5. Other miscellaneous causes 
1. Cervical spondylosis 








SHOULDER CLINIC PATIENTS 
SHOULDER GROUP (N = 328) No. of Patients 
ROTATOR CUFF LESIONS 
Supraspinatus tendinitis 96 
Infraspinatus tendinitis 20 
Supra and infraspinatus tendinitis 11 
Subscapularis tendinitis 7 
Acute calcific tendinitis 4 
Rupture of rotator cuff 10 




HAND-SHOULDER SYNDROME 4 
ACROMIOCLAVICULAR ARTHRITIS 50 
GLENOHUMERAL ARTHRITIS 
Osteoarthritis 6 
Rheumatoid arthritis 3 
Milwaukee shoulder 2 
TRAUMATIC LESIONS 
Severe trauma 4 
Mild sprain 3 
PERISCAPULAR PAIN 15 
SUBSCAPULARIS NERVE PALSY 2 
MISCELLANEOUS 7 
REFERRED PAIN GROUP (N = 64) No. of Patients 
CERVICAL SPINE 





POLYMYALGIA RHEUMATICA 4 
FIBROSITIS 3 
UNDETERMINED (N = 48) 






























The complexity of shoulder movement and the difficulty in the measurement of 
its range has resulted in a paucity of knowledge with regard to the normal 
range and factors that influence this in the general population. The 
American Academy of Orthopaedic Surgeons (6) described an approach for the 
documentation of shoulder movement and the average range in the general 
population. They recognised the importance of differentiating glenohumeral 
from total range but did not base their findings on population studies or 
describe a method for the accurate recording of each movement parameter. 
Freedman and Munro (87) used a radiological and Doody et al (71) a 
goniometric method for the measurement of shoulder elevation, but neither 
proved suitable for routine use. Lee et al (152) and Allander et al (2) 
described methods for recording shoulder rotation, but both were cumbersome 
and failed to give reproducible results. Nevertheless Allender's population 
survey did suggest a decrease in passive rotation with age and a lesser 
range in males when compared to females and the left when compared to the 
right shoulder. Beighton et al (14) also found a decrease in range with age 
and a difference between the dominant and non-dominant shoulders. 
Clarke et al (41) used a spirit goniometer to measure the passive range of 
movement in normal controls. Their method was reproducible and showed a 
definite decrease in range with age, females having a superior range to 
males for any given age group. They found no difference between the 
dominant and non-dominant sides. However, they only measured glenohumeral 
abduction, external and total rotation and failed to report their findings 
in sufficient detail to determine the variatton in range in the normal 
population. The passive range was therefore assessed in a group of healthy 
people of similar age to the shoulder patients using a spirit goniometer 
modified from that used by Clarke, but considering 6 movements - total and 
glenohumeral abduction and flexion, external and total rotation. 
THE CONTROLS 
Seventy-six normal people aged from 42 - 75 years (Figure 5:1) had the 
passive range of movement of both shoulders measured with a spirit 
goniometer using an identical method to that of the frozen shoulder patients 
(see Chapter 6). Forty-two of the controls were carefully age (within 2 
years) and sex-matched to the Major Frozen Shoulder Study patients (see 
below) to provide a specific control group for clinical and laboratory 
aspects of the study. The controls were drawn from hospital staff and their 
relatives and other hospital visitors who volunteered to help in the study. 
All the controls were in good health with no shoulder pain and no past 
history of shoulder pain or injury or other joint disease. 
Age and Sex: The mean and the maximum and minimum limits of the range for 
each individual movement parameter (both shoulders) in the female and male 
controls is shown (Table 5:1). The females had a better range in all age 
groups, the difference increasing with age. 
Ignoring age, a comparison between the females and males (Table 5:2), using 
unpaired t-tests and 150° of freedom, showed a significant advantage 
(p<0.001) for the females for all movements, glenohumeral and total. 
Comparison of the mean range of each movement parameter in male and female 
controls in the different age groups showed the greatest difference between 
the sexes in patients over 60 years, although young males (under 50) had a 
poor range of rotation (Table 5:3). 
Performing a linear regression against age for males and females, 
significant decreases (p<0.001) in the range of total flexion (Figure 5:2), 
total abduction (Figure 5:3), total rotation (Figure 5:4) and external 
rotation (Figure 5:5) occurred with increasing age. The decrease in range 
in the males was greater than in the females for total flexion and abduction 
but not rotation. 
Arm Dominance: The range of movement in the controls was compared using 
unpaired t-tests for dominant and non-dominant (Table 5:4) and also for 
right and left shoulders (Table 5:5). No significant differences were noted 
between the groups. Rotation and forward flexion was slightly better in the 
left or non-dominant shoulder and abduction was better in the right or 
dominant side. Twelve of the controls were left dominant. 
The Major Frozen Shoulder Study Control Group: The mean and maximum and 
minimum range of movement in the right shoulder of the 42 patients who were 
age and sex-matched to the Major Frozen Shoulder Study patients was very 
similar to the range in the right shoulders of the entire control group 
(Table 5:6). 
DISCUSSION 
Detailed analysis of the movement in the normal controls has confirmed (2, 
14, 41) that females of all ages have a superior range to males and that the 
decrease with age is more marked in the males. The younger males (less than 
50 years) had a particularly poor range of rotation which was thought to be 
due to their increased muscle bulk, as many of these controls were manual 
workers. The dominance of the arm was not found to influence the range of 
movement in the normal population in either sex. 
TABLE 5: 1 
RANGE OF SHOULDER MOVEMENT IN THE NORMAL CONTROLS OF DIFFERENT AGE 
AND SEX (BOTH SHOULDERS) 
40 - 49 YEARS 50 - 59 YEARS 60 - 74 YEARS 
Female Male Female Male Female Male 
Number of 16 18 38 20 32 28 
Shoulders 
TF Mean 176° 171 ° 170° 166° 164 ° 158° 
Range 170-180 165-180 150-180 155-175 150-180 140-170 
GF Mean 90° 88° 95° 90° 86° 76° 
Range 80-100 80-100 80-100 80- 95 65-100 60- 90 
TA Mean 172° 165° 166° 161° 161° 153° 
Range 160-180 155-170 140-180 150-175 150-180 130-140 
GA Mean 85° 85° 83° 82° 78° 66° 
Range 80- 90 80- 95 70-100 65- 90 65-100 50- 90 
ER Mean 74° 54° 69° 63° 61° 49° 
Range 60- 90 45- 70 50- 90 50- 75 45- 80 40- 60 
TR Mean 173° 158° 170° 165° 158° 147° 











COMPARISON OF RANGE IN FEMALE (F) AND MALE (M) CONTROLS 
Mean Difference in Range 
















COMPARISON OF RANGE IN FEMALE (F) AND MALE (M) CONTROLS 
ACCORDING TO AGE 
Mean Difference in Range Unpaired T-test 
(F - M) DF T p< 
40-49 YEARS 32 
TF 4.3° 2.886 0.01 
TA 7.5° 3.942 0.001 
ER 20.8° 7.400 0.001 
TR 15.9° 7.017 0.001 
50-59 YEARS 56 
TF 3.9° 1.624 N/S 
TA 5.4° 2.317 0.05 
ER 6.2° 2.357 0.05 
TR 2.5° 0.548 N/S 
6o+ YEARS 58 
TF 6.2° 3.185 0.001 
TA 8.2° 3.610 0.001 
ER 11. 9° 5.264 0.001 
TR 11.5° 4.757 0.001 






COMPARISON OF NON-DOMINANT (N-D) AND DOMINANT (D) SHOULDERS 
IN CONTROLS 
Mean Difference in Range 














N/S = Not Significant 
TABLE 5:5 






Mean Difference in Range 










o. 806 N/S 
o. 904 N/S 
TABLE 5:6 
MEAN (AND MAXIMUM AND MINIMUM) RANGE IN THE RIGHT SHOULDER OF ALL 
CONTROLS AND OF THE CONTROLS WHO WERE AGE AND SEX-MATCHED TO THE 







Major Frozen Shoulder 
Study Controls 
(N = 42) 
Mean (Range) 
167° (145 - 180) 
90° ( 65 - 105) 
163° (140 - 180) 
83° ( 60 - 100) 
65° ( 40 - 90) 
164° (140 - 180) 
All Controls 
(N = 76) 
Mean (Range) 
166° (140 - 180) 
87° ( 65 - 105) 
163° (140 - 180) 
79° ( 60 - 100) 
61 o ( 40 - 90) 
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FIGURE 5 I. Shoulder controls according to sex and age. 
FIGURES 5 : 2 - 5. THE RANGE OF MOVEMENT IN THE CONTROLS (RIGHT 
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F I G U R E 5 5. External rotation. 
PART III 
THE PAINFUL STIFF (FROZEN) SHOULDER 
CHAPTER 6 
FROZEN SHOULDER: CLINICAL ASSESSMENT AND 
FROZEN SHOULDER STUDY GROUPS 
Periarthritis humero-scapularis (73), checkrein shoulder (221), adhesive 
capsulitis (199) and frozen shoulder (45) are some of the terms applied to 
describe the painful stiff shoulder. Whether all refer to the same 
condition is uncertain, as few of the reports have defined the patient 
populations studied. This has resulted in problems in comparative 
assessment of the different studies. The intention of this present work was 
to study patients at the more severe end of the spectrum of the painful 
stiff shoulder. Frozen shoulder (F/S) and painful stiff shoulder (PSS) will 
be used synonymously. 
INCLUSION CRITERIA: 
1. Shoulder pain for at least one month with night pain resulting in sleep 
disturbance and an inability to lie on the affected shoulder. 
2. All active and passive movements restricted with passive external 
rotation reduced by at least 50% when compared to the opposite side or age 
and sex-matched controls. In the 'Major Frozen Shoulder Study' (see below) 
total abduction also had to be 100° or less. 
3. Onset of symptoms spontaneous or following trivial trauma. 
EXCLUSION CRITERIA: 
1. Cervical spondylosis, neurological abnormality in the upper limbs or 
radiation of pain up to the neck or below the elbow. 
2. Clinical or radiological evidence of a generalised arthropathy, 
glenohumeral or acromioclavicular arthritis. 
3. Severe injury to soft tissue, fracture of the humerus or dislocation of 
the shoulder joint. 
4. PSS precipitated by cerebrovascular accident, myocardial infarction, 
loss of consciousness or other diseases. 
S. Severe systemic illness such as malignancy, chronic infection or 
connective tissue disease. 
6. Symptoms for more than 12 months or where therapy such as local steroid 
injections or physiotherapy had already begun. 
7. Positive rheumatoid factor. 
CLINICAL ASSESSMENT: 
The patients were considered with regard to their eligibility for inclusion 
in the studies. The protocol for clinical assessment is shown in Appendix 
I. The clinical features at presentation with possible relevance to the 
rate and extent of recovery were age, sex and dominance of the affected 
shoulder. The occupation, hobbies, type of onset (traumatic or spontaneous) 
and duration of symptoms at presentation was also noted. 
The clinical features for serial assessment were:-
Pain: Pain was particularly severe at night and on movement but an ache 
often persisted even when sitting at rest during the day. Ten centimetre 
horizontal visual analogue scales were used to quantify the severity of pain 
'at night', 'on movement' and 'at rest'. The duration before patients were 
able to lie on the affected shoulder and the analgesic consumption from the 
previous visit was also recorded. 
Pain on 'resisted' abduction, external and internal rotation: This was 
assessed on examination • . 
Passive range: A spirit goniometer similar to that described by Clarke et 
al (41) was strengthened and fitted with a curved perspex base and velcro 
straps and was used to measure the range of movement in the frozen shoulder 
studies. Although both the active and passive range was recorded, only the 
passive range was used for serial assessment. Six passive movements were 
measured. Abduction and forward flexion were recorded with the patient 
seated in an upright position and with the goniometer attached to the upper 
arm. For flexion it faced forward and for abduction laterally. For total 
flexion (TF) and total abduction (TA) the shoulder was moved as far as 
possible without restraint. Measurement of glenohumeral flexion (GF) and 
abduction (GA) was similar but with the observer exerting firm pressure over 
the acromion to prevent scapula movement. Passive external rotation (ER) 
and total rotation (TR) were recorded with the patient lying supine with the 
goniometer attached to the dorsal aspect of the forearm, ER being measured 
with the upper arm held against the side of the body and the elbow flexed to 
0 0 90 • For TR the shoulder was abducted to 90 or as far as possible and 
rotated from full internal to full external rotation. Internal rotation 
(IR) was recorded using the highest vertebral level reached by the extended 
thumb in the "Major Frozen Shoulder Study" and by the distance (in cm) from 
the extended thumb to the spine of the 7th cervical vertebra in the 
"Supplementary Frozen Shoulder Study Group". All measurements were 
0 
performed twice, and if they differed by more than 5 they were repeated 
once more and the mean of the closest 2 observations was taken. The passive 
range of the opposite shoulder was recorded on each occasion to provide a 
within-patient control to detect change in the goniometer function. 
RELIABILITY OF CLINICAL PARAMETERS 
Pain scores: Many of the patients reported difficulty in transcribing their 
verbal descriptions of pain to the visual analogue scales, so that these 
could not be used in isolation in the assessment of recovery. 
Passive range: Twenty patients had the passive range of movement recorded 
by 2 independent observers (A & B) using the method described above. 'Sign' 
test comparison of the measurements by the 2 observers (Table 6:1) showed no 
significant differences at the 5% level for any movement parameter except 
internal rotation (measured in ems below C7 vertebra). A paired t-test 
analysis (Table 6:2) produced similar results. As internal rotation did not 
give reproducible results, it was not used in the routine assessment. 
FROZEN SHOULDER STUDY GROUPS 
A. The Major Frozen Shoulder Study: Forty-five patients were recruited 
into the study but 3 withdrew within 6 weeks and were excluded from the 
analysis. The reasons for withdrawal were pain induced by the arthrogram (1 
patient), desire for physiotherapy elsewhere and 1 patient moved away from 
the area. The patients took 18 months to recruit, emphasising that the 
frozen shoulder using the strict criteria for diagnosis, is not all that 
common. The Major Frozen Shoulder Study patients were subjected to detailed 
investigations at presentation and were followed up weekly for 6 weeks and 
then monthly for a further 6 months. Many of the investigations (see below) 
were then repeated at the end of this time. Forty of the patients were also 
re-examined 40-48 months (mean 44 months) after their initial presentation. 
The investigations performed at presentation(** repeated after 8 months) 
were: 
1. Haematology ** - haemoglobin; white cell count; erythrocyte 
sedimentation rate. 
2. Biochemistry** - blood glucose; thyroid function tests. 
3. Immunology ** - immunoglobulin classes; immune complex levels; 
C-reactive protein levels; lymphocyte numbers, sub-populations and 
transformation studies; complement levels; tests for anti-nuclear antibodies 
and rheumatoid factor. 
4. HLA Typing for A and B loci antigens. 
5. Radiology - plain X-rays of both shoulders and acromioclavicular joints; 
technetium diphosphonate scans; arthrography of the affected shoulder. 
Patients were randomly allocated to 1 of 4 treatment groups according to a 
pre-arranged randomisation schedule. Eleven patients had steroid injection 
therapy, 11 mobilisation physiotherapy and 12 ice-pack treatment. Eight 
patients were given no specific therapy. All the patients were encouraged 
to perform home pendular exercise for 2-3 minutes each hour during waking 
hours. 
B. The Supplementary Frozen Shoulder Study: A further 40 patients with 
frozen shoulder were included in the Supplementary Study comparing oral 
prednisolone therapy to no specific treatment. Hourly home pendular 
exercise was again encouraged. Patients were randomly allocated to one or 
other treatment group and were followed up fortnightly for 6 weeks and then 
monthly for a further 6 months. Investigations at presentation were 
erythrocyte sedimentation rate, rheumatoid factor and plain X-ray of the 
shoulders. 
TABLE 6: 1 
COMPARISON OF INDIVIDUAL SHOULDER RANGE PARAMETERS BY TWO 
INDEPENDENT OBSERVERS USING THE 'SIGN' TEST 
Movement +ve's Zero 
, +ve' s + , +ve's Probability -ve s -ve s 
(2-sided) 
* TF 8 8 4 12 8 0.40 
* GF 6 8 6 12 6 1.00 
* TA 6 9 5 11 6 1.00 
GA 8 8 4 12 8 0.40 * 
* ER 4 7 9 13 4 0.08 
* TR 3 8 9 12 3 0.15 
IR 11 7 2 13 11 0.05 
*=Not Significant 
TABLE 6: 2 
PAIRED T-TEST COMPARISION OF INDIVIDUAL SHOULDER RANGE PARAMETERS 
BY TWO INDEPENDENT OBSERVERS 
Movement Observer Mean Range Paired T-test 
, A' , B, T20 p< 
TF 100. 8° 98.8° 1. 773 N/ S 
GF 57.3° 57 .o 0 0.463 N/S 
TA 82.8° 82.6° 0.002 N/S 
GA 47.3° 46.5° 1.165 N/S 
ER 15.5° 18.5° -1. 7 38 N/S 
TR 61.5° 63.8° -1. 584 N/S 
IR 20. 7 11. 8 3.593 0.05 
(cm) 
N/S = Not Significant 
CHAPTER 7 
FROZEN SHOULDER AT PRESENTATION 
The 82 patients included in the Major and Supplementary Frozen Shoulder 
Study groups will be considered together, but important differences between 
the groups will be noted. Patient details are shown in Table 7:1. 
GENERAL FEATURES 
Age and Sex: 52 patients (63%) were female and 30 (37%) male. Patients 
were aged from 44 - 76 years (mean 55.S years). The mean age in females was 
54.8 years and in males 57.S years. The age distribution in both sexes 
(Figure 7:1) was similar with 28 females (54%) and 17 males (57%) presenting 
between the ages of 50 - 60 years. 
Arm Dominance: 47 patients (57%) had non-dominant and 35 (43%) dominant arm 
involvement. 23 females (44%) and 12 males (40%) had dominant and 29 
females (56%) and 18 males (60%) non-dominant lesions. The non-dominant arm 
was therefore more common in both sexes. 
Occupation: At the onset of symptoms, 17 patients were performing heavy 
manual labour, 7 involving toolwork, bricklaying or painting and decorating 
(Table 7:2). A further 16 patients did only light manual labour such as 
driving a lorry, nursing or engineering. The other 49 were housewives, 
sedentary workers or were unemployed. There was no association between 
occupation and the arm dominance of the lesion (Table 7:3). 12 patients who 
performed light or heavy manual labour stopped work before presentation 
because of shoulder pain. Most patients also reported an inability to 
perform housework, carry heavy loads and perform many other normal daily 
activities. 
Hobbies: Gardening, home improvements, knitting and sport were the most 
common hobbies undertaken by the patients (Table 7:4). While over 40% of 
patients were able to continue gardening and knitting, few were able to 
continue with home improvement or sporting activities. 
Unassociated Disease and its Therapy: 
(a) Active Disease: At presentation 5 patients were being treated for 
angina pectoris or systemic hypertension. 3 patients had thyroid disease 
requiring treatment and 1 diabetes mellitus (Table 7:5). 
(b) Inactive Disease: Cervical spine lesions, low back pain and lateral 
humeral epicondylitis were the most common conditions in the past medical 
history (Table 7:6). Other miscellaneous conditions included duodenal 
ulceration, subarachnoid haemorrage, pulmonary tuberculosis and sarcoidosis 
of the lung. 
(c) Symptoms in the Opposite Shoulder: 11 patients (13%) gave a past 
history of pain or pain and stiffness in the opposite shoulder before 
inclusion in the study (Table 7:7). 7 other patients had symptoms in the 
opposite shoulder at presentation, 2 being frozen shoulders, 3 rotator cuff 
tendinitis and 1 acromioclavicular arthritis. 
Onset of Symptoms: 16 patients (11 Major and 5 Supplementary Study 
patients) reported that symptoms followed minor trauma, usually a fall onto 
the shoulder or the outstretched arm. More severe trauma which induced 
bruising, fractures or dislocations around the shoulder resulted in patient 
exclusion. Of the other 66 patients in whom the condition arose 
spontaneously, 55 could not attribute the symptoms to any cause, 3 followed 
stretching awkwardly, 2 each driving, painting and decorating or lifting a 
heavy load and 1 hedge clipping. In one patient symptoms followed 2 months 
after a herpes zoster infection of the eighth thoracic dermatome on the same 
side as the frozen shoulder. Of the 66 patients with a spontaneous onset of 
symptoms, 11 lesions began from January - March, 18 from April - June, 22 
from July - September and 15 from October - December. 
Only 7 of the 82 patients (9%) admitted to any shoulder pain before the 
onset of the frozen shoulder. The duration of this pain varied from 2 weeks 
to 3 years (mean 6.6 months), but only 2 patients sought medical aid for 
these symptoms. 
Duration of Symptoms: All the patients in the Major and Supplementary 
Frozen Shoulder groups were seen from 1 - 12 months after the onset of 
symptoms (Figure 7:1). 31 patients were seen between 1 - 3 months, 35 from 
4 - 6 months and the other 16 from 6 - 12 months after the onset. The 
general practitioners were circulated before the Major Study, thus more 
patients in this group were seen within 3 months (Table 7:8). Patients with 
a traumatic onset (mean 3.3 months) presented earlier than those with a 
spontaneous onset (mean 5.9 months). 
Treatment for Shoulder Symptoms Before Referral: Non-steroidal 
anti-inflammatory agents (NSAIDS) were prescribed to 51 of the 82 (62%) 
frozen shoulder patients, but only 5 of these patients (10%) found them 
beneficial (Figure 7:2). In contrast, 17 of 33 patients (52%) who received 
simple analgesic agents found them helpful - particularly in the reduction 
of night pain. Topical (counter-irritation) creams, infra-red lamps and 
slings were occasionally prescribed. 9 patients were still taking NSAIDS 
and 24 analgesic tablets at the time of presentation, although many patients 
did not regard the tablets as effective (Figure 7:3). 
16 patients (20%) had no therapy before referral and 46 (56%) were taking no 
therapy at presentation. The mean duration of symptoms at presentation was 
3.8 months in the untreated patients. 
Of the 82 patients studied, 10 had been advised to exercise the shoulder 
despite the pain, 12 to use the shoulder normally but avoid undue strain and 
5 to rest the shoulder. 55 patients had been given no advise regarding use 
of the shoulder. 
SYMPTOMS AT REFERRAL 
A. Pain Score: The severity of pain at rest, on movement and at night 
varied greatly from patient to patient, but there were no significant 
differences between the study groups (Table 7:9). The mean score for all 82 
patients was therefore calculated (Table 7:10). The severity of pain was 
not dependent on the duration of symptoms at presentation (Table 7:11) or 
whether the symptoms arose spontaneously or following trauma (Table 7:12). 
Dominant or non-dominant arm involvement also did not influence the initial 
severity of the pain. 
B. An Inability to Sleep on the Affected Shoulder: This was found at 
presentation in 78 of the 82 (95%) patients. 
FEATURES ON EXAMINATION 
A. Tenderness: The presence and severity of tenderness on palpation of 
the shoulder was an inconsistent and unreliable finding. 17 patients (21%) 
had slight tenderness over the greater tuberosity of the humerus and 6 (7%) 
over the lesser tuberosity, but these patients did not differ in severity 
from the other 72 patients with no localised tenderness. 
B. Pain on Resisted Movement: 77 of the 82 patients (94%) had pain 
exacerbated by resisted abduction; 75 (92%) pain on resisted external 
rotation and 72 (88%) pain on resisted internal rotation. 
C. Passive Range: As the entry criteria for the Major and Supplementary 
Frozen Shoulder Study groups differed with regard to the severity of the 
restriction of abduction, the 2 groups will be considered separately (Table 
7:13). The mean range for all the frozen shoulder patients at presentation 
is also shown. The duration of symptoms at presentation (Table 7:14) and 
type of onset (Table 7:15) did not affect the passive range of movement at 
the initial visit. 
DISCUSSION 
This study has confirmed (113, 139, 168) that the painful stiff shoulder 
(PSS) occurs over a narrow age range (50 - 70 years), with symptoms very 
rarely beginning below the age of 40 years (291). While a slight female 
preponderance was noted in agreement with the general literature, this study 
did not confirm Lundberg's (168) observation that females develop symptoms 
at a younger age. In keeping with Lundberg (168), Kessel et al (139), and 
others (46, 162, 200), but in contrast to Wright et al (291) and Sheldon 
(246), non-dominant arm involvement was more common. 
The PSS has been associated with manual labour (53, 291), but like Kozin 
(148), De Palma (63) and Herberts et al (116), there was no relationship of 
symptoms to any specific occupation or hobby. There was also no 
confirmation (168) of a seasonal variation in the onset of symptoms. 
Unlike several other reported series (179, 246, 263, 291) and possibly as a 
reflection of the stringent entrance criteria used, the patients were in 
good general health. However, this study did confirm (63, 168, 228, 233, 
246) that symptoms were common in the opposite shoulder, but were rarely 
evident on the affected side (233) in the weeks or months preceding the 
onset of the frozen shoulder. 
Minor trauma was an infrequent precipitating factor for the PSS (233, 291) 
and the only difference at presentation between the traumatic and 
spontaneous lesions, was that those following trauma presented earlier in 
the course of the disease. 
Non-steroidal anti-inflammatory agents are still the mainstay of general 
practitioner therapy of the PSS, but were ineffective in most the trial 
patients. Reported studies (72, 130, 229) have compared two or more of 
these agents to each other, but several of these authors have doubted their 
value in this condition. A higher proportion of the patients who used 
simple analgesic agents found them of value, particularly in the 
amelioration of pain at night. Few of the patients had been given any 
advice regarding the need to gently move the shoulder and several had been 
told to avoid any movement of the affected limb. 
The clinical details at presentation of a group of patients with the PSS has 
been documented to permit their careful prospective study. 
TABLE 7: 1 
CLINICAL DETAILS OF FROZEN SHOULDER PATIENTS AT PRESENTATION 
Major F/S Study Supplementary 
F/S Study 
(N = 42) (N = 40) 
Sex - F :M 28 : 14 24 : 16 
Age range in years (Mean) 44 - 74 (55.5) 45 - 76 (54.8) 
Onset - spontaneous:traumatic 28 14 36 4 
Arm - dominant:non-dominant 22 20 13 27 
Duration of symptoms in months (Mean) 1 - 12 (4.8) 1 - 12 (5.5) 
TABLE 7: 2 
OCCUPATION OF FROZEN SHOULDER PATIENTS AT THE ONSET OF SYMPTOMS 
(N = 82) 
Occupation No. of % of N 
Patients 
Housewife 25 30% 
Non-manual 24 29% 
Light manual 16 20% 
Heavy manual 17 21% 
TABLE 7:3 








(N = 47) 
18 
29 
X~ With Yates Correction= 0.0356 (Not Significant) 
TABLE 7:4 
MORE COMMON HOBBIES UNDERTAKEN BY FROZEN SHOULDER PATIENTS 
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ACTIVE MEDICAL CONDITIONS AND THERAPY IN FROZEN SHOULDER 


























MEDICAL CONDITIONS IN THE PAST IN FROZEN SHOULDER PATIENTS 
Condition 










SYMPTOMS IN THE OPPOSITE SHOULDER BEFORE OR AT THE TIME 
OF PRESENTATION (N = 82) 
Shoulder Pain 










DURATION OF SYMPTOMS AT PRESENTATION IN THE MAJOR AND 
SUPPLEMENTARY FROZEN SHOULDER GROUPS 
Major Frozen Supplementary Frozen 
Duration at Presentation Shoulder Study Shoulder Study 
(N = 42) (N = 40) 
No. % No. % 
1 - 3 months 20 (48%) 11 (27%) 
4 - 6 months 14 (33%) 21 (53%) 
6 - 12 months 8 (19%) 8 (20%) 
TABLE 7:9 
MEAN PAIN SCORES FOR PAIN AT REST, ON MOVEMENT AND AT NIGHT IN 
MAJOR AND SUPPLEMENTARY FROZEN SHOULDER STUDY PATIENTS (N = 82) 
Mean Score in Mean Score in Unpaired T-test 
Major F/S Study Supplementary Tso 
F/S Study 
Pain at rest 2.83 3.40 1.540 
Pain on movement 6.33 6.19 -0.278 
Pain at night 5.74 6.06 0.615 
N/S = Not Significant 
TABLE 7: 10 
MEAN PAIN SCORE AT PRESENTATION FOR PAIN AT NIGHT, AT REST 
AND ON MOVEMENT IN ALL THE FROZEN SHOULDER PATIENTS (N = 82) 
Pain at rest 
Pain on movement 














TABLE 7: 11 
ASSOCIATION BETWEEN THE DURATION OF SYMPTOMS AND SEVERITY 
OF PAIN AT PRESENTATION 
1-3 Months 4-6 Months 7-12 Months 
(N=31) (N=34) (N=l 7) 
Mean (SEM) Mean (SEM) Mean (SEM) 
Pain at rest 3.26 (0. 23) 2.97 (0.24) 3.12 (0.46) 
Pain on movement 6.29 (0.43) 5.99 (O. 45) 6.76 ( 1. 64) 
Pain at night 6.21 (O. 47) 5.71 (0.38) 5.71 (0.56) 
TABLE 7: 12 
ASSOCIATION BETWEEN THE TYPE OF ONSET (TRAUMATIC OR SPONTANEOUS) 
AND SEVERITY OF PAIN AT PRESENTATION 
Pain at rest 
Pain on movement 













TABLE 7: 13 
PASSIVE RANGE OF SHOULDER MOVEMENT IN THE MAJOR AND SUPPLEMENTARY 
FROZEN SHOULDER GROUPS AT PRESENTATION 
Major F/S Group Supplementary All F/ S 
F/S Group Patients 
(N = 42) (N = 40) (N = 82) 
Mean (Range) Mean (Range) Mean 
TF 99° (50-135) 106° (60-145) 103° 
GF 51° (40- 70) 68° ( 40- 80) 60° 
TA 69° (20-110) 79° (40-130) 74° 
GA 40° ( 0- 70) 46° ( 20- 75) 43° 
ER 130 ( 0- 35) 21° ( 0- SO) 170 










PASSIVE RANGE OF MOVEMENT IN FROZEN SHOULDER PATIENTS OF 
VARYING DURATIONS OF SYMPTOMS AT PRESENTATION 
1-3 Months 4-6 Months 7-12 Months 
(N = 31) . (N = 35) (N = 16) 
Mean (SEM) Mean (SEM) Mean (SEM) 
99.7° (3. 8) 105.6° (3. 3) 105. 9° (6.9) 
71.8° (5.0) 79.3° (3.0) 77.2° (8.8) 
20.3° (2.4) 16.0° (2.1) 12. 8° (2.1) 
46.6° (3. 5) 51.2° (3. 3) 57.5° (6.4) 
TABLE 7: 15 
PASSIVE RANGE OF MOVEMENT AT PRESENTATION IN PATIENTS WITH 
A SPONTANEOUS AND TRAUMATIC ONSET OF SYMPTOMS 
Spontaneous Onset Traumatic Onset Unpaired T-test 
(N = 66) (N = 16) 
Mean (SEM) Mean (SEM) Tso p< 
105.4° ( 2. 7) 95.3° (4.5) 1. 665 N/S 
77 .9° (3.0) 68.4 ° (7.6) 1.323 N/ S 
16.7° (1. 5) 18.1° ( 2. 7) -0. 401 N/S 
48.9° (2.8) 57.8° (6.5) -1. 349 N/S 
N/S = Not Significant 
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FIGURE 7 : I. The distribution of frozen shoulder patients 











• therapy stopped 
D therapy continued 
46 
number of patients 
FIGURE 7 : 2. Initial treatment prescribed by general 
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FIGURE 7 : 3. Treatment being taken at the first out-patient 
visit. (NSAID = non-steroidal anti-inflammatory drug ). 
CHAPTER 8 
FROZEN SHOULDER DURING THE FIRST 8 MONTHS FOLLOW-UP 
Few studies have considered the rate of recovery of the frozen shoulder and 
the factors which may affect this. Lee et al (153) reported the use of 
multivariate analysis to simplify analysis of the recovery of the range of 
movement in different treatment groups. As the patients in the Major and 
Supplementary Frozen Shoulder Groups differed slightly with regard to entry 
criteria and timing of follow-up visits they will be considered separately. 
Therapy will be ignored but where a parameter was unevenly distributed 
amongst the treatment groups, it will not be considered. 
ASSESSMENT OF RECOVERY The two main symptoms in the frozen shoulder are 
pain and restriction of range. 
Pain: The severity of pain at night, at rest and on movement was assessed 
using 10 cm horizontal visual analogue scales (VAS) as previously described. 
To simplify the analysis of improvement in pain, a 'pain score' was 
formulated from the sum of these 3 VAS's. The mean difference between 
consecutive visits was then used to plot recovery curves. 
In addition to the VAS's - the other parameters to assess pain were the 
duration before (a) patients felt they were much improved 
(b) able to sleep on the affected shoulder 
(c) lost pain on resisted movements 
(d) stopped using analgesics. 
Range of Movement: The recovery in the passive range of movement between 
consecutive visits was analysed using multivariate analysis. The principal 
component (C) was based on the range of movement at the initial visit. As 
this range was different in the Major and Supplementary Frozen Shoulder 
groups, different formulae were calculated for the two studies. In the 
Major Frozen Shoulder Study, the principal component (C) = (0.536 x total 
flexion) + (0.201 x glenohumeral flexion) + (0.679 x total abduction)+ 
(0.263 x glenohumeral abduction)+ (0.079 x external rotation)+ (0.369 x 
total rotation) - 137.7. C accounted for 58.6% of the total variation in 
range between the patients at the initial visit. 
In the Supplementary Frozen Shoulder Study group, C = (0.506 x TF) + (0.215 
x GF) + (0.583 x TA)+ (0.253 x GA)+ (0.124 x ER)+ (0.528 x TR) - 163.388. 
In this study, C accounted for 57.25% of the variation between patients at 
the initial visit. The three major components - TF, TA and TR were 
therefore very comparable in the 2 studies. Using the respective formulae, 
the principal component was calculated for each patient at each visit. From 
this data the difference between consecutive visits was found. Recovery 
curves were then plotted from the mean cumulative change, so a higher value 
of C signified an improvement and a lower value of C, a deterioration in the 
passive range of movement. 
Follow-up: The Major Frozen Shoulder patients were seen weekly for 6 weeks 
and then .monthly for a further 6 months. The Supplementary Frozen Shoulder 
patients were seen fortnightly for the first 6 weeks and then monthly for a 
further 6 months. 
RESULTS 
A. The Improvement in Pain: The mean reduction in pain at night, at rest 
and on movement was similar in the Major (Figure 8:1) and Supplementary 
(Figure 8:2) Frozen Shoulder Study patients with the maximum improvement 
occurring within 6 weeks of inclusion in the studies. Further improvement 
continued until the end of the follow-up period. 
52 of the 82 patients (63%) reported the pain as 'much improved' by 3 months 
and 69 (85%) by 6 months (Figure 8:3). 8 patients (10%) still regarded the 
pain as severe even after 8 months follow-up. With an end point of 8 months 
(the end of the study), the mean duration(+ SEM) before marked improvement 
was reported was 3.3 (+ 0.4) months in the Major and 3.1 (:t_ 0.4) months in 
the Supplementary Frozen Shoulder Study groups. Although the duration 
before patients were able to lie on the affected shoulder also varied 
greatly from patient to patient (Figure 8:4), this was very similar to when 
the patients reported the pain as 'much improved'. The mean duration (:t_ 
SEM) before patients were able to sleep on the affected shoulder was 2.7 (+ 
0.4) months in the Major and 3.0 (+ 0.3) months in the Supplementary groups. 
The loss of pain on resisted movement mirrored exactly the time before 
patients were able to sleep on the affected shoulder. 
32 patients (39%) did not use any paracetamol during the study. The other 
SO patients (61%) used the analgesic tablets for variable periods but mainly 
during the first 6 weeks of follow-up (Figure 8:5). 30 of these patients 
only used the paracetamol before retiring to facilitate sleep and the other 
20 also used analgesics during the day. 14 patients (17%) also requested 
diazepam at night to aid sleep. 2 patients regarded their NSAIDS tablets as 
effective in reducing pain and restarted this therapy. The use of 
analgesics and diazepam showed no association with the severity of pain and 
probably reflected the patients attitudes to this therapy. 
B. The Recovery of Range: The mean recovery in the range of the individual 
movement parameters was similar in the Major (Figure 8:6) and Supplementary 
Study (Figure 8:7) patients, with the most rapid improvement in the first 6 
weeks, but further recovery continuing throughout the entire period of 
follow-up. The improvement in the glenohumeral movements and external 
rotation showed greater variability between the 2 studies. 
CLINICAL FACTORS WHICH POSSIBLY INFLUENCE THE RATE OF RECOVERY: The 
importance of age, sex, arm dominance, occupation and duration of symptoms 
at presentation on the rate of recovery was considered. Whether patients 
with a traumatic onset behaved differently from those arising spontaneously 
was also assessed. Each parameter was considered both with regard to the 
reduction in pain and improvement in range between consecutive visits in the 
both studies. To simplify these analyses, pain was assessed using the pain 
score and range using the cumulative principal component (.1C). Wilcoxon 
rank sum tests were used for comparisons of the rate of recovery. 
Age: Patients aged 55 or less at presentation were compared to those aged 
56 or more. The older patients showed a small advantage in reduction of 
pain (Figure 8:8 and 8:9) and improvement in range (Figure 8:10 and 8:11) 
within the first 6 weeks, but no difference thereafter. 
Sex: The reduction in pain (Figure 8:12 and 8:13) and improvement in range 
(Figure 8:14 and 8:15) showed no consistent advantage for the male or female 
patients in either study. 
Duration at Presentation: Patients who presented within 3 months of the 
onset of symptoms showed a better initial reduction in the pain score when 
compared to patients who presented later in both the Major (Figure 8:16) and 
Supplementary (Figure 8:17) studies. The initial improvement in range was 
also better in patients who presented early in the Major (Figure 8:18) but 
not the Supplementary (Figure 8:19) study. Wilcoxon rank sum tests did not 
show the difference in the rate of recovery of pain or range to be 
significant. 
Arm Dominance: There was no significant difference in the rate of recovery 
in patients with dominant or non-dominant arm involvement (Figure 8:20-23), 
although the initial improvement in range was more rapid in patients with 
dominant arm involvement in the Major Frozen Shoulder Study. 
Occupation: The patients who resumed manual labour in the convalescent 
phase recovered as rapidly as the sedentary workers with regard to reduction 
in pain (Figure 8:24), but improvement in range (Figure 8:25) was slower 
after 3 months in the manual labourers in the Major Study. As the manual 
workers were unevenly distributed amongst the treatment groups in the 
Supplementary Study (only 2 being in the treated group), this parameter was 
not considered in this study. 
Type of Onset: Major Frozen Shoulder patients with a traumatic onset showed 
some initial advantage in the reduction in pain (Figure 8:26) and the 
recovery of range (Figure 8:27). However, by 3 months no difference was 
found between the groups. Patients with a traumatic onset presented earlier 
(mean 3.3 months) than those with a spontaneous onset (mean 5.9 months) and 
this may have accounted for at least some of the initial advantage of the 
traumatic group. As only 4 patients in the Supplementary Study had a 
traumatic onset, this parameter was not considered in this study. 
DISCUSSION 
The rate of recovery of the pain score and the range of movement within the 
first 8 months was similar in the Major and Supplementary Study patients 
despite differences in the entrance criteria and therapy. Both parameters 
showed the most rapid improvement within the first 6 weeks after inclusion 
in the studies, with continuing recovery until the end of the follow-up 
period. This supports Sheldon's (246) observation of a striking consistency 
in the time of recovery from presentation, irrespective of the duration of 
symptoms at that time. 
Because of the difficulty many patients experienced in transcribing the 
verbal descriptions of pain to the visual analogue scales, it was not felt 
reasonable to use this parameter in isolation to determine the improvement 
in pain. The duration before the pain was reported to be 'much improved', 
the ability to lie on the affected shoulder was regained and pain on 
resisted movements had been lost, showed remarkable consistency in most 
cases. Thirty-eight patients (46% of all cases) were 'much improved' and 44 
(54%) were able to sleep on the affected side and had lost the pain on 
resisted movements by 6 weeks. However, 15 patients (18%) still had severe 
pain at 6 months and this persisted in 8 case (10%) until the end of the 
follow-up period. The analgesic consumption did not reflect the severity of 
the pain, but more often the personality and individual preference of the 
patient. 
Multivariate analysis simplified the assessment of the recovery of the range 
of movement and accurately reflected the rate of improvement of the 
individual movement parameters. This supports the observation by Lee et al 
(153) and Clarke et al (42) that there is a constant relationship between 
all movements in the PSS. The continuing improvement in the range of 
movement after 8 months suggests that longer follow-up is necessary to 
determine the eventual outcome. 
There is a paucity of data on the factors which influence the rate of 
recovery of the PSS. Patients with a traumatic onset of symptoms showed a 
slight initial advantage in the rate of recovery when compared to those with 
a spontaneous onset. This may simply reflect the earlier presentation of 
these patients, for like Hazleman (113) and Roy and Oldham (238), early 
presentation was associated with a slightly better initial rate of recovery. 
However, this study has not confirmed (226) that the post-traumatic lesions 
have a radically different outcome. Clarke et al (42) reported that the 
dominant arm improved more slowly, but like Lundberg (168) this was not 
found. The patients aged 56 or more showed a slight advantage in the 
initial period, but this difference was not sustained after 3 months. 
Pain and loss of range of movement are the two cardinal features of the PSS 
and the rate of improvement of these during the first 8 months of follow-up 
has been carefully documented with a consideration of the factors which may 
influence this recovery. 
FIGURES 8: I - 2. THE IMPROVEMENT IN THE PAIN PARAMETERS 
IN THE FIRST 8 MONTHS IN THE MAJOR AND SUPPLEMENTARY FROZEN SHOULDER 
STUDIES. 
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FIGURE 8: 2. The Supplementary Frozen Shoulder Study. 
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FIGURE 8: 5. Duration of analgesic use following inclusion 
in the Major and Supplementary Frozen Shoulder Studies. 
FIGURES 8: 6 - 7. THE MEAN RECOVERY IN INDIVIDUAL MOVEMENT 
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FIGURE 8: 7. The Supplementary Frozen Shoulder Study. 
FIGURES 8 : 8 - 27. THE INFLUENCE OF CLINICAL FACTORS AT 
PRESENTATION ON THE RATE OF RECOVERY OF THE PAIN SCORE AND RANGE 
OF MOVEMENT (.dC) IN THE FROZEN SHOULDER STUDIES. 
A) PATIENT AGE IMPROVEMENT IN PAIN SCORE. 
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Frozen Shoulder Study. 
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CHAPTER 9 
FROZEN SHOULDER AT 8 MONTHS 
The natural history of the frozen shoulder is poorly documented. While 
Watson-Jones (272) reported that less than 5% of his 226 patients with 
frozen shoulder had any disability at 6 months, Simmonds (248), Clarke et al 
(42) and Reeves (228) found severe and persistent disability many years 
later. 
PATIENTS 
The 82 frozen shoulder patients in the Major and Supplementary Studies 
remained under regular follow-up for 8 months and the extent of their 
disability when compared to the normal controls (right shoulder) was 
determined at the end of this period. To permit further detailed 
comparative analysis of the Major Study patients who remained under review, 
the 2 study groups will be considered separately, again ignoring therapy. 
RESULTS 
Pain: Thirty-three of the 82 patients (40%) still had some residual pain at 
8 months, although this was worse than at presentation in only 1 patient. 
Of these 33 patients, 17 were in the Major and 16 in the Supplementary 
group. The number of patients with residual pain at night, at rest and on 
movement was similar in the 2 studies (Table 9:1). Only considering the 33 
patients with residual pain at 8 months, the severity of pain at night and 
on movement was similar in both studies (Table 9:2). However, pain at rest 
was significantly worse (unpaired t-tests, p(0.05) in the Major Frozen 
Shoulder group. 8 patients (6 Major, 2 Supplementary) still considered the 
pain severe (Figure 8:3) and 9 (6 Major, 3 Supplementary) were not yet able 
to sleep on the affected shoulder (Figure 8:4). All had pain at night and 7 
also pain on movement. 5 were taking regular analgesics and 3 nocturnal 
diazepam. 
Range: The mean and the maximum and minimum ranges of each movement 
parameter in the normal controls and the Major and Supplementary Frozen 
Shoulder groups at 8 months is shown (Table 9:3). A comparison of the range 
of movement in the controls with the Major Frozen Shoulder Group (Table 9:4) 
and the Supplementary Frozen Shoulder Group (Table 9:5), using unpaired 
t-tests, showed a highly significant advantage (p<0.0001) for the controls 
for all the movement parameters in each study. 
When the range in the patients at 8 months was compared to the controls 
matched for age (in decades) and sex, over 50% of the patients had not 
attained a range equal to the minimum of the (age, sex) matched controls in 
any movement parameter except glenohumeral flexion and abduction (Table 
9:6). Using the cumulative principal component at 8 months, 73 of the 82 
patients (89%) had not attained a range equal to the minimum of the matched 
controls. However, only 45 of the 82 patients (55%) were aware of this 
persisting restriction in range. 
The range of movement at 8 months was better in the Supplementary than the 
Major Study (Table 9:7), but the difference between the groups was only 
significant (unpaired t-tests) for total rotation (p(0.05). The recovery in 
range from presentation to 8 months (Table 9:8) showed a slight advantage 
for the Major Study, although only with glenohumeral flexion did the 
difference reach significance (p(0.05). 
Clinical Factors Which Possibly Influence The Outcome: To simplify the 
assessment of a possible influence of clinical factors on the outcome, the 
pain score (sum of pain at rest, at night and on movement) and the principal 
component (i1C) was used. There was no association between the age, sex, 
arm dominance, type of onset (traumatic or spontaneous) or the duration of 
symptoms at presentation and either the pain score or range (i1C) at 8 
months in either study (Table 9:9). However, the Major Frozen Shoulder 
Study patients who resumed manual labour in the convalescent phase had a 
significantly lower principal component at 8 months than the sedentary 
group. Significant restriction in all movements except total rotation was 
also evident at that time (Table 9:10). The pain score was also higher in 
the manual workers, but the difference did not reach significance. The 
Supplementary Study showed a similar result, but detailed analysis was not 
carried out as the manual and sedentary workers were not evenly distributed 
in the treatment groups, and a possible bias from this source could not be 
excluded. 
DISCUSSION 
Thirty-three of the patients (40%) still had some pain at 8 months, but in 
only 8 (10%) was this severe. Restriction of the range of movement on the 
other hand was present in 73 patients (89%), when compared to the minimum 
range of the controls matched for age and sex. Objective measurements of 
range showed a highly significant (p<0.0001) restriction in all the movement 
parameters when compared to the controls, refuting Watson-Jones's (272) 
contention that 95% of frozen shoulder patients regain a normal range by 6 
months. Like Allander et al (2), Clarke et al (42) and Hazleman (113), many 
of the patients who claimed they have regained full movement were found to 
have marked restriction on objective testing. 
The initial advantage in the rate of recovery within the first 6 weeks found 
in association with older patients, early presentation and lesions following 
trauma conveyed no long-term benefits to these patients. The only factor 
associated with a significantly worse outcome at 8 months was the resumption 
of manual labour in the convalescent phase. While these patients were no 
worse at presentation or at 6 weeks, they showed a slower rate of recovery 
from three months until the end of the study (Figure 8:25). This suggests 
that excessive use of the shoulder in the convalescent phase may be harmful • 
• 
TABLE 9: 1 
NUMBER OF FROZEN SHOULDER PATIENTS WITH RESIDUAL PAIN AT 8 MONTHS 
Patients with Residual Pain 
Major F/ S Study Supplementary F/S Study 
(N = 17) (N = 16) 
Pain only at night 2 2 
Pain only on movement 5 6 
Pain at night and on movement 2 5 
* Pain at rest, at night and 8 3 
on movement 
* = 1 patient worse than at presentation 
TABLE 9:2 
COMPARISON OF THE MEAN SEVERITY OF PAIN AT 8 MONTHS IN THE 
33 PATIENTS WITH RESIDUAL SYMPTOMS IN THE MAJOR AND SUPPLEMENTARY 
FROZEN SHOULDER GROUPS 
Pain at rest 
Pain at night 
Mean Severity of Pain 
Major F/S Study Supplementary F/S 
(N = 17) Study (N = 16) 
Mean (SEM) Mean (SEM) 
1.06 (0.3) 
1.29 (0.3) 








0 .101 N/S 
1.693 N/S 
TABLE 9:3 
MEAN 2 MAXIMUM AND MINIMUM RANGES OF MOVEMENT IN CONTROLS AND PATIENTS IN 
THE MAJOR AND SUPPLEMENTARY FROZEN SHOULDER STUDIES AT 8 MONTHS 
Major F/S Control Group Supplementary F/S 
Study at 8 Months Group at 8 Months 
(N = 42) (N = 76) (N = 40) 
Mean (Range) Mean (Range) Mean (Range) 
TF 144° (80-160) 167° (140-180) 150° (110-175) 
GF 74° (50- 90) 87° ( 60-100) 770 ( 70- 85) 
TA 135° ( 60-175) 163° (140-180) 140° ( 90-170) 
GA 69° (30- 85) 79° ( 50-100) 720 ( 40- 85) 
ER 41° ( 0- 70) 62° ( 40- 90) 43° ( 25- 80) 
TR 100° (50-160) 162° (135-185) 116° ( 65-165) 
TABLE 9:4 
COMPARISON OF RANGE IN THE MAJOR FROZEN SHOULDER STUDY PATIENTS 
AT 8 MONTHS (M) AND THE CONTROLS (C). 
Mean Difference in Range Unpaired T-test 
(C - M) Tll6 p( 
TF 220 11. 984 .0001 
GF 130 7.474 .0001 
TA 28° 10. 982 .0001 
GA 100 6.895 .0001 
ER 210 9.142 .0001 
TR 61° 21.746 .0001 
, 
TABLE 9:5 
COMPARISON OF RANGE IN THE SUPPLEMENTARY FROZEN SHOULDER STUDY 
PATIENTS AT 8 MONTHS (S) AND THE CONTROLS (C) 
Mean Difference in Range Unpaired T-test 
(C - S) T114 p< 
TF 170 8.848 .0001 
GF 100 6.840 .0001 
TA 220 10. 947 .0001 
GA 70 4.562 .001 
ER 90 7. 926 .0001 
TR 46° 17.473 .0001 
TABLE 9: 6 
PERCENTAGE OF PATIENTS IN THE MAJOR AND SUPPLEMENTARY FROZEN 
SHOULDER STUDIES WITH AN 8 MONTH RANGE LESS THAN THE MINIMUM FOR 
AGE (IN DECADES) AND SEX-MATCHED CONTROLS 
Major F/S Study Supplementary F/S Study 
(N = 42) (N = 40) 
N % N % 
TF 27 64% 22 55% 
GF 18 43% 9 23% 
TA 24 57% 27 68% 
GA 12 29% 7 18% 
ER 24 57% 20 57% 
TR 39 93% 34 85% 
TABLE 9:7 
COMPARISON OF THE RANGE OF MOVEMENT AT 8 MONTHS IN PATIENTS IN THE 
SUPPLEMENTARY (S) AND MAJOR (M) FROZEN SHOULDER GROUPS 
Mean Difference in Range Unpaired T-test 
(S minus M) T80 p< 
TF 60 1.680 N/S 
GF 30 1.397 N/S 
TA 60 1.174 N/ S 
GA 30 1.423 N/S 
ER 20 1.354 N/S 
TR 16° 2.263 .05 
N/S = Not Significant 
TABLE 9:8 
COMPARISON OF MEAN RECOVERY IN THE RANGE OF MOVEMENT FROM 
PRESENTATION TO 8 MONTHS IN THE SUPPLEMENTARY (S) AND MAJOR (M) 
FROZEN SHOULDER STUDIES 
Mean Difference in Recovery Unpaired T-test 
(M - S) T80 p< 
TF 40 0.935 N/S 
GF 80 2.362 .05 
TA 90 1.491 N/S 
GA 20 0.657 N/S 
ER 60 1.260 N/S 
TR lo 0.374 N/S 
N/S = Not Significant 
TABLE 9: 9 
ASSESSMENT OF THE EFFECT OF CLINICAL PARAMETERS ON THE PAIN SCORE 
AND 
PRINCIPAL COMPONENT AT 8 MONTHS IN THE 2 FROZEN SHOULDER STUDIES 
(UNPAIRED T-TEST COMPARISONS) 
MAJOR FROZEN SHOULDER STUDY 
CLINICAL PARAMETER PAIN SCORE PRINCIPAL COMPONENT 
N Mean SD Mean SD 
A. AGE: 
55 years or less 21 1.3 3.5 107.8 30.5 
56 years or more 21 2.6 3.2 100.4 38.6 
T = 1.254+ T = 0.685+ 
B. SEX: 
Male 14 1.8 2.7 101.0 27.8 
Female 28 2.0 3.7 105. 6 37.9 
T = 0.193+ T = 0.387+ 
c. ARM: 
Dominant 22 2.2 3.5 109.0 35.4 
Non-dominant 20 1.6 3.3 98.8 33.6 
T = o. 602+ T = 0.956+ 
D. DURATION AT PRESENTATION: 
3 months or less 20 1. 2 1. 9 105. 2 39.7 
4 months or more 22 2.6 4.2 103.1 30.1 
T = 1.360+ T = 0.198+ 
E. OCCUPATION: 
Manual 15 2.7 4.0 86.1 42.7 
Sedentary 27 1.2 2.6 114.1 24.7 
1. 518+ * T = T = 2.697 
F. CAUSE: 
Traumatic 11 1. 2 2.1 111. 9 25.0 
Spontaneous 31 2.2 3.7 101. 3 37.3 
T = 0. 859+ T = 0.869+ 
* = p<0.05 
+=Not Significant 
TABLE 9:9 (CONTINUED) 
SUPPLEMENTARY FROZEN SHOULDER STUDY 
PAIN SCORE PRINCIPAL COMPONENT 
N Mean SD Mean SD 
A. AGE: 
55 years or less 18 0.9 1.7 101.0 27.7 
56 years or more 22 1.4 1.9 104.0 31.9 
T= 0.835+ T = 0.318+ 
B. SEX: 
Male 16 1.0 1. 8 103 .1 24.6 
Female 24 1.2 1. 9 101.8 32.5 
T = 0.354+ T = 0.140+ 
c. ARM: 
Dominant 13 0.9 1.8 104.0 21.0 
Non-dominant 27 1. 1 1. 7 101.5 32. 9 
T = O. 260+ T = 0.250+ 
D. DURATION AT PRESENTATION: 
3 months or less 11 1. 3 1. 6 102. 2 24.9 
4 months or more 29 1.1 1. 9 102.4 31.2 
T = 0.387+ T = 0.020+ 
E. OCCUPATION: 
Manual 13 1. 5 2.2 88.8 29.6 
Sedentary 27 0.9 1.6 108.8 27.4 
1. 008+ * T = T = 2.126 
* = p(0.05 
+=Not Significant 
TABLE 9: 10 
RANGE OF MOVEMENT AT 8 MONTHS IN MANUAL AND SEDENTARY WORKERS 
IN THE MAJOR FROZEN SHOULDER STUDY 
Mean Range Mean Range Mean Difference Unpaired T-test 
Sedentary Manual Workers in Range 
Workers 
(S=27) (M=l5) (M - S) T40 p( 
TF 148° 138° 10° 2.193 0.05 
GF 76° 68° 80 2.920 0.01 
TA 142° 122° 20° 2.667 0.02 
GA 720 63° 90 2.585 0.02 
ER 45° 33° ll 0 2.188 0.05 
TR 100° 94° 70 o. 725 N/S 
N/S = Not Significant 
CHAPTER 10 
FROZEN SHOULDER AFTER 3 - 4 YEARS 
Hazleman (113) in a retrospective survey of 130 patients with painful stiff 
shoulder found 15% to have persistent disability. Simmonds (248) reported 
15 of his 21 patients (71%) to be symptomatic after 3 years. Clarke et al 
(42) retrospectively reviewed 48 patients after a period of 6 years and 
found 20 (42%) to have some range deficit. A prospective 5 - 10 years study 
of 49 patients by Reeves (228) showed 3 patients to have severe and 22 mild 
persistent disability. Dickson and Crosby (66) and Meulengracht and 
Schwartz (179) also reported prolonged disability in many patients. On the 
other hand, Watson-Jones (272) reported that less than 5% of his 226 
patients with frozen shoulder had any disability by 6 months, although 
simple pendular exercise was the only therapy given. Grey (99) also found 
recovery of 24 of 25 patients with "untreated" frozen shoulder followed up 
for 2 years. Withers (286), Haggart et al (105) and Lundberg (168) also 
reported a favourable outcome. These conflicting reports probably reflect 
on both patient selection and the criteria used for diagnosis and recovery. 
As recovery was not complete at 8 months, patients in the Major Frozen 
Shoulder Study were recalled after 3 -4 years to record the long-term 
outcome of the frozen shoulder and also to try to assess whether any 
clinical features at presentation influence this outcome. 
PATIENTS 
40 of the 42 Major Frozen Shoulder Study patients attended for an interview 
and re-examination 40-48 (mean 44) months after initial presentation. 1 
patient could not be traced and the other was excluded as she had undergone 
mastectomy on the affected side 2 months before recall. 
METHOD 
At review, persistent or recurrent pain and/or restriction of movement was 
recorded. Symptoms in the opposite shoulder since discharge were also 
documented. The passive range of movement was measured using a spirit 
goniometer as previously described. 
CONTROLS 
The 76 normal people of similar age also provided a control group for 
passive range in each decade (40-70) in this study. Forty of the controls 
had been carefully matched for age and sex with the patients. Unpaired 
t-tests were used for statistical analysis unless otherwise stated. 
RESULTS 
Residual Symptoms: Although 18 patients (45%) had residual symptoms at 
review, these were only severe in 1 case (Table 10:1). The pain was most 
severe on shoulder movement - especially performing manual tasks, but 4 
patients also had pain at night. Only the one patient with severe symptoms 
still had residual pain at rest and also inability to lie on the affected 
shoulder and was using regular analgesics. 7 patients (18%) had also 
developed pain in the opposite shoulder, 4 having a frozen shoulder. 
Passive Range: Comparison of the mean range of passive movement at 
'discharge' (8 months follow-up) with the mean range at 'review' (mean 
follow-up 44 months), using paired t-tests (Table 10:2) showed significant 
improvements in all movements, although 5 patients had shown some 
deterioration of range during this time. However, when the range at review 
was compared to the matched controls (Table 10:3), significant restriction 
in range of all movements except glenohumeral abduction and flexion was 
still present. 
Of the 11 patients (28%) who considered their range restrict~d at review, 
only five were found to have this on objective testing (Table 10:1). 
However, many other patients who regarded their range as normal were found 
to have significant restriction. Sixteen of the 40 patients (40%) had still 
not attained a range of total flexion, abduction and rotation comparable 
with the minimum range of the controls of similar age (in decades from 40 -
70) and sex. In five of these patients the reduction in total range was 
still severe (more than 25%). Using the principal component as previously 
described, 18 patients (45%) still had a range below the minimum for the 
matched controls. 
Age and Sex: The range in the male patients was less than in the females 
(Table 10:4) and showed a proportionately larger decrease with age, but the 
difference did not reach statistical sigrificance and was similar to the 
differences reported in the Control Group. The older patients (56 or older) 
had a better range of external and total rotation, but not total flexion or 
abduction when compared to the younger (55 or less) patients, but these 
differences were not significant (Table 10:5). 
Arm Dominance: At review, the patients with non-dominant arm involvement 
had a better range than those with the dominant arm involved - the 
difference being significant (at the 5% level) for total abduction, total 
flexion and total rotation but not external rotation (Table 10:6). During 
the first 8 months, the dominant arm had consistently shown a better (but 
not significant) range. Comparison of the recovery from 8 months to review, 
showed that the accelerated recovery of the non-dominantly affected group 
was a later development (Table 10:7). 
Manual Work: The patients who resumed manual labour or strenuous activity 
in the convalescent phase also had a more restricted range at review (Table 
10:8). However, significant restriction was already evident at 8 months 
follow-up and there was no further differences in the recovery from 8 months 
to review (Table 10:9), so this constituted an earlier development. 
Duration of Symptoms at Presentation: The 18 patients who presented early -
within 3 months of the onset of the symptoms - showed no advantage over the 
rest who presented between 4 and 12 months, with regard to the rate or 
extent of recovery (Table 10:10). 
Mode of Onset: The 11 patients who reported trivial trauma as a 
precipitating factor also showed no difference from those lesions which 
arose spontaneously (Table 10:11). 
DISCUSSION 
This study has concentrated on both the subjective and objective outcome 
after at least 3 years, as the long term prognosis in frozen shoulder 
remains uncertain. 
The marked discrepancy between the patients subjective awareness of residual 
range deficit and measurable (objective) restriction when compared with a 
normal control group of similar age and sex has again been high-lighted. 
Only half of the patients (5/11) who regarded their range as abnormal were 
found to have any reduction in total range. However, 40% of the entire 
patient group (16/40) had some range deficit on objective measurement. 
While 1 patient complained of severe pain and restriction, 5 were considered 
to have severe (greater than 25%) residual restriction. That so many 
patients with range deficit considered their recovery to be complete shows 
the excellent adaptation to this minor disability achieved by a majority of 
patients. This difference in subjective and objective assessment of 
recovery (2, 42, 113) and the variation in the diagnostic criteria for 
frozen shoulder and length of follow-up probably account for the conflicting 
reports with regard to prognosis. 
This study has shown that although significant improvement continued after 8 
months, the mean range after 3-4 years was still markedly less than matched 
controls. 
The observations of Clarke et al (42) that age and sex affect the range of 
movement in both patients and controls has been confirmed. Dominant arm 
involvement was associated with a less satisfactory recovery, although 
interestingly this phenomenon was a later development. The resumption of 
manual labour in the convalescent phase may also retard the recovery. This 
study has not confirmed that the duration of symptoms before therapy (113) 
or the mode of onset (226) affect the long-term prognosis. 
5 patients (13%) still had severe and 11 (28%) mild shoulder restriction on 
objective testing after 3 years. However, only 1 patient regarded symptoms 
as severe. This accords with the experience of Clarke et al (42) who 
retrospectively assessed their patients. The patients in this study were 
followed prospectively and subjected to close and detailed examination. 
It was concluded that although the range of movement remains objectively 
restricted there is little functional impairment in the late stage of frozen 
shoulder. 
TABLE 10:1 
SYMPTOMS AT REVIEW IN AFFECTED SHOULDER (N = 40) 
No. % of Total N. 
Mild ache 7 18% 
Mild restriction 4 10% 
Mild ache and restriction 6 15% 
Severe pain and restriction 1 3% 
TABLE 10:2 
IMPROVEMENT IN RANGE OF MOVEMENT FROM 8 MONTHS (DISCHARGE) TO REVIEW 
At 8 Months At Review Mean Improvement Paired T-test 
From Discharge 
Movement Mean (Range) Mean (Range) To Review T38 p< 
TF 144° (80-160) 156° (90-175) 12° 4.525 0.0001 
GF 69° (50- 80) 89° (60-100) 20° 6.254 0.0001 
TA 134° (60-175) 146° (70-175) 12° 3.581 0.0009 
GA 66° (30- 85) 80° (55- 90) 14° 5.363 0.0001 
ER 40° ( 0- 70) 52° (15- 85) 12° 4.581 0.0001 
TR 99° (50-140) 147° ( 60-180) 48° 11. 353 0.0001 
TABLE 10:3 
COMPARISON OF RANGE IN PATIENTS AT REVIEW WITH MATCHED CONTROLS 
At Review (R) Controls (C) Mean Difference Paired T-test 
Movement Mean (Range) Mean (Range) (C - R) T78 p< 
TF 156° (90-175) 167° (145-180) 110 4.062 0.0002 
GF 89° (60-100) 90° ( 65-105) lo o. 901 N/S 
TA 146° (70-175) 163° (140-180) 170 5.291 0.0001 
GA 80° (55- 90) 83° ( 60-100) 30 1.132 N/S 
ER 52° (15- 85) 65° ( 40- 90) 13° 3. 671 0.0007 
TR 147° (60-180) 164° (140-180) 170 3.983 0.0003 
N/S = Not Significant 
TABLE 10:4 
COMPARISON OF RANGE IN FEMALE AND MALE PATIENTS AT REVIEW 
Mean Range Mean Range Mean Difference Unpaired T-test 
in Females in Males (F - M) 
(F=26) (M=l4) T38 p< 
TF 157° 156° 0.8° 0.161 N/S 
TA 148° 144° 40 0.696 N/S 
ER 54° 49° 50 o. 947 N/S 
TR 151° 140° 110 1. 308 N/S 
N/S = Not Significant 
TABLE 10:5 
COMPARISON OF THE RANGE AT REVIEW IN PATIENTS IN DIFFERENCE AGE GROUPS 
Mean Range in Mean Range in Mean Difference Unpaired T-test 
Patients Aged Patients Aged (Y - 0) 
55 or Less 56 or More 
(Y = 20) (0 = 20) T33 p< 
TF 159° 154° 60 1.147 N/S 
• 
TA 150° 143° 70 1.154 N/S 
ER 49° 56° -80 1.482 N/S 
TR 145° 150° -60 o. 700 N/S 
N/S = Not Significant 
TABLE 10:6 
COMPARISON OF THE RANGE AT REVIEW IN PATIENTS WITH DOMINANT AND 
NON-DOMINANT ARM INVOLVEMENT 
Mean (Range) in Mean (Range) in Mean Difference Unpaired T-test 
Non-D0minant Dominant Group 
Group (N-D=27) (D=l3) (N-D - D) T38 p< 
TF 161° (150-175) 152° (90-170) 10° 2.096 0.050 
TA 153° (130-175) 140° (70-160) 130 2.084 0.044 
ER 56° ( 30- 85) 49° (15- 75) 70 1.323 0.194 * 







COMPARISON OF MEAN RECOVERY IN RANGE FROM DISCHARGE (8 MONTHS) TO 
REVIEW (44 MONTHS) IN PATIENTS WITH NON-DCMINANT AND DOMINANT 
ARM INVOLVEMENT 
Mean Recovery Unpaired T-test 
Non-Dominant Dominant T38 p< 
TF 19° 50 2.743 0.009 
TA 25° 0.7° 2.740 0.009 
170 70 * ER 1.944 0.073 
TR 57° 40° . 2.421 0.05 
*=Not Significant 
TABLE 10:8 
COMPARISON OF RANGE AT REVIEW IN MANUAL AND SEDENTARY WORKERS 
Mean (Range) Mean (Range) in Mean Unpaired T-test 
in Sedentary Manual Workers Difference 
Workers (S=15) (M=25) (S - M) T38 p< 
164° (135-170) 149° (90-175) 15° 2.035 0.05 
152° (130-165) 138° (70-175) 14° 2.439 0.02 
57° ( 40- 85) 44° (15- 70) 130 2.687 0.01 
156° (125-180) 132° (60-165) 24° 2.877 0.01 
TABLE 10:9 
MEAN RECOVERY IN RANGE FROM DISCHARGE (8 MONTHS) TO 
REVIEW (44 MONTHS) IN MANUAL AND SEDENTARY WORKERS 
Mean Recovery Unpaired T-test 
Sedentary Workers Manual Workers T38 p< 
(N = 15) (N = 25) 
TF 16° 110 0.270 N/S 
TA 10° 16° -0. 658 N/S 
ER 120 110 0.323 N/S 
TR 55° 38° 1. 855 N/S 
N/S = Not Significant 
TABLE 10:10 
COMPARISON OF RANGE AT REVIEW IN PATIENTS PRESENTING EARLY (1-3 MONTHS) 






Early Presentation Late Presentation 

















TABLE 10: 11 
COMPARISON OF RANGE AT REVIEW IN PATIENTS WITH A SPONTANEOUS (S) 
OR TRAUMATIC (T) ONSET 
Mean Range Unpaired T-test 
Spontaneous Onset Traumatic Onset 
(N = 29) (N = 11) T38 p< 
TF 157° 156° 0.178 N/S 
TA 146° 144° 0.316 N/S 
ER 58° 50° 1. 304 N/S 
TR 150° 140° 1.152 N/S 




IMMUNOLOGY AND THE FROZEN SHOULDER 
Cadman (45) first proposed that the initial lesion in frozen shoulder was a 
supraspinatus tendinitis. Simmonds (248) histological studies supported 
this view and suggested that it was due to chronic inflammation secondary to 
impairment of blood supply to the tendons. Rathbun and Macnab (225) 
demonstrated a constant hypovascular area in the supraspinatus tendon, close 
to its insertion, which they felt was due to the "milking" action of the 
head of the humerus on the tendon during activity. However, Macnab (70) 
later produced identical central degenerative changes in the tendon by 
partial interruption to its blood supply. He felt that the frozen shoulder 
was due to a type IV immunological reaction to the damaged collagen in the 
supraspinatus tendon. Bulgen et al (31) reported evidence of deficiency of 
the cellular immune system in patients with frozen shoulder which could 
predispose them to autoimmune disease (5). In a study of 25 patients with 
frozen shoulder, they (31) found reduced lymphocyte transformation to 
phytohaemagglutinin and low serum IgA levels. A possible genetic element 
was also suggested by Bulgen et al (30) who reported an increased incidence 
of HLA-B27 in a study of 38 frozen shoulder patients. Kessel et al (139), 
in a recent study of 50 patients with a spontaneous onset of frozen 
shoulder, found no such abnormalities. The aim of the immunological study 
was to confirm and extend the work of Bulgen et al (30, 31) which suggested 
immunological abnormality and to try to link the immunological abnormalities 
to the clinical pattern. 
PATIENTS 
The 42 patients in the Major Frozen Shoulder Study had blood samples taken 
at the first visit (pre Rx) and repeated after 8 months (post Rx). 
CONTROLS 
The 42 controls matched for age (within 2 years) and sex to the Major Frozen 
Shoulder Study group also had blood samples taken on one occasion to provide 
control data for many of the blood tests. All these patients were free of 
systemic illness and had no history of joint symptoms. 
IMMUNOLOGICAL TESTS 
a. Immunoglobulin classes IgG, IgM and IgA. 
b. C-reactive protein (CRP). 
c. Total haemolytic complement (CH50) and the third component of 
complement (C3). 
d. Immune complex (IC) levels. 
e. Lymphocyte count. 
f. Lymphocyte transformation studies with 3 mitogens -
phytohaemagglutinin (PHA), concanavalin A (Con A) and pokeweed mitogen 
(PWM). 
g. Lymphocyte sub-populations - T cell, Fe and C3 rosettes. 
h. Erythrocyte sedimentation rate (ESR, Westergren). 
i. Auto-antibody screen including anti-thyroid and anti-nuclear 
antibodies. 
j. Rose-Waaler test for rheumatoid factor. 
OTHER BLOOD TESTS 
a. Haemoglobin and full blood count. 
b. Blood glucose. 
c. Thyroxine, tri-iodothyronine and thyroid stimulating hormone levels. 
d. HLA tissue typing for A+ B loci antigens. 
METHODS 
THE IMMUNOGLOBULIN (IgG, IgA, IgM) AND C-REACTIVE PROTEIN (CRP) LEVELS were 
measured by a single radial immunodiffusion technique. The antigen was 
loaded into wells bored into agar plates containing a fixed concentration of 
antibody. By diffusion the antigen combined with antibody in the gel until 
equivalence was reached. At this point an immunoprecipitin "halo" formed 
around the well. The diameter of the halo at equivalence reflected the 
antigen concentration. Standard commercial plates were used for the 
immunoglobulin assays. Commercial anti-CRP and CRP standard sera 
(Behringwerke) were used for the CRP estimations. The normal range for IgG 
was 7-13 g/1; IgA 1-3.5 g/1 and IgM 0.5-2 g/1. The normal range for CRP was 
0-60 mg/ dl. 
TOTAL HAEMOLYTIC COMPLEMENT (CH50) was estimated using the kinetic 
turbimetric method (50% haemolytic time assay) (149). 0.5 ml of complement 
fixing diluent was mixed with 12.5 ml of serum at 37°c. 0.5 ml of 0.1% 
rabbit anti-sheep red cells were also warmed to 37°c and both were rapidly 
mixed in a 4 mm x 1 cm cuvette and incubated at 37°c in a Unicam SP 500 
spectrophotometer with a thermostatically controlled 4-cuvette changer and a 
plotter. A reaction followed at 600 nm where haemolysis was seen as a 
reduction in turbidity. The time taken to achieve a 50% lysis of the 
sensitised red cells was measured. Using normal serum, a standard line was 
plotted on log-log paper of the 50% haemolysis time against CHSO units. 
From this line the amount of normal complement activity could be obtained 
from a single determination. Using this technique the normal range (mean +3 
SD) was 900 - 1800 units/ml. 
THIRD COMPONENT OF COMPLEMENT (C3). This was measured using a rocket 
immunoelectrophoretic technique. Antigen was loaded into wells bored into 
antibody containing agar and was driven into the gel by electrophoresis. At 
equivalence, the resultant immunoprecipitation gave a rocket-shaped line, 
the height of the rocket being proportional to the antigen concentration. 
The normal range was 60 - 180 mg/dl. 
IMMUNE COMPLEX (IC) LEVELS. A polyethylene glycol precipitation -
complement consumption assay (PEG-CC) (110) was used to measure the IC 
levels. The complexes were first isolated from the serum by precipitation 
in 2.5% polyethylene glycol and then concentrated. Functional assay was 
achieved by measurement of their ability to fix complement using the kinetic 
turbimetric assay for CHSO as described above. Normal range was 0-24%. 
LYMPHOCYTE TRANSFORMATION STUDIES. Lymphocyte culture was performed by a 
method described by Jones et al (135). 20 ml of heparinised blood was 
incubated at 37°c for 30 minutes, rotating the blood with 200 mg of carbonyl 
iron which was then removed (twice) using a magnet. 2 ml of dextran 240 was 
added to the blood which was allowed to stand for 30 minutes at 37°c. The 
white cell rich supernatant was then layered onto 5 ml of Ficoll Hypaque and 
centrifuged at 400 g for 20 minutes. The lymphocytes were washed twice with 
Eagles Medium MEM (pH 7.2) supplemented by non-essential amino acids 1%, 
glutamine 200 mM, foetal calf serum 10%, penicillin 100 units/ml, 
streptomycin 0.01%, sodium bicarbonate and HEPES buffer 25 mM. Each 
microtiter well in a microtiter plate was filled with 100 ul of medium 
5 
containing 10 lymphocytes. The lymphocytes were cultured for 72 hours at 
37°c with SO ul of medium containing either -
a. Purified phytohaemagglutinin (PHA, Wellcome) in 9 dilutions, 2.5 - 0.01 
ug, 
b. Concanavalin A (Con A, Sigma Type IV) in 7 dilutions, 50 - 0.79 ug, 
or 
c. Pokeweed Mitogen (PWM, Gibco) 
1 1 8 dilutions /3 - /384. in 
1 uCi of tritiated thymidine was added four hours before harvesting. The 
stimulation index (SI) was calculated for each mitogen concentration. SI= 
counts with medium plus mitogen / counts with medium alone. 
LYMPHOCYTE POPULATION STUDIES. Lymphocytes were prepared with an identical 
method described for the transformation studies. T cells were identified by 
their ability to rosette with washed sheep red cells (T rosettes). B cells 
were recognised by rosette formation with ox cells sensitised with IgM 
anti-ox and mouse complement (C3 rosettes) and ox cells sensitised with IgG 
anti-ox (Fe rosettes). The percentage of cells which showed rosette 
formation with each method was calculated. 
LYMPHOCYTE COUNTS. Both automated (Coulter-counter) and manual methods were 
used to count the number of lymphocytes in each specimen. 
AUTO-ANTIBODY SCREENING. Antibody to cell nuclei (ANF), mitochondria, 
smooth muscle, parietal cell and thyroid microsomes were detected by direct. 
immunoelectrophoresis. The Rose-Waaler test was used to detect the presence 
of rheumatoid factor. 
HAEMOGLOBIN was measured by an automated Coulter-counter. The ERYTHROCYTE 
SEDIMENTATION RATE (ESR) employed the Westergren method with 0-20 mm/hr as 
the accepted normal range. 
THYROXINE (T4), TRI-IODOTHYRONINE (T3), AND THYROID STIMULATING HORMONE 
(TSH) levels were measured by the hospital biochemistry department. The 
normal range for T4 = 65 - 145 nmol/L; T3 = 1 - 2.8 nmol/L and TSH = less 
than 4.0 mU/L. 
BLOOD GLUCOSE was estimated by automatic analyser. 
HLA TYPING was performed using the standard NIH microcytotoxicity method and 
national plate sera. Normal frequencies were taken to be those reported by 
Nelson et al (197) in a study of normal blood donors. The control group 
also had HLA typing performed. 
RESULTS 
Immune complexes (IC) were raised above the accepted normal range of O - 24% 
complement consumption in 17 of 39 (44%) pretreatment patients (pre Rx) and 
2 of 40 (5%) controls (Figure 11:1). This rise was significant at the 5% 
level (Wilcoxon rank sum test). Eleven of 40 (28%) posttreatment patients 
(post Rx) also had raised IC levels (3 being normal preRx), but these values 
were not significantly different from those of the preRx patients or the 
controls. Nine of the 39 (23%) preRx patients had CH50 levels below the 
normal range (5 less than 700 U/ml) and of these, 5 also showed raised IC 
levels. All except 1 of these CH50 levels returned to normal postRx and a 
further 7 (18%) fell to below normal postRx. One preRx and one postRx serum 
showed a low C3 but neither was associated with a reduction in CH50. 
CRP levels (Figure 11:2) were raised above the accepted normal range of O -
60 mg/dl in 10 of 40 (25%) preRx patients and 1 of 40 (3%) controls. This 
difference was significant at the 5% level (X
2 
test). Only 3 of the 39 (8%) 
postRx group had raised levels. The fall in CRP measured in these patients 
postRx was significant at the 5% level (McNemar's test). An ESR above 20 
mm/hr was noted in 8 patients preRx (5 were) 30 mm/hr) - 6 of the 8 also 
showed an elevated CRP level. The abnormal ESR persisted in 3 patients 
postRx and became abnormal in a further 3 (with no other obvious cause 
manifesting). Only 1 control had an abnormal ESR (31 mm/hr). 
Lymphocyte counts were all within the normal laboratory range. Lymphocyte 
transformation in the preRx group showed a significant reduction, p<0.01, 
using Wilcoxon rank sum test, in the maximum SI irrespective of mitogen 
concentration, to both PHA and Con A compared to the controls (Figure 11:3). 
The postRx levels tended towards the control levels. Lymphocyte response to 
PWM was similar in all groups. When comparing the SI at each dilution for 
the 3 mitogens, significant differences were noted between preRx and control 
groups at 5 concentrations of PHA (Figure 11:4), 1 of these also being 
significant when comparing the postRx and control groups. Neither Con A 
(Figure 11:5) nor PWM (Figure 11:6), showed sequential significant 
differences along the dilution curves, although with Con A (preRx compared 
to controls) the difference was significant (p<0.05) at the concentration 
giving the maximum SI (1.57 ug) and at one other concentration. Lymphocyte 
populations were similar in all groups (Table 11:1) and although 
immunoglobulin levels tended to be slightly higher in the preRx patients 
(Table 11:2), this was not significantly different from the other groups. 
The results of the innnunological tests are summarized in Table 11:3. 
To see if abnormal immunological tests at presentation were associated with 
differences in the severity of the pain, range limitation or their rate of 
recovery, patients with abnormal preR.x parameters were compared to those 
with normal levels. To simplify these comparisons the 'pain score' (sum of 
pain at night, at rest and on movement) and the principal component was 
used. Five immunological parameters had sufficient patients with abnormal 
pre-treatment levels to permit comparative study. These were immune 
complexes (IC - raised in 17 patients), C-reactive protein (CRP raised in 10 
patients), sedimentation rate (ESR raised in 8 patients) and total 
complement (CH50 reduced in 9 patients). Patients with an initial (pre Rx) 
lymphocyte stimulation index below the lowest level of the controls for 
phytohaemagglutinin (PHA abnormal in 16 patients) and concanavalin A (Con A 
abnormal in 18 patients) were also considered. 
Using unpaired t-test, there were no significant differences (at the 5% 
level) between patients with normal and abnormal pre-treatment parameters 
with regard to the pain score (Table 11:4) or principal component (Table 
11:5) at presentation or subsequent follow-up. 
The mean recovery of range (principal component) from Oto 8 months and from 
8 to 44 months (Table -11:6) was also similar, whether the initial parameter 
was normal or not. 
The rate of recovery of the pain score and principal component in the first 
8 months (Figure 11:7 - 18) was also similar whether the initial 
immunological tests were normal or not. 
Other Blood Tests: 
5 patients (13%) had elevated thyroid function tests - thyroxine in 3, 
tri-iodothyronine in 1 and both in a further patient. 4 of these were 
associated with elevated thyroid microsomal antibody titres and a further 3 
patients had positive thyroid microsomal antibodies but normal thyroid 
function. 1 patient had a positive anti-nuclear antibody (1:400) at 
presentation which was negative at follow-up. Rose-Waaler test was negative 
and the blood glucose normal in all patients at presentation and when 
repeated after 8 months. 
HLA tissue typing for common A and B loci antigens showed no preponderance 
for any histocompatibility antigens (Table 11:7). HLA-B27 was found in only 
5 of the 42 (12%) frozen shoulder patients and 4 of the 42 (10%) controls, 
compared with 7.4% in the normal British population (197). 
DISCUSSION 
This study has found a range of immunological abnormalities in patients with 
frozen shoulder. IC, as measured by the PEG-CC test and the CRP levels were 
significantly raised in the preRx patients. These findings would support 
the concept of an inflammatory response in the shoulder. However, they do 
not form a consistent pattern and . no relationship could be identified 
between them. 
The reported observation (31) of reduced lymphocyte responsiveness to 
stimulation with the mitogen PHA in patients with frozen shoulder has been 
confirmed. This fact was further strengthened by a similar suppression 
noted with Con A and the improvement in lymphocyte reactivity in the postRx 
group. The response to PWM was the same in all 3 groups which is not 
unexpected as unlike PHA and Con A, it stimulates Bas well as T cells (69, 
131). The finding of reduced IgA concentrations (31) has not been confirmed 
despite using a similar method in both studies. An increased incidence of 
HLA-B27 (30) was also not found in this as in several recent studies (139, 
206, 234, 243). Kessel et al (139) did not detect any immunological 
abnormalities in 50 patients with spontaneous onset of frozen shoulder. 
They measured immunoglobulin levels, IC, complement, ESR, full blood count 
and auto-antibodies and also performed tissue typing. The findings are 
similar apart from the IC levels. Kessel does not disclose which method was 
used to detect them nor their experimental error. The assays measure 
different components of the re, such as size, immunoglobulin class and 
complement fixing ability, and thus results will vary (158). Kessel also 
used patients with osteoarthritis (OA) as controls, but Cooke et al (47, 48) 
and Pringle (220) have described the deposition of immunoglobulin and 
complement in the cartilage and synovial membrane in OA, making this a poor 
control group. Significantly raised CRP and IC levels and evidence of 
impaired cell-mediated immunity which show improvement in time, has been 
found in patients with frozen shoulder. However, these abnormalities are 
random and form no consistent pattern. Their presence lends some support to 
Macnab's hypothesis (170) of an autoimmune reaction accounting, in part, for 
the clinical syndrome of frozen shoulder. 
TABLE 11: 1 
T AND B CELL LYMPHOCYTE POPULATIONS IN FROZEN SHOULDER PATIENTS 
AND CONTROLS : MEAN AND RANGE(% ROSETTES FORMED) 
Lymphocyte PRE-RX POST-RX CONTROLS 
Populations (N = 38) (N = 31) (N = 40) 
T Cells 61.4 69.4 72. 9 
( 45.0 - 89. 7) (27.0 - 86.6) (53.0 - 89.0) 
Fe Rosettes 30. 6 24.8 23.0 
(6.3 - 74.0) (9.0 - 37.0) (9.5 - 56.0) 
C3 Rosettes 11. 5 10.0 10. 3 
(0 - 26. 7) (2.7 - 37.0) (2.0 - 30.0) 
TABLE 11 :2 
IMMUNOGLOBULIN LEVELS IN FROZEN SHOULDER PATIENTS AND CONTROLS 
MEAN AND RANGE (G/L) 
Immunoglobulin PRE-RX POST-RX CONTROLS 
(N = 38) (N = 38) (N = 40) 
IgG 11. 3 10.3 9.7 
(3.5 - 17.5) (4.1 - 27.6) (5.9 - 13.2) 
IgA 3.0 2.5 2.6 
(1.1 - 7.4) (0.7-3.3) (0.9 - 5.5) 
IgM 1. 2 1.0 1.0 
(0.3 - 4.0) (0.4 - 2. 8) (0.4 - 2.1) 
TABLE 11 :3 
SUMMARY OF RESULTS OF IMMUNOLOGICAL TESTS IN 
FROZEN SHOULDER PATIENTS AND CONTROLS 
TEST NORMAL RANGE SAMPLE OUTSIDE NORMAL 
SIZE RANGE N (%) 
A. PRE-RX 
IC 0-24 %cc 39 17 (44) 
CH50 900-1800 u/ ml 39 9 (23) 
C3 60- 180 mg/ dl 39 1 (3) 
CRP 0-60 mg/ dl 40 10 (25) 
ESR 0-20 mm/hr 40 8 (20) 
Lymphocyte 1.5 9 4.0 40 0 (0) count X 10 /1 
B. POST-RX 
IC 0-24% cc 40 11 (28) 
CH50 900-1800 u/ml 40 8 (20) 
C3 60-180 mg/dl 38 1 (3) 
CRP 0-60 mg/dl 39 3 (7) 
ESR 0-20 mm/hr 40 6 (15) 
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TABLE 11:3 (CONTINUED) 
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TABLE 11 :4 
COMPARISON OF MEAN PAIN SCORE IN PATIENTS WITH 
NORMAL AND ABNORMAL PRE-RX IMMUNOLOGICAL PARAMETERS 
PARAMETER MEAN PAIN SCORE 
Normal Group Abnormal Group Unpaired T-test 
T38 p< 
A. AT PRESENTATION 
IC 14.2 15.7 0.889 N/S 
CRP 14.6 15.9 0.637 N/S 
ESR 14.3 16.5 1. 227 N/S 
CH50 15.1 14.5 -0.316 N/S 
PHA 15.0 14.7 -0.158 N/S 
CON A 15.3 14.5 -0. 425 N/S 
B. AT 8 MONTHS 
IC 2.4 1. 4 -1.022 N/S 
CRP 2.2 1.0 o. 911 N/S 
ESR 1. 7 2.4 0.523 N/S 
CH50 2.2 1.1 -1. 034 N/S 
PHA 1. 6 2.5 0.903 N/S 
CON A 1.1 3.1 1. 877 N/S 
N/S = Not Significant 
TABLE 11 :5 
COMPARISON OF MEAN PRINCIPAL COMPONENT IN PATIENTS 
WITH NORMAL AND ABNORMAL PRE-RX IMMUNOLOGICAL PARAMETERS 
PARAMETER MEAN PRINCIPAL COMPONENT 
Normal Group Abnormal Group Unpaired T-test 
T38 p< 
A. AT PRESENTATION 
IC 2.0 - 2.1 0.368 N/S 
CRP 4.5 -16.4 -1.576 N/S 
ESR 2.7 - 7.3 -o. 784 N/S 
CH50 -0.8 2.2 0.242 N/S 
PHA 1.1 - 1.9 -0. 264 N/S 
CON A 5.3 -11. 9 1. 526 N/S 
B. AT 8 MONTHS 
IC 101. 3 107. 2 0.545 N/S 
CRP 104.8 101. 6 -0.243 N/S 
ESR 105.5 100. 2 0.435 N/S 
CH50 102. 9 107.1 0.353 N/S 
PHA 101. 2 109. 2 0.713 N/S 
CON A 103.7 102.4 0.117 N/S 
c. AT 44 MONTHS 
IC 135.6 150.2 1. 617 N/S 
CRP 142.4 144.7 0.205 N/S 
ESR 139. 4 152.1 1.235 N/S 
CH50 142.6 143.5 0.090 N/S 
PHA 142.7 143.3 0.058 N/S 
CON A 147.8 139. 3 -0.878 N/S 
N/S = Not Significant 
TABLE 11: 6 
MEAN RECOVERY IN PRINCIPAL COMPONENT IN PATIENTS WITH 
NORMAL AND ABNORMAL IMMUNOLOGICAL TESTS 
PARAMETER MEAN RECOVERY IN PRINCIPAL 
COMPONENT 
Normal Group Abnormal Group Unpaired T-test 
T40 p< 
A. 0 - 8 MONTHS 
IC 99.3 109. 3 o. 826 N/S 
CRP 100. 3 118.0 1. 217 N/S 
ESR 102.9 107.5 0.334 N/S 
CH50 103.7 104.9 0.088 N/S 
PHA 100 .1 111. 2 0.879 N/S 
CON A 94.7 114. 3 1.597 N/S 
B. 8 - 44 MONTHS 
IC 35.8 43.0 0.619 N/S 
CRP 38.4 43.1 0.336 N/S 
ESR 34.7 51. 9 1.345 N/S 
CH50 41. 7 35.3 -0.525 N/S 
PHA 44.3 38.4 -0.514 N/S 
CON A 40.7 36.4 -0.337 N/S 
N/S = Not Significant 
TABLE 11: 7 
FREQUENCY OF COMMON HLA A & B LOCI ANTIGENS IN FROZEN SHOULDER PATIENTS 
COMPARED WITH FREQUENCY IN CONTROLS AND BRITISH BLOOD DONORS* 
HLA-Antigen Frozen Shoulder Frozen Shoulder British Blood 
Patients (N = 42) Controls (N = 40) Donors (N = 1036) 
no. % no. % no. % 
Al 15 (36%) 16 (40%) 348 (34%) 
A2 15 (36%) 18 (45%) 536 (52%) 
A3 10 (24%) 9 (23%) 265 (26%) 
A9 4 (10%) 6 (15%) 190 ( 18%) 
AlO 7 ( 17%) 5 (13%) 87 ( 8%) 
All 6 (14%) 6 (15%) 106 (10%) 
BS 7 ( 17%) 4 (10%) 114 (11%) 
B14 3 ( 7%) 3 ( 8%) 72 ( 7%) 
B15 2 ( 5%) 3 ( 7%) 30 ( 3%) 
B17 2 ( 5%) 2 ( 5%) 79 ( 8%) 
B18 2 ( 5%) 1 ( 3%) 35 ( 3%) 
B27 5 (12%) 4 (10%) 77 ( 7%) 
* Reference 197 
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FIGURES II : 4 - 6. THE S.I. FOR LYMPHOCYTES FROM FROZEN 
SHOULDER PATIENTS AND CONTROLS AT DIFFERENT CONCENTRATIONS OF 
MITOGEN SHOWING THE SEM'S AND A COMPARISON (WILCOXON RANK SUM TESTS) 
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FIGURES II : 7 - I8. COMPARISON OF THE RATE OF RECOVERY OF THE 
PAIN SCORE AND RANGE OF MOVEMENT (LlC) IN PATIENTS l•JITH NORMAL AND ABNORMAL 
IMMUNOLOGICAL PARAMETERS AT PRESENT A TI ON. 
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CHAPTER 12 
RADIOLOGICAL ASPECTS OF THE FROZEN SHOULDER 
Frozen shoulder is used to describe the clinical condition of a painful 
stiff shoulder. Neviaser (199) suggested that adhesive capsulitis was a 
more suitable name, as his pathological studies revealed chronic 
inflammation and fibrosis of the joint capsule which became closely adherent 
to the humeral head. Neviaser (201) later described the arthrographic 
features in patients with painful stiff shoulder. Most showed capsulitis 
with reduced joint volume and obliteration of the inferior and subscapularis 
recesses. However, 11 of his 53 patient (21%) showed no arthrographic 
abnormality. He considered the restriction in range in these latter 
patients was due to muscle spasm and that a good response to treatment and a 
good prognosis for early recovery was likely. Reeves (226) reported 
arthrography to be useful in differentiating post-traumatic stiff shoulders 
with a small distensible shoulder joint from frozen shoulder where 
distensibility was also lost. Treatment and prognosis were considered to be 
different. Lundberg (168) found a correlation between the severity of range 
l 
restriction and reduction in joint volume, but recognised that 9% of 
patients had a normal arthrogram. Wright and Haq (292) found variable 
features at arthrography of their patients with clinical frozen shoulder and 
regarded the investigation of little use. Other authors have considered 
arthrography to be of value (196, 219, 233, 273) or even essential (200, 
274) to make a correct diagnosis and decide on appropriate therapy and 
likely prognosis in patients with painful stiff shoulder. It has also been 
suggested to have therapeutic value (7, 49,207). Minor degenerative changes 
on X-ray in both affected and unaffected shoulder (52, 95, 208, 292) has 
been reported. An increased incidence of acromioclavicular arthritis has 
also been mentioned (292) in frozen shoulder patients. 
The aim of this study was to assess the plain X-ray and arthrographic 
features at presentation in patients with clinical frozen shoulder and 
examine the relevance to the rate and extent of recovery. The importance of 
a traumatic onset was also assessed. 
PATIENTS AND METHODS 
The 42 patients included in the Major Frozen Shoulder Study had plain X-rays 
taken of both shoulders with special views to demonstrate the 
acromioclavicular joints (ACJ). Thirty-six of the patients also had 
arthrography of the affected shoulder performed, although this was only 
successful in 31 cases. The arthrography was performed via the anterior 
route with a maximum of 20 ml of Conray 280 being introduced through a 22 
gauge needle under fluoroscopic control. This procedure was performed 
within 1 week of presentation and before beginning treatment. 
RESULTS 
A. PLAIN X-RAY OF SHOULDERS: The X-ray of the affected shoulder (Table 
12:1) was normal in 30 of the 42 patients (71%). The other 12 patients 
showed a variety of minor abnormalities. The most common abnormality was 
minor degenerative changes in the humeral head. These changes were most 
commonly seen in the greater tuberosity but also affected the lesser 
tuberosity. Degenerative change involving the glenohumeral joint was not 
accepted as part of the frozen shoulder syndrome and resulted in patient 
exclusion from the study. 5 patients showed reduction in the distance 
between the acromion and the humeral head. Only 6 patients (14%) had any 
radiological abnormality in the unaffected shoulder. 15 patients were 
manual labourers (Table 12:2) and 11 had a traumatic onset (Table 12:3), but 
neither factor was associated with an increased incidence of · degenerative 
change on plain X-ray. 
The mean pain score at presentation was higher in the patients with X-ray 
abnormality (Table 12:4), but unpaired t-tests did not show the difference 
to be significant. The pain score at 8 months also showed a slight 
advantage for patients with normal shoulder X-rays. There was no difference 
between the groups in the rate (Figure 12:1) or extent of recovery of the 
pain score. Of the 14 patients with mild persistent pain at review (mean 
follow up 44 months), 6 had abnormal and 8 normal X-rays. The 2 patients 
with the highest pain scores at review both had ACJ degeneration on X-ray. 
The abnormal X-ray group also had a more restricted range, that is a lower 
principal component, at presentation (Table 12:5) than the group with normal 
X-rays. This difference increased during the first 3 months of follow-up 
(Figure 12:2), although it never reached significance. 
B. ARTHROGRAPHY: Although this was attempted in 36 patients, 4 were 
excluded due to difficulty in entering the joint. One further patient 
withdrew from the study due to the severity of the pain following 
arthrography. Five other patients reported the injection to be unacceptably 
painful and 27 (87%) noted a definite exacerbation of the shoulder pain 
starting 4 - 6 hours after injection and lasting 24 - 48 hours thereafter. 
In 3 patients the pain lasted 2 - 4 weeks after the procedure. Five 
patients felt the shoulder was improved by the arthrography. 
Of the 31 patients who had successful arthrography, three different 
subgroups emerged: 
1. Normal Group (5 patients). The arthrogram was accepted as normal if it 
revealed a distensible shoulder joint with a smooth regular outline and a 
volume of at least 15 ml. An inferior and subscapularis recess was usually 
noted and contrast entered the bicipital tendon sheath but not the 
subacromial bursa. 
2. Capsulitis Group (15 patients). A marked reduction in joint volume 
(often under 5 ml) with loss of distensibility of the shoulder joint was 
found. Marked irregularity of joint outline (Figure 12:3) and early 
lymphatic filling (Figure 12:4) was sometimes seen. 
3. Rupture Group (11 patients). Rupture of the rotator cuff was 
considered to be present if an immediate flow of contrast into the 
subacromial/subdeltoid bursa occurred (Figure 12:5). With contrast medium 
present in the shoulder joint and subacromial bursa, the rotator cuff was 
clearly visible as a crescent above the humeral head. In 3 patients the 
rupture was small and revealed a normal looking shoulder joint. In the 
other 8 patients it was not possible to outline the joint sufficiently to 
assess detail. All 5 patients with a decrease in the distance between the 
acromion and the humeral head showed rupture of the rotator cuff. 
The mean pain score at presentation (Table 12:6) was greater in the patients 
with normal arthrography, although analysis of variance did not show this 
difference to be significant. The rate of recovery of the pain score within 
the first 8 months (Figure 12:6) was similar in the 3 groups, but the 
capsulitis group (Table 12:6) had a lower mean pain score at 8 months. Of 
the 14 patients with persistent ache at review, 6 were in the capsulitis 
group, 3 in the rupture and 2 in the normal group. 
The capsulitis group had the best range (that is the highest principal 
component, C) at presentation (Table 12:7), but analysis of variance did not 
show the difference to be significant. Contrasting C in the capsulitis to 
that in the other two groups at this time just reached significance at the 
5% level. Assessment of the individual movements parameters at presentation 
(Table 12:8) confirmed that the capsulitis group had a better range for all 
movements - glenohumeral and total. However, the rate of recovery of range 
(Figure 12:7) was slower in the capsulitis group in the first 6 weeks, 
allowing the other two groups to 'catch up'. After 6 weeks there was no 
further difference between the groups. The mean range of total flexion, 
abduction and rotation during the follow-up period (Table 12:9) revealed 
that the initial advantage for the capsulitis group disappeared by 3 months. 
The range was similar at 8 months and the normal group was slightly worse 
when patients were reviewed between 40 - 48 months after their initial 
presentation. The principal component (Table 12:7) at 8 and 44 months 
reflected these slight differences. The mean duration of symptoms at 
presentation was 9.0 months (range 3 - 12) in the normal group and 3.8 
months (range 1 - 12) in the other two groups. Analysis of variance showed 
this difference to be significant, p<0.0092. However, the normal group 
could not be distinguished from the other 2 groups by the severity of the 
initial pain or range limitation or an improved rate or extent of recovery. 
Patients with a traumatic onset were similar to those which arose 
spontaneously, both with regard to the distribution of patients in the 3 
arthrographic groups (Table 12:10), initial severity and the rate and extent 
of recovery. 
There was no association between the arthrographic features and 
immunological abnormalities at presentation, although raised CRP levels were 
more common in the capsulitis group (Table 12:11). IC, ESR, Con A and PHA 
levels were abnormal in a higher percentage of patient with a normal 
arthrogram but this group was too small to study in detail. 
DISCUSSION 
This study has attempted to evaluate the initial and long-term significance 
of radiological investigations performed at presentation in a carefully 
defined group of patients with clinical frozen shoulder. The high incidence 
of minor degenerative changes on plain X-ray of the affected shoulder (52, 
95, 208, 292) was confirmed, but a high incidence of abnormality in the 
acromioclavicular joint (292) or opposite shoulder was not found. The only 
X-ray finding of practical value was the reduction in distance between the 
acromion and humeral head, which reliably predicted rupture of the rotator 
cuff. 
The shoulder arthrography results differ markedly from many other reported 
series where the features of capsulitis are said to always be present. 
Kernwein et al (138), Samilson et al (241) and Preston and Jackson (219) 
found capsulitis in all their patients but provided little clinical detail. 
Neviaser (200) regarded arthrography as essential for the diagnosis of 
adhesive capsulitis but his initial clinical study (201) did not confirm 
that the patients with normal arthrography had a better prognosis than the 
clinically identical patients showing capsulitis. Reeves (226) showed that 
arthrography was normal when performed in the convalescent phase after the 
recovery of range. The normal group in the present study did have a 
significantly longer mean duration at presentation, but their range was just 
as restricted as the other arthrographic groups. The rate and extent of 
recovery was also no different in patients with normal arthrography, so the 
lack of arthrographic abnormality in these patients cannot be attributed 
solely to the duration of symptoms at presentation. It is unclear if the 
patients with a traumatic onset in this study are similar to those described 
by Reeves (226), as he has given little clinical detail. However, no 
difference in prognosis was found in patients with a traumatic or 
spontaneous onset. There was also no association between the type of onset 
(traumatic or spontaneous) and the features at arthrography. As only half 
the patients showed evidence of capsulitis at arthrography, no attempt was 
made to confirm the reported correlation (168) between range restriction and 
joint volume. 
The variability in the features at arthrography may reflect differences in 
the underlying pathology, but were not useful in predicting outcome. 
Arthrography is an invasive procedure which produced increased pain in most 
patients. This study has not suggested that arthrography is of value in the 
routine assessment of the frozen shoulder. 
TABLE 12:1 
PLAIN X-RAY FEATURES IN THE AFFECTED AND UNAFFECTED SHOULDERS IN THE 
MAJOR FROZEN SHOULDER STUDY (N = 42) 
Normal X-ray 
Degenerative Changes of the Humeral Head 
Supraspinatus Tendon Calcification 
Degenerative Change of Acromioclavicular 
Joint 
















PLAIN X-RAY FEATURES IN THE AFFECTED SHOULDER OF MANUAL AND SEDENTARY 
WORKERS IN THE MAJOR FROZEN SHOULDER STUDY 
Sedentary Manual 
Workers Workers 
(N = 27) (N = 15) 
no. % no. % 
Normal X-ray 20 (74%) 10 ( 67%) 
Degenerative Changes of the -Humeral Head 4 ( 15%) 4 ( 2 7%) 
Supraspinatus Tendon Calcification 1 ( 4%) 1 (7%) 
Degenerative Changes of Acromioclavicular 
Joint 3 ( 11%) 1 (7%) 
Reduction in the Acromiohumeral Distance 3 (11%) 1 (7%) 
TABLE 12 :3 
PLAIN X-RAY FEATURES IN THE AFFECTED SHOULDER OF MAJOR FROZEN SHOULDER 
STUDY PATIENTS WITH A SPONTANEOUS OR TRAUMATIC ONSET 
Normal X-ray 
Degenerative Changes of the Humeral Head 
Supraspinatus Tendon Calcification 
Degenerative Changes of Acromioclavicular 
Joint 
Reduction in the Acromiohumeral Distance 
TABLE 12:4 
Spontaneous 














2 ( 18%) 
1 (9%) 
2 ( 18%) 
COMPARISON OF PAIN SCORE AT PRESENTATION AND AT 8 MONTHS IN PATIENTS 
WITH NORMAL AND ABNORMAL SHOULDER X-RAYS 
N Pain Score at Presentation Pain Score at 8 Months 
Mean (SEM) Mean (SEM) 
Normal X-ray 30 14.3 ( 1.0) 1.5 (0.5) 
Abnormal X-ray 12 16.2 ( 1. 3) 3.1 ( 1. 2) 
* * Unpaired T- test T = 1.161 1.396 
*=Not Significant 
TABLE 12:5 
COMPARISON OF PRINCIPAL COMPONENT AT PRESENTATION, 8 AND 44 MONTHS IN 





at 8 Months 
Mean (SEM) 
Principal Component 
at 44 Months 
Mean (SEM) 
Normal X-ray 6.3 









* T = 1. 636 
Not Significant 
* 1.207 
TABLE 12 :6 
* 0.745 
COMPARISON OF PAIN SCORE AT PRESENTATION AND 8 MONTHS IN PATIENTS IN 










( 1. 4) 
( 1.0) 





( 1. 5) 
(0.5) 
( 1. 8) 
TABLE 12:7 
COMPARISON OF THE PRINCIPAL COMPONENT AT PRESENTATION, 8 AND 44 
MONTHS IN THE 3 ARTHROGRAPHIC GROUPS 
Principal Principal Principal 
Component at Component at Component at 
Presentation 8 Months 44 Months 
Mean (SEM) Mean (SEM) Mean (SEM) 
Rupture Group -16.6 (10.9) 98.3 (14. 7) 145.5 (8.3) 
Capsulitis Group 15.6 ( 8.5) 105. 2 ( 6.9) 145.6 (6.8) 
Normal Group -23.2 (12.7) 99.1 (15.6) 126.3 (27.7) 
TABLE 12:8 
MEAN, MINIMUM AND MAXIMUM RANGE AT PRESENTATION IN THE 3 
ARTHROGRAPHIC GROUPS 
Capsulitis Group Rupture Group Normal Group 
(N=l5) (N=ll) (N=5) 
Mean Range Mean Range Mean Range 
TF 111 o (70-135) 90° (50-120) 86° (50-120) 
GF 52° (35- 70) 50° (20-65) 46° (30-70) 
TA 80° (30-110) 53° (20-110) 54° (35-90) 
GA 41° (20-70) 34° ( 0-60) 35° (30-45) 
ER 170 ( 0-35) 16° ( 0-30) 50 ( 0-10) 
TR 47° ( 20-80) 43° ( 0-80) 35° (20-60) 
TABLE 12:9 
MEAN RANGE OF THE MAIN MOVEMENT PARAMETERS AT DIFFERENT TIMES IN THE 
3 ARTHROGRAPHIC GROUPS 
A: TOTAL FLEXION 
Capsulitis Rupture Normal 
Group Group Group 
Presentation lll O 90° 86° 
At 6 Weeks 132° 113° ll8° 
At 3 Months 133° 123° 128° 
At 8 Months 148° 137° 144° 
At 44 Months 160° 155° 147° 
B: TOTAL ABDUCTION 
Capsulitis Rupture Normal 
Group Group Group 
Presentation 80° 53° 54° 
At 6 Weeks 108° 98° 88° 
At 3 Months ll8° 106° 108° 
At 8 Months 134° 128° 138° 
At 44 Months 148° 149° 138° 
C: TOTAL ROTATION 
Capsulitis Rupture Normal 
Group Group Group 
Presentation 47° 43° 35° 
At 6 Weeks 710 920 66° 
At 3 Months 81° 87° 58° 
At 8 Months 95° 113° 85° 
At 44 Months 147° 149° 138° 
TABLE 12: 10 
ARTHROGRAPHIC FEATURES IN PATIENTS WITH A 
TRAUMATIC OR SPONTANEOUS ONSET 
Spontaneous 
N Onset 
Capsulitis Group (15) 12 
Rupture Group (11) 7 
Normal Group (5) 4 
x2 with Yates Correction= 0.98, p Not Significant 






ASSOCIATION BETWEEN THE ARTHROGRAPHIC FEATURES AND ABNORMALITY 
OF IMMUNOLOGICAL PARAMETERS AT PRESENTATION 
Capsulitis Group Rupture Group Normal Group 
(N=l5) (N=ll) (N=5) 
N % N % N % 
Raised IC Levels 5 (33%) 5 (45%) 3 (60%) 
Raised CRP Levels 4 (27%) 1 (9%) 0 (0%) 
Raised ESR Levels 4 (27%) 1 (9%) 1 (20%) 
Reduced Con A 
Transformation 5 (33%) 5 (45%) 3 ( 60%) 
Reduced PHA 
Transformation 3 (20%) 4 (36%) 2 (40%) 
FIGURES I2 : I - 2. COMPARISON OF THE RATE OF RECOVERY OF THE 
PAIN SCORE AND RANGE OF MOVEMENT (L'.1C) IN PATIENTS ~JITH NORMAL .A.ND 
ABNORMAL X-RAYS OF THE SHOULDER AT PRESENTATION. 
weeks 
O 123456 
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F I G U R E I2 : 2. Improvement in range of movement (L1C). 
FIGURE I2 : 3. Arthrography showing marked irregularity of 
outline due to 'capsulitis'. 
FIGURE I2 : 4. Arthrography showing early lymphatic filling 
associated with 'capsulitis'. 
FIGURE I2 : 5. Arthrography showing rupture of the rotator 
cuff with contrast medium present in the shoulder joint and sub-
acromial bursa. The rotator cuff is indicated above the humerus. 
FIGURES I2 : 6 - 7. COMPARISON OF THE RATE OF RECOVERY OF THE 
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FIGURE I2 6. Improvement in pain score. 
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FIGURE I2 : 7. Improvement in range of movement (,1C). 
CHAPTER 13 
RADIO-NUCLEAR SCANNING AND THE FROZEN SHOULDER 
Wright et al (290) reported an increased uptake of 99-m technetium 
pertechnetate in 4 of 10 patients with capsulitis of the shoulder thus 
suggesting an inflammatory component. All 4 responded to intra-articular 
steroid as did one of the negative patients and it was felt that this might 
be a way of identifying steroid responsiveness. Stodell et al (258) 
confirmed the increased uptake of pertechnetate, but showed a greater uptake 
if the diphosphonate isotope was used. 
The aim of this study was to assess the technetium diphosphonate uptake at 
presentation and to examine its relevance to the initial symptoms and the 
subsequent rate and extent of recovery. 
PATIENTS AND METHOD 
Thirty-eight of the 42 Major Frozen Shoulder Study patients had 99-m 
technetium methylene diphosphonate scans performed before any treatment was 
given and usually on the same day and immediately before the arthrogram. 
Three hours after the injection of 10 - 15 mCi of 99-m technetium 
diphosphonate, an Elscint wholebody scanner was used to search for the 
hottest spot over each shoulder. The count was read with a 5 inch (12.7 cm) 
crystal and the ratio of the counts at the affected/unaffected shoulder (the 
uptake ratio) was calculated. 
Forty patients of similar age and sex with no shoulder complaints but having 
diphosphonate scans for unrelated reasons also had counts taken over both 
shoulder to provide a control group. The count showed little variation 
between shoulders whether dominant or non-dominant, so control ratios were 
obtained from uptake in the right/left shoulders. 
RESULTS 
Thirty-five of the 38 patients had an increased technetium diphosphonate 
uptake (Figure 13:1-2) in the affected shoulder when compared to the 
opposite side (uptake ratio greater than 1), 11 of these scans showing more 
than a 50% increase in uptake. Comparison of the 2 shoulders (unpaired 
t-test) showed the increase in uptake by the affected shoulder to be 
significant (p<0.0001). The distribution of the uptake ratios (Figure 13:3) 
showed a mean of 1.31 in the patients and 1.04 in the controls, the 
difference again being significant (p<0.001, unpaired t-test). 
The 11 patients with an uptake ratio of 1.5 or more (High Scan Uptake Group) 
were compared to the 27 patients with a lower uptake ratio (Low Scan Uptake 
Group) to assess its relevance to initial severity of symptoms and the rate 
and extent of recovery. 
The High Scan Uptake Group had a higher mean pain score at presentation and 
also at 8 months follow-up when compared to the Low Scan Uptake Group, but 
the difference between the groups was not significant (Table 13:1). The 
former group also showed a slower rate of recovery of the pain score within 
the first 6 weeks, but no difference thereafter (Figure 13:4). When the 
patients were reviewed from 40 - 48 months after presentation, 4 of 10 (40%) 
in the High and 6 of 27 (22%) in the Low Scan Uptake Groups still had some 
shoulder pain. 
The passive range of movement as assessed by the principal component also 
showed greater restriction (Table 13:2) in the High Scan Uptake Group at 
presentation and also at 8 and 44 months follow-up. The difference at 8 
months just failed to reach significance. However, the rate of recovery of 
the principal component was similar in both groups (Figure 13:5). 
The incidence of abnormally raised immune complex, CRP and ESR levels and 
reduced stimulation to PHA and Con A at presentation was independent of the 
technetium uptake (Table 13:3). There was also no association between the 
arthrographic features and technetium uptake (Figure 13:6). 
An uptake ratio )1.5 was found in 4 of 19 patients (21%) who presented 
within 3 months of the onset of symptoms and 7 of 12 (37%) who presented 
from 4 - 12 months. Three of 10 (30%) with a traumatic and 8 of 28 (29%) 
with a spontaneous onset of symptoms had a high uptake ratio, so that the 
duration of symptoms and type of onset did not influence the technetium 
uptake. 
DISCUSSION 
This study confirmed (258) the increased uptake of technetium diphosphonate 
by the painful stiff shoulder when compared to the opposite side or a 
control group, but has not shown any significant correlation with the 
duration of symptoms, type of onset (traumatic or spontaneous), initial 
severity or recovery. Patients with a marked increase in technetium uptake 
showed no better recovery than those with little or no increase. The 
explanation for the increased uptake of the diphosphonate ('bone-seeking') 
isotope remains unclear. Only 2 of the patients had macroscopic 
calcification of the supraspinatus tendon on plain X-ray. Microscopic 
calcium hydroxyapatite crystal deposition, increased vascularity (101) and 
interaction between collagenous structures and microcrystalline complexes 
containing calcium (290) have been suggested. 
An increased uptake of technetium diphosphonate in frozen shoulder lesions 
has been confirmed but this has not been found useful in the assessment of 
the painful stiff shoulder. 
TABLE 13: 1 
COMPARISON OF PAIN SCORES AT PRESENTATION AND 8 MONTHS FOLLOW-UP 
IN PATIENTS WITH HIGH OR LOW SCAN UPTAKE RATIOS 
N 
Low Scan Uptake Group 27 
High Scan Uptake Group 11 
Unpaired T-test 
*=Not Significant 
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COMPARISON OF PRINCIPAL COMPONENT AT PRESENTATION, 8 AND 44 MONTHS 






Uptake Group 3.3 (7.0) 
High Scan 
Uptake Group -11.1 (11.0) 
Unpaired T-test * 























INCIDENCE OF ABNORMAL IMMUNOLOGICAL PARAMETERS IN PATIENTS 
WITH HIGH AND LOW SCAN UPTAKE RATIOS 
Low Scan Uptake High Scan Uptake 
Group (N = 27) Group (N = 11) 
no. % no. % 
Raised IC Levels 16 (59%) 4 (36%) 
Raised CRP Levels 5 ( 19%) 2 ( 18%) 
Raised ESR Levels 6 (22%) 3 (27%) 
Reduced Con A Transformation 11 (41%) 4 (36%) 
Reduced PHA Transformation 11 (41%) 3 (27%) 
FIGURES I3 : I - 2. TECHNETIUM DIPHOSPHONATE SCANS FROM TWO 
FROZEN SHOULDER PATIENTS SHOWING THE INCREASED UPTAKE OF ISOTOPE BY 
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FIGURE 13 : 3. Technetium uptake ratios in frozen shou 1 d~r 
(affected/unaffected) patients and controls (right/left) showing 
the mean value in each group. 
FIGURES I3: 4 - 5. COMPARISON OF THE RATE OF RECOVERY OF THE 
PAIN SCORE AND RANGE OF MOVEMENT (LlC) IN PATIENTS WITH A HIGH AND LOW 
TECHNETIUM UPTAKE RATIO AT PRESENTATION. 
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FIGURE I3 : 6. The technetium uptake ratios in patients in 
the different arthrographic groups. 
CHAPTER 14 
THERAPY AND THE FROZEN SHOULDER 
A wide range of therapeutic regimes have been suggested to treat painful 
stiff shoulders. These include locally injected and oral steroids, 
physiotherapy, manipulation under anaesthesia (MUA), infiltration brisement 
(249), radiotherapy, stellate ganglion block (280) and traction associated 
with transcutaneous nerve stimulation (232). There is no general agreement 
in favour of one form of treatment and the response to a particular 
treatment varies in different series. Hazleman (113) in a retrospective 
survey of 130 patients, could not find any difference in outcome in patients 
treated with local steroid injections, physiotherapy or MUA. 
Disuse and immobility have for a long time been considered important in the 
aetiology of the frozen shoulder and prophylactic and therapeutic exercise 
has been advocated alone or in combination with other measures (53, 159, 
248). Lee et al (153) showed that an exercise programme produced equally 
beneficial effects if it was combined with local steroid injections at 
different sites or heat. All these groups had a better outcome than was 
obtained using simple analgesics but without exercise. Quin (224) also 
showed that exercise alone was as effective as a similar regimen combined 
with ultrasound. Watson-Jones (272) and more recently Neviaser (200), 
Jayson (132) and Bruckner (25) have considered simple pendular exercise as 
effective as any other therapeutic measure. Heat and massage with or 
without an exercise programme (32, 159, 249), ultrasound (28, 154, 192) and 
shortwave diathermy (66) have all produced conflicting results. When the 
studies of ultrasound included a control group (15, 83, 189), the beneficial 
effects were much less evident. Ice packs are widely employed in 
physiotherapy departments for the treatment of the frozen shoulder 
especially in the acute phase, but little literature exists to support their 
use. 
Local steroid injections have been used in this condition since Hollander's 
report (124) of encouraging results. Lloyd-Roberts and French (164) 
reported that steroid injections and MUA were superior to oral steroids. 
Roy and Oldham (238), Crisp and Kendall (55) and Steinbrocker and Argyros 
(256) claimed much better results if multiple sites of injection were used. 
Quin (223) found that local steroid injections reduced the pain but did not 
accelerate the recovery of the range of movement. Murnaghan and McIntosh 
(194) were unable to show that local steroid injections were any more 
effective than local anaesthetic agents injected in a similar way. Cyriax 
and Trosier (59), Glyn and Newton (93), Fearnley and Vadasz (79) and 
Hollingsworth et al (125) failed to demonstrate any beneficial effects and 
Neviaser (201) even suggested that a marked response to this therapy cast a 
doubt on the accuracy of the original diagnosis. 
The use of oral (systemic) steroid therapy has been subjected to even less 
controlled study. Ehlich et al (78), Coventry (53), Bateman (13) and Bland 
et al (17) have advocated its use without study. Blackey et al (19) 
compared oral steroids to placebo in 31 cases of frozen shoulder and 
reported significant improvement in pain but not range of movement in the 
treated group. Kessel et al (139) also found oral steroids and MUA more 
effective than MUA alone. However, Lloyd-Roberts and French (164) reported 
systemic steroids to be of little benefit. 
Manipulation under anaesthesia has been variously accepted as the treatment 
of choice (105, 106, 118, 286) or outrightly condemned (62, 241) because of 
unacceptable side effects. Bloch and Fisher (18) reported an 80% success 
rate for MUA in the treatment of over 2000 frozen shoulder lesions. Thomas 
et al (263) also found MUA and steroid injections superior to injection 
alone. Kessel et al (139) felt oral steroids and MUA were most effective. 
Charnley (39), Reeves (226) and Lundberg (168) found MUA useful in reducing 
pain but less effective in improving range. Many reports (62, 176, 231, 
241) considered MUA too hazardous for routine use, as it sometimes resulted 
in tears of the capsule and rotator cuff, fracture or dislocation of the 
humerus, nerve injury or haemorrhage around the shoulder. Poor efficacy 
(32, 231) has also been reported in many studies. 
Non-steroidal anti-inflammatory agents (NSAIDS) and simple analgesics are 
still the mainstay of general practitioner treatment of the PSS but have not 
been subjected to controlled study. Lee et al (153) found analgesics much 
less effective than any other treatment regimes providing the latter 
included an exercise regime. Duke et al (72), Rhind et al (229) and 
Huskisson and Bryans (130) compared different NSAIDS to each other and were 
not convinced that this therapy influenced the natural history of the 
condition. 
Based on the physiotherapeutic policy in Cambridge at that time, the Major 
Frozen Shoulder Study sought to assess the value of mobilisation exercise 
and ice therapy compared to steroid injection in treating the frozen 
shoulder. Home pendular exercise was considered as the minimum therapy 
possible and was given to all the patients, but was the only treatment given 
to the control (non-treatment) group. The value of oral prednisolone was 
then assessed in the Supplementary Frozen Shoulder Study again comparing the 
response to home pendular exercise (non-treatment), which was performed by 
all the patients. MUA is still advocated by some people as the treatment of 
choice, but was not in use in Cambridge in view of the potentially serious 
risks. It was therefore not included in the studies. 
PATIENTS 
A. The Major Frozen Shoulder Study: The 42 patients were randomly 
allocated to one of four treatment groups using a predetermined 
randomisation schedule:-
1. Steroid Injection Group (11 patients). 20 mg of methylprednisolone 
acetate and 0.5 ml of 1% lignocaine hydrochloride was injected into the 
subacromial bursa and a similar amount into the shoulder joint by the 
anterior route. Both injections were given weekly for 3 weeks. 
2. Mobilisation Group (11 patients). Maitlands mobilisations (171) were 
given to these patients by a research physiotherapist. Therapy was given 
for 30 minutes, three times a week for 6 weeks. 
3. Ice Therapy Group (12 patients). Ice packs followed by proprioceptive 
neuromuscular facilitation (PNF), was supervised by the same research 
physiotherapist with a similar time schedule to the Mobilisation Group. 
4. Non-treatment Group (8 patients). 
All the patients were taught pendular exercise and advised to do them for 2 
- 3 minutes every hour. Non-salicylate analgesics and diazepam 5 mgs at 
night were available as required. 
B. The Supplementary Frozen Shoulder Study: The 40 patients in this study 
were randomly allocated to one of two groups:-
1. Oral Steroid Group (20 patients). 10 mg of enteric coated prednisolone 
was given to these patients as a morning-only dose for a period of 4 weeks. 
The dose was then reduced to 5 mg for a further 2 weeks before therapy was 
stopped. 
2. Non-treatment Group (20 patients). 
All the patients in this study were also taught pendular exercise using an 
identical regime to the Major Study. Analgesics and nocturnal diazepam was 
also permitted if required. 
The Major Study patients were assessed weekly for 6 weeks and monthly for a 
further 6 months, while the Supplementary patients were seen fortnightly for 
6 weeks and then monthly till the 8 months follow-up period was complete. 
RESULTS 
A. The Major Frozen Shoulder Study: While the steroid injection group 
showed an initial advantage and the ice therapy group a disadvantage in the 
rate of improvement in 'pain at night' (Figure 14:1), one-way analysis of 
variance did not show the difference between the groups to be significant. 
The rate of recovery of 'pain on movement' (Figure 14:2) was also similar in 
all 4 groups. However, the steroid injection and mobilisation groups had a 
better (not significant) initial improvement in 'pain at rest' (Figure 
14:3). The (summated) pain score (Figure 14:4) showed an overall initial 
advantage for the steroid injection group, although analysis of variance 
still failed to show the difference between the groups to be significant. A 
comparison of the mean pain score in the treatment groups at presentation 
and at 8 months follow-up revealed no significant differences at either time 
(Table 14:lA). At 8 months, severe and disabling pain was still present in 
3 patients treated with ice therapy; 2 with mobilisation physiotherapy; 1 
with steroid injection and 2 with no therapy. When 40 of the patients were 
reviewed at a mean follow-up of 44 months, mild residual pain was present in 
3 of the mobilisation group (30%), 4 of the ice therapy group (33%), 3 of 
the steroid injection (30%) and 2 of the non-treatment (25%) patients. The 
one patient with severe pain and restriction at this time had received 
mobilisation physiotherapy. 
From the graphs (Figure 14:5-9), it can be seen that the initial rate of 
improvement in the individual movement parameters and the principal 
component was more rapid in the steroid injection group, although this 
advantage was not maintained after 3 months. This difference between the 
groups was confirmed by performing a one-way analysis of variance on the 
mean principal component in the four treatment groups at different times 
during the study (Table 14:2). At presentation, the non-treatment group had 
a better range - that is a higher principal component - although there was 
no signficant differences between the groups. At the end of therapy (at 6 
weeks), the steroid injection group had the best range - that is the highest 
principal component, and the mobilisation group the worst range. Analysis 
of variance showed that the groups differed significantly at the 2% level. 
The mobilisation group continued to recover more slowly, but at the end of 
the study (8 months) there was no significant difference between the groups. 
However, this trend for a slower recovery by the mobilisation group 
continued even after 8 months. While analysis of variance did not show a 
significant difference between the groups at review (44 months), contrasting 
the principal component in the mobilisation group with that in the other 3 
groups (general linear models procedure) showed a significant difference at 
the 5% level. The mean and the maximum and minimum ranges of individual 
movement parameters in the treatment groups at presentation (Table 14:3A) 
showed no significant differences between the groups, although the 
non-treatment group had a slightly better and mobilisation group a slightly 
worse range. The range at 8 months showed greater restriction of all 
movement parameters in the mobilisation group and no difference between the 
other groups (Table 14:4A). This poor outcome for the mobilisation group 
was even more marked at review (Table 14:5). While analysis of variance 
still failed to show a significant difference between the groups, 
contrasting the range of the mobilisation group with the other 3 groups 
(general linear models procedure) showed a significantly worse range (at the 
5% level) for the mobilisation group for all individual movements except 
external rotation. 
B. The Supplementary Frozen Shoulder Study: The oral prednisolone group 
showed a significantly more rapid initial improvement (p<0.05, Wilcoxon rank 
sum tests) in 'pain at rest' (Figure 14:10) and 'pain at night' (Figure 
14:11) when compared to the non-treatment group. The level of significance 
is indicated on the graphs. 'Pain on movement' (Figure 14:12) also showed 
an advantage for the treated group, but the difference was not significant. 
However, the recovery of the (summated) pain score was significance (Figure 
14:13). After the prednisolone was tailed off, two prednisolone treated 
patients had a recurrence of severe pain and four mild pain which settled 
spontaneously. After 6 weeks, there was no difference in the level of pain 
in the 2 groups. The mean pain score in the treatment groups was similar 
at presentation and at the end of the study (Table 14:lB). At 8 months, 3 
patients (2 in non-treatment group) still complained of severe pain and one 
other could not sleep on the affected side. There was no advantage for the 
treated group in recovery of individual movement parameters including total 
flexion (Figure 14:14), total abduction (Figure 14:15), total rotation 
(Figure 14:16) and external rotation (Figure 14:17). A cumulative recovery 
curve using the principal component also failed to show a significant 
difference between the groups (Figure 14:18). The range of movement at 
presentation (Table 14:3B) and at 8 months follow-up (Table 14:4B) and the 
principal components at these times (Table 14:6) showed no significant 
differences between the groups. 
SIDE-EFFECTS OF THERAPY 
Three of the patients treated with local steroid injections complained of 
exacerbation of the shoulder pain lasting for 12-24 hours after the 
injections. Five of the mobilisation group also noted an increased ache 
especially at rest following the physiotherapy sessions. Two patients 
developed mild indigestion on full dosage oral prednisolone which settled on 
reducing the dose. No other untoward reactions were reported. 
DISCUSSION 
Therapy for the frozen shoulder remains empirical as few long-term 
prospective studies have been performed. The therapeutic measures most 
widely used in Cambridge to treat the frozen shoulder were subjected to 
careful study. Both pain and passive range of movement were recorded at 
each visit to determine if any of the therapeutic measures could influence 
the rate or extent of recovery. Recovery curves in both frozen shoulder 
studies showed that the most marked improvement in pain and range occurred 
within 4 - 6 weeks of initiating therapy, suggesting that a course of 
therapy should be limited to this period. Manipulation under anaesthesia 
was not included in the studies as the potential side-effects of this 
therapy were considered to be unacceptable. 
Roy and Oldham (238) reported an excellent response to paired local steroid 
injections. A similar steroid dosage, frequency and method of injection was 
used in the Major Study but with less satisfactory results. While 95% of 
their 55 patients were pain-free 8 weeks after being seen, only 36% of 
patients in this study and treated with steroid injections were pain-free at 
the same stage. 
also achieved. 
Similarly less improvement in the range of movement was 
These differences may reflect patient selection - our 
patients were more severe - and differences in measurement techniques. 
Nevertheless, steroid injection therapy was the most effective treatment in 
the Major Study with regard to a reduction in pain and to a lesser extent 
improvement in passive range. However, this benefit was only short-lived. 
The report by Blackey et al (19) that oral steroids are effective at 
decreasing pain, but have no effect in hastening the recovery of range of 
movement was confirmed. Only two patients had recurrence of symptoms after 
stopping this therapy and few side-effects were encountered. Non-steroidal 
anti-inflammatory agents are ineffective in reducing pain in this condition 
so the anti-inflammatory actions of steroid may not alone explain their 
efficacy whether given by local injection or systemic routes. 
The patients who received Maitland's mobilisations (171) as part of the 
physiotherapy treatment in the first 6 weeks, had the least satisfactory 
outcome at both 8 and 44 months. This group had slightly greater 
restriction at presentation and may not be strictly comparable to the other 
groups, but the differences were not significant at that time and only 
became so during the follow-up period. This suggests that active 
physiotherapy in the acute stage may aggravate the condition and should 
probably be avoided. Lee et al (152) reported very good results with 
physiotherapy, but they studied a slightly different group of patients in 
that 16/25 of their patients had suffered symptoms for more than one year. 
Their placebo group was measured after 6 weeks, while the active treatment 
groups were measured weekly and this may have influenced their results. The 
ice packs proved to be ineffective in terms of pain relief and improvement 
in range and like mobilisation exercises did not justify the time and 
expense for patient or physiotherapist. 
Home pendular exercise alone produced a less satisfactory initial reduction 
in pain than steroid given by injection or orally. Nevertheless these 
patients did improve rapidly within the first 4 weeks after inclusion in the 
study, following a similar recovery curve to the other treatment groups. 
There was also no difference in the rate of recovery of range in these 
patients when compared to the other groups. Indeed the long-term results 
are better than the mobilisation group in the Major Study. Home pendular 
exercise was chosen for the control (non-treatment) groups as it was 
considered impossible and unethical to offer these patients no treatment 
during regular follow-up over a prolonged period. These patients received 
no hospital treatment and permitted study of the natural history of the 
frozen shoulder subjected to the minimum therapy. A comparison of the 
improvement in the non-treatment group before with that after entering the 
study is difficult, but supports the belief (25, 132, 272) that home 
pendular exercise may be important in initiating recovery in this condition. 
The role of pendular exercise requires further study. 
In summary, paired local steroid injection therapy was most effective in 
accelerating recovery, but these benefits were only short-lived. Oral 
steroids also reduced shoulder pain but did not enhance the recovery of the 
passive range of movement. Physiotherapy especially assisted mobilisations 
were possibly detrimental to the recovery of range and should probably be 
avoided. The improvement in pain and passive range in the patients who only 
performed home pendular exercises was much better after than before 
inclusion in the studies and suggests that this therapy may be important in 
promoting recovery in this condition. 
TABLE 14:1 
COMPARISON OF THE (SUMMATED) PAIN SCORE AT PRESENTATION AND 8 MONTHS 
FOLLOW-UP IN THE TREA'IMENT GROUPS OF (A) MAJOR FROZEN SHOULDER AND 
(B) SUPPLEMENTARY FROZEN SHOULDER STUDIES 
N 
Pain Score at 
Presentation 
Mean (SEM) 
A. MAJOR FROZEN SHOULDER STUDY 
Mobilisation 11 17.2 ( 1. 2) 
Group 
Steroid Injection 
Group 11 15.0 ( 1.1) 
Ice Therapy 
Group 12 14.6 ( 1. 6) 
Non-Tr ea tmen t 
Group (I) 8 11. 8 ( 1. 4) 




1.5 (0. 8) 
3.8 ( 1. 4) 
0.4 (0.4) 









(0. 7) 1.1 (0.4) 
( 1. 2) 1. 2 (0.4) 
Mean Recovery 








COMPARISON OF MEAN PRINCIPAL COMPONENTS IN THE 4 
MAJOR FROZEN SHOULDER TREATMENT 
GROUPS AT DIFFERENT TIMES DURING THE STUDY 
MEAN PRINCIPAL COMPONENT 
At Presentation 
(Time O) 
Mobilisation Group - 7 .1 
Steroid Injection Group -7. 7 
Ice Therapy Group -1.3 
Non-Tr ea tmen t 
Group (I) 16 
* 
+ 
Analysis of Variance 
Contrasting Mobiliation Group 










End of At Review 
Study 
(8 Months) (44 Months) 
85.S 124.9 
110. 6 150.0 
109.0 148.4 
113. 2 151. 2 
+ 
TABLE 14:3 
RANGE OF MOVEMENT IN THE THERAPY GROUPS AT PRESENTATION 
Total Total Total 
Flexion Abduction Rotation 
External 
Rotation 
N Mean (Range) Mean (Range) Mean (Range) Mean (Range) 
A. MAJOR FROZEN SHOULDER STUDY 
Mobilisation Group 11 94° 710 33° 50 
(50-120) ( 20-100) (0-70) (0-30) 
Steroid Injection 11 95° 61° 45° 19° 
Group (60-130) (20-110) (20-80) (0-35) 
Ice Therapy Group 12 100° 65° 47° 14° 
(70-135) (40-135) (20-80) (0-30) 
Non-treatment 8 106° 84° 53° 15° 
Group (I) (80-130) ( 40-120) (20-100) (0-50) 
B. SUPPLEMENTARY FROZEN SHOULDER STUDY 
Oral Steroid Group 20 106° 79° 54° 22° 
(60-135) (45-120) (10-80) (5-40) 
Non-treatment 20 111 o 87° 61° 20° 
Group (II) (70-140) (40-120) (20-130) (0-50) 
TABLE 14:4 
RANGE OF MOVEMENT IN THE THERAPY GROUPS AT 8 MONTHS FOLLOW-UP 
Total Total Total External 
Flexion Abduction Rotation Rotation 
N Mean (Range) Mean (Range) Mean (Range) Mean (Range) 
A. MAJOR FROZEN SHOULDER STUDY 
Mobilisation Group 11 138° 123° 84° 33° 
(80-160) ( 60-160) (50-115) (0-60) 
Steroid Injection Group 11 147° 137° 107° 47° 
(140-160) (85-175) (80-125) (15-70) 
Ice Therapy Group 12 145° 140° 104° 41° 
(120-160) (90-160) (60-140) (15-70) 
Non-treatment Group (I) 8 148° 139° 108° 41° 
(130-160) (100-160) (65-160) (25-65) 
B. SUPPLEMENTARY FROZEN SHOULDER STUDY 
Oral Steroid Group 20 147° 138° 116° 40° 
(110-175) (90-170) (80-160) (25-80) 
Non-treatment Group (II) 20 153° 142° 116° 41° 
(130-170) (100-165) (65-165) (25-70) 
TABLE 14:5 
COMPARISON OF MEAN RANGE OF MOVEMENT AT REVIEW IN THE 4 MAJOR 
FROZEN SHOULDER TREA'IMENT GROUPS 
Mobilisation Steroid Injection Ice Therapy Non-treatment 
Group Group Group Group 
(N= 11) (N= 10) (N= 11) (N=8) 
Mean (Range) Mean (Range) Mean (Range) Mean (Range) 
TF 147° (90-170) 161° (140-175) 156° (140-175) 163° (160-170) 
TA 135° (70-175) 150° (110-165) 152° (130-175) 151° (140-165) 
TR 132° (70-180) 153° (120-175) 152° (139-170) 154° (125-180) 
ER 46° (15- 80) 52° (40- 75) 55° (30- 70) 57° (40- 80) 
TABLE 14:6 
COMPARISON OF MEAN PRINCIPAL COMPONENT AT PRESENTATION AND 8 MONTHS 
FOLLOW-UP IN THE SUPPLEMENTARY FROZEN SHOULDER TREA'IMENT GROUPS 
Presentation 
8 Months Follow-up 
N/S = Not Significant 
Oral Steroid 
Group 














FIGURES I4 : I - 4. MEAN IMPROVEMENT IN PAIN PARAMETERS AND 
PAIN SCORE IN THE MAJOR FROZEN SHOULDER STUDY TREATMENT GROUPS. 
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FIGURES I4 : 5 - 8. MEAN IMPROVEMENT IN INDIVIDUAL MOVEMENT 
PARAMETERS IN THE MAJOR FROZEN SHOULDER STUDY TREATMENT GROUPS. 
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FIGURE I4: 9. Comparison of the recovery in the cummulative 
principal component (.dC) in the Major Frozen Shoulder Study 
treatment groups. 
FIGURES I4 : IO - I3. MEAN IMPROVEMENT IN PAIN PARAMETERS AND 
PAIN SCORE IN THE SUPPLEMENTARY FROZEN SHOULDER STUDY TREATMENT GROUPS. 
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FIGURE I4: I8. Comparison of the recovery of the cummulative 
principal component (LlC) in the Supplementary Frozen Shoulder Study 
treatment groups. 
PART IV 
PERSISTENT ROTATOR CUFF TENDINITIS AND 
PULSED ELECTRO-MAGNETIC FIELD THERAPY 
CHAPTER 15 
PERSISTENT ROTATOR CUFF TENDINITIS AND STUDIES OF 
PULSED ELECTRO-MAGNETIC FIELD (PEMF) THERAPY 
Rotator cuff tendinitis whether symptomatic or not, is believed to be the 
initiating lesion for the painful stiff (frozen) shoulder (45), although 
documentation of this progression is incomplete (233). Patient with 
persistent rotator cuff tendinitis lesions were therefore studied to 
determine if this progression was usual. As the lesion is common, it also 
permitted study of the earlier tendon lesions. Rotator cuff tendinitis is 
particularly disabling in patients who do not respond, or show no more than 
a transient response, to local corticosteroid injections (79), as all other 
forms of conventional conservative therapy are of limited or unproven 
benefit (15, 140). Of three hundred and twenty-eight patients with primary 
shoulder pathology referred to the shoulder clinic over a period of two 
years (see Chapter 4), 138 (42%) were diagnosed as having rotator cuff 
tendinitis. Twenty-three percent of this group failed to respond or derived 
no more than temporary benefit from local corticosteroid injections. This 
latter group formed the nucleus for the clinical studies. The possible 
relevance of partial interruption of the blood supply to the rotator cuff 
tendons by impingement between the humeral head and the acromion (170, 208) 
to the initiation of tendon degeneration has previously been considered. 
The conflicting views regarding the importance of trauma (45) and attrition 
with age (142, 180, 181) has also been presented. Irrespective of the cause 
of tendon degeneration, once present, this renders the rotator cuff liable 
to damage by trivial, often unrecognised trauma. As the vascular supply to 
adult tendon is normally poor, healing of these lesions is slow and often 
incomplete. 
Pulsed electro-magnetic fields (PEMF) have been reported to influence bone 
repair (10, 11, 191, 245, 262). Similar stimulatory effects have also been 
observed in nerve regeneration (147, 283), skin ulcer healing (287) and 
recovery from both soft tissue injuries of the ankle (284) and avascular 
necrosis of the femoral head (12). In addition, the formation of collagen 
has been promoted in various model systems (23, 82, 166). These findings 
prompted study of this therapy in rotator cuff tendinitis lesions which, 
despite the use of conventional therapy had persisted for over three months. 
Information on whether these patients with severe and long-standing rotator 
cuff tendinitis lesions did show progression to a painful stiff (frozen) 
shoulder was also sought. 
DIAGNOSTIC CRITERIA 
The diagnosis of rotator cuff tendinitis (RCT) was based on the criteria of 
Cyriax (58) - that is shoulder pain being exacerbated by movement against 
resistance in one or more of the following:-
abduction (supraspinatus tendinitis); external rotation (infraspinatus 
tendinitis); internal rotation (subscapularis tendinitis). Although the 
active range of shoulder movement was usually limited by pain, the passive 
range was approximately normal when compared to the opposite side or 
(age/sex) matched controls. A 'painful arc' on abduction was often but not 
invariably present. 
Patients were accepted if symptoms had persisted for at least 3 months with 
no more than transient benefit from previous conservative therapy and if 
lesions arose spontaneously or followed minor trauma. Patients were 
excluded if they had severe neck pain, neurological changes in the upper 
limbs, clinical or radiological evidence of glenohumeral, acromioclavicular 
or generalised arthritis, radiological calcification of the soft tissues, or 
a clinical diagnosis of rupture of the rotator cuff or a painful and 
restricted (frozen) shoulder. Subjects also needed a normal erythrocyte 
sedimentation rate (Westergren) and Rose-Waaler test for rheumatoid factor. 
15 patients with rotator cuff tendinitis of at least 3 months duration were 
included in a pilot study of PEMF therapy. As the results were promising, a 
further 29 patients were included in a double-blind controlled study. The 
data from both these studies will be presented separately. 
METHODS 
Shoulder Assessment: At each visit the following clinical parameters were 
recorded: 
1. Pain score. This consisted of the sum of the severity of pain at night, 
on movement and at rest (to the nearest 0.5 cm) as estimated by the patient 
on visual analogue scales as previously described. 
2. Pain on resisted movement. The pain induced by resisted abduction, 
external and internal rotation was assessed on a 4-point scale and the 
results summated (O = no pain; 1 = slight pain but full power; 2 = moderate 
pain and reduced power; 3 = severe pain with absent power against even 
minimal resistance). 
3. Painful arc on active abduction was also assessed on a 4-point scale (0 
= no pain; 1 = catching only at 1 point; 2 = painful arc; 3 = unable 
actively to overcome the painful arc). 
4. The total range of active movement was calculated as the sum of the 
range of total abduction, forward flexion and rotation. Measurements were 
made with a spirit goniometer (41) in an identical manner to the frozen 
shoulder studies but using active rather than passive movements. The 
passive range of movement was also recorded to detect progression to a 
painful stiff (frozen) shoulder, but these measurements were not used for 
serial assessment. 
5. Paracetamol tablets were permitted during both studies but non-steroidal 
anti-inflammatory agents were stopped. The number of analgesic tablets used 
each week was recorded and used as a parameter for serial assessment in the 
pilot but not the controlled study. 
Patients were reviewed fortnightly while undergoing therapy and monthly 
thereafter. 
The time at which the patient and the observer considered the shoulder much 
improved was also recorded. 
PEMF Regimen: A single ovoid coil (12.22:_l.2 x 13.2+0.7 cm
2
) consisting of 
50 turns of copper wire (1.4 mm diameter) covered by insulating tape was 
fitted over padding to the outer aspect of the affected shoulder so that it 
protruded through the centre. Two velcro straps held it in place. Patients 
were instructed to use the coil for 5 - 9 hours each day. Treatment 
sessions had to last at least 1 hour at any time. The coils were supplied 
with pulse generators set at 73+2Hz; waveform parameters (Figure 15:1) for 
each active coil were regularly checked so they did not vary by more than 
7%. For the controlled study, some patients initially used dummy coils 
which were identical to the active coils but provided no electro-magnetic 
stimulation. 
PILOT STUDY 
PATIENTS: Clinical details of the 15 patients included in the pilot study 
are shown (Table 15:1). Previous therapy given to these patients will be 
considered together with the controlled study. All the patients used active 
coils for 4 - 8 weeks but remained under follow-up for at least 20 weeks. 
One patient failed to complete 4 weeks therapy and was withdrawn from the 
study. 
RESULTS: The improvement in the mean score for pain, painful arc on 
abduction, pain on resisted movement, active range and the decrease in 
analgesic consumption is summarised in Table 15:2. The maximum improvement 
in all clinical parameters was noted within 4 weeks of initiating therapy. 
By 16 weeks, 7 patients (50%) were asymptomatic; 5 (35%) patients had only 
minor residual disability; 2 were unchanged and 1 had developed a painful 
stiff shoulder. 
SIDE-EFFECTS: One patient with a past history of cervical spondylosis and a 
cervical laminectomy had recurrence of neck pain and neurological 
abnormality in both upper limbs following successful treatment of the 
shoulder. Therapy was otherwise well tolerated. 
DOUBLE-BLIND STUDY 
STUDY DESIGN: Patients fulfilling the entrance criteria were randomly 
allocated to the treated group (A), or the control group (B). In the first 
4 weeks (phase I), group A received active coils and group B received dummy 
coils. Neither patient nor medica, assessor was aware of the treatment 
group. At the end of the 4 weeks and without breaking the code, both groups 
were given active coils and therapy was continued for another 4 weeks (phase 
II). Treatment was then stopped but patients continued to be reviewed for 
another 8 weeks (phase III), at the end of which the grouping was revealed 
to patient, medical assessor and others involved in the study. After the 
code was broken patients were either discharged or offered alternative 
therapy. 
STATISTICAL ANALYSIS: The rate of recovery of each clinical parameter in 
the two groups from time Oto each follow up visit was compared by the use 
of Wilcoxon rank sum tests. 
RESULTS: 
Patients: 29 fulfilled the criteria for the study. 15 entered the treated 
group (A) and 14 the control group (B). There were no significant 
differences between the groups (Table 15:3). The supraspinatus tendon was 
most commonly affected, although this was often in association with 
infraspinatus involvement. All the lesions arose spontaneously. 
Twenty-eight of the 29 patients had received non-steroidal anti-inflammatory 
agents (NSAIDS) before inclusion in the study, but only 3 patients (12%) 
found them beneficial. Analgesics on the other hand were considered to be 
of some value in 8 of the 18 patients (44%) who had received this therapy. 
A particular benefit was reduction of night pain facilitating sleep. 
Twenty-seven of the 29 patients had also received local steroid injection 
(mean 2.2 injections) therapy, but not within 1 month of inclusion in the 
study. Two patients (1 in each group) had refused injection therapy because 
of the pain induced by this therapy during treatment of lesions in the 
opposite shoulder. In the pilot study, 2 of 13 (15%) patients found NSAIDS 
helpful and 5 of 12 (42%) found analgesic tablets of value. All these 
patients had prior local corticosteroid injection (mean 3.5 injections) 
therapy. 
Phase I (Week O - 4): The improvement in the mean pain score (Figure 15:2) 
was greater in the treated than the control group at both 2 (p(0.05) and 4 
(p(0.02) weeks. The reduction in the scores for the painful arc on 
abduction (Figure 15:3) and for pain on resisted movement (Figure 15:4) and 
the improvement in range (Figure 15:5) showed an even greater advantage 
(p(0.005) for group A, at both 2 and 4 weeks. 
Phase II and III (Weeks 4 - 16+): With the rapid improvement in group B 
after the change to active coils (Figures 15:2-5), there was no significant 
difference between the groups in any of the clinical parameters at week 6. 
Although 7 patients (25%) had a minor flare-up of symptoms after stopping 
therapy (phase III), this resolved without further treatment. 
Outcome: Nineteen of 29 patients (66%) were symptom-free at week 16 (Table 
15:4) and were discharged. Of the 10 who remained under follow-up, 2 became 
symptom-free; 3 were discharged with only minor residual disability; 2 had 
pain and tenderness at the acromioclavicular joint and received local 
steroid injections; and 3 had no improvement despite further steroid 
injections into the subacromial bursa. No untoward reactions occurred 
during the study, although many patients found the coils cumbersome 
especially at night. 
Timing of Maximum Improvement: If the 4 weeks of placebo therapy in group B 
were disregarded, maximum subjective pain relief occurred at a mean of 5.7 
weeks (range 2 weeks to 6 months). Full recovery on examination was, 
however, delayed until 13.2 weeks (4 weeks to) 6 months) from initiating 
therapy. 
Factors of Possible Relevance to Outcome: Nineteen patients were able to 
sleep with the coils in situ and achieved treatment times of 6 - 10 (mean 
8.2) hours per day. The other 10 achieved treatment times of only 3 - 8 
(mean 4.7) hours per day during waking hours. Four patients (all group A) 
refused therapy after four weeks since symptoms has resolved. Thus 11 
patients had active therapy over 8 weeks and 18 patients over only 4 weeks. 
However, the duration of therapy did not affect the outcome. The duration 
of symptoms before the start of active therapy was also not important; but 
outcome was influenced by the severity of the lesion and in particular, 
involvement of more than one tendon which was present in 8 of the 10 
controlled study (and all 3 pilot study) patients who were still symptomatic 
at 4 months. The development of acromioclavicular tenderness (2 patients) 
was also associated with a poor result. Three of the 5 patients with 
recurrence of severe pain during the extended follow-up period were manual 
labourers and this activity was considered responsible for several of the 
minor and temporary flares following cessation of therapy. 
DISCUSSION 
Rotator cuff tendinitis is extremely common and is usually responsive to 
local corticosteroid injections, but 23% of these patients at the shoulder 
clinic responded poorly or only transiently to this treatment. The response 
to non-steroidal anti-inflammatory agents is usually unsatisfactory, but 
analgesics may be of some value, especially in patients in whom night pain 
is a prominent feature. The design of the controlled study was chosen 
because many patients in the pilot study improved rapidly with PEMP therapy. 
In the first phase, the treated group had a significant advantage over the 
placebo-treated control group, but the latter group soon improved once they 
were put on active therapy and no significant differences were noted 
thereafter. Patient and observer bias was minimised by maintaining the code 
relating to treatment groups until all the patients had completed 4 months 
of follow-up. 
Rotator cuff tendinitis, like many soft tissue lesions, offers few objective 
clinical parameters for use in serial follow-up. All 4 parameters chosen 
for this study reflect pain and therefore presumably severity of the 
underlying condition. All improved more with treatment than placebo. The 
pain score, based on visual analogue scales, was the most subjective 
parameter and showed a greater placebo effect and lesser (but still 
significant) advantage for the treated group than did the other 3 
parameters, which were based on observer assessment. Subjective improvement 
was noted by many of the patients before objective evidence of healing was 
recorded by the medical assessor. This difference suggests that there may 
be other local effects which induce pain relief. 
Treatment was generally well tolerated, although many patients found the 
treatment coils cumbersome and uncomfortable. The duration of therapy 
varied from 3 - 10 h per day over 4 - 8 weeks, but there was no evidence 
that either longer daily treatment sessions or longer overall treatment 
times conveyed an advantage. The stimulation signal pulse used was 
empirically based on other clinical (11) and experimental (82) data. 
More than 70% of patients improved on PEMF therapy. All the patients were 
followed up for at least 4 months, with few showing evidence of recurrence 
during this time. This study suggests that PEMF therapy is safe and may be 
effective in the treatment of persistent soft tissue lesions such as rotator 
cuff tendinitis which have been resistant to conventional conservative 
measures. 
Two of the 44 patients with persistent rotator cuff tendinitis lesions 
developed some restriction in the passive range of movement while under 
review. However, the loss of range was not severe enough to fulfill the 
criteria for a frozen shoulder. All the patients in the PEMF studies were 
encouraged to keep their shoulders moving and this may have influenced the 
clinical features. 
FURTHER CLINICAL STUDIES OF PEMF 
A pilot study of PEMF therapy was also carried out in 15 other patients with 
tendon lesions which had persisted despite therapy for at least 4 months. 
PATIENTS 
1. The Frozen Shoulder Group: 6 patients with frozen shoulder according to 
the previously described criteria were studied. All these patients were 
symptomatic despite prior local corticosteroid injection (mean 1.5 
injections) therapy. All except 1 patient had received NSAIDS with no 
benefit. 
2. The Tennis Elbow Group: 9 patients with tennis elbow were studied. All 
had received local corticosteroid (mean 5.3 injections) therapy and had used 
NSAIDS with no more than transient benefit. 
Details of patients included in the 2 groups is summaried in Table 15:5. 
Patients with neck pain, acromioclavicular joint tenderness or motor or 
sensory abnormality in the affected limb were excluded. All the patients 
had a normal sedimentation rate (Westergren), Rose-Waaler test for 
rheumatoid factor and normal plain X-ray of the affected region (shoulder or 
elbow). 
METHODS 
Clinical Assessment: Serial assessment of frozen shoulder patients included 
pain score (sum of pain at night, at rest and on movement), total passive 
range (sum of total flexion, abduction and rotation) and mean weekly 
paracetamol consumption. Tennis elbow patient assessment was with a pain 
score (10 cm horizontal visual analogue scales) and grip strength with the 
elbow extended and forearm pronated. The response to therapy in both frozen 
shoulder and tennis elbow groups on discharge was assessed as much improved, 
slightly improved or unchanged. 
PEMF Regimen: a single coil identical to that used in the tendinitis 
studies was fitted to the affected shoulder or elbow and treatment given as 
previously described using a similar regimen. All the coils were active and 
therapy was given over an 8 week period. Shoulder patients were asked to 
perform pendular exercise for 2 - 3 minutes each hour as previously 
described. 
RESULTS 
1. The Frozen Shoulder Group: The improvement in the clinical parameters 
with time (Table 15:6) suggested possible benefits for this therapy. All 6 
patients considered themselves much improved and this was substantiated on 
examination. 
2. The Tennis Elbow Group: The improvement in the clinical parameters is 
shown (Table 15:7). 2 patients withdrew before completing therapy due to 
lack of improvement and the discomfort induced by prolonged innnobilisation. 
A third patients withdrew from follow-up after 8 weeks of therapy with no 
benefit. The response to therapy (Table 15:8) showed marked improvement in 
5 patients (56%). The patient who was slightly improved by the therapy 
relapsed within 8 weeks of completing therapy. 
DISCUSSION 
Soft tissue lesions such as frozen shoulder and tennis elbow which becomes 
chronic or recurrent can considerably disrupt work or hobbies but are only 
rarely considered severe enough to justify surgery, usually only after 
prolonged attempts at conservative treatment. Only steroid injection has 
been shown to enhance resolution, but not necessarily prevent recurrence. 
All 15 patients with frozen shoulder or tennis elbow had received local 
corticosteroid injections with no more than transient benefit. The 6 
patients with frozen shoulder showed a satisfactory rate of recovery, but as 
these patients also performed home pendular exercise, the true value of PEMF 
requires further controlled study. Only five of the nine patients with 
lateral epicondylitis were improved, but all these patients had severe and 
chronic lesions. Some modification in the coil design may improve patient 
compliance and possible efficacy. 
The studies of PEMF have suggested a possible use in the treatment of tendon 
lesions which show no more than a transient benefit to conventional 
conservative therapy. 
TABLE 15:1 
CLINICAL DETAILS OF ROTATOR CUFF TENDINITIS 
PATIENTS IN THE PILOT STUDY (N=lS) 
Age (Years) Mean (Range) 
Male : Female 
57. 2 (30-80) 
Sex 
Arm Dominant : Non-dominant 
Onset Spontaneous : Traumatic 
Duration at Mean 
Presentation (months) (Range) 











(3 - 18) 
9 
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MEAN SCORE OF CLINICAL PARAMETERS DURING FOLLOW-UP OF THE PILOT STUDY 
* (N = 14 l 
Parameter Week 0 2 
Pain Score 14.5 6.6 
Painful Arc of Abduction 2.5 1.1 
Pain on Resisted Movement 3.6 2.3 
Active Range of Movement 184° 233° 
Analgesic Use/Week 20.8 12.3 



























CLINICAL DETAILS OF ROTATOR CUFF TENDINITIS PATIENTS 
IN THE CONTROLLED STUDY 
Mean Age (Years) 
Sex Male : Female 
Duration at Presentation (Months) 
































STATUS OF PATIENTS 16 WEEKS AFTER ENTRY INTO THE CONTROLLED STUDY 
Status at 16 Weeks 
Asymptomatic 
Minor Residual Symptoms 
Severe Disability 
Treated Group 










CLINICAL DETAILS OF PATIENTS IN THE PILOT FROZEN SHOULDER 
AND TENNIS ELBOW PEMF STUDIES 
Frozen Shoulder 
(N = 6) 
Lateral Epicondylitis 
(N = 9) 
Mean Age (Years) 58.8 40.5 
Sex - Male : Female 5:1 4:5 
Duration at Presentation (Months) 
Mean 10 24 
Range 5-18 7-84 
TABLE 15:6 
IMPROVEMENT IN MEAN CLINICAL PARAMETERS WITH TIME IN FROZEN 
SHOULDER PATIENTS TREATED WITH PEMF (N = 6~ 
Week 0 2 4 6 12 20 
Analgesics/Week 12.2 5.1 3.2 2.5 0 0 
Pain Sco!'e 15.4 10.0 5.0 2.4 0.2 0.5 
Total Passive Range 235° 283° 329° 367° 398° 433° 
TABLE 15:7 
IMPROVEMENT IN MEAN CLINICAL PARAMETERS WITH TIME IN TENNIS ELBOW 






* ** Week 0 2 4 6 
Score 3.5 2.4 2.6 1.4 
Strength (nnn Hg) 138 176 198 260 
1 Patient Withdrawn 
2 Patients Withdrawn 
3 Patients Withdrawn 
TABLE 15:8 
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FIGURE I5 : I. Wave fonns showing the magnetic flux density (TOP) 
and rate of change of magnetic flux density (BOTTOM) as measured by a 
Hall probe and search coil (7mm diameter), respectively. 
FIGURES IS : ·2 - 5. IMPROVEMENT WITH TIME IN THE CLINICAL 
PARAMETERS IN THE TREATED AND CONTROL ROTATOR CUFF TENDINITIS GROUPS. 
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PART V 
LATERAL HUMERAL EPICONDYLITIS - TENNIS ELBOW 
INTRODUCTION 
As the anatomy and function of the shoulder is so complex and the 
evaluation of conditions in this region so difficult, lateral epicondylitis 
which is discrete superficial and easy to diagnose clinically was chosen 
for study, despite some disagreement on its pathology and pathogenesis. 
Runge (1873) (239) first described the clinical features under the title 
"writers cramp". Morris (1882) (186) called it the "lawn tennis elbow", a 
sporting connotation which has persisted despite the recognition that this 
is an uncommon cause of the condition. Lateral humeral epicondylitis was 
proposed as a more accurate term, but general agreement on nomenclature has 
not been reached and tennis elbow and lateral (humeral) epicondylitis are 
used synonymously. 
CHAPTER 16 
REVIEW OF THE LITERATURE RELATING TO PATHOLOGY AND PATHOGENESIS 
OF LATERAL EPICONDYLITIS 
PATHOLOGY 
Degeneration and tears of the common extensor tendon (CET) close to its 
origin is the most widely accepted pathological lesion in tennis elbow, but 
many other local lesions have been proposed, on the basis of the few 
patients treated surgically after prolonged conservative therapy. It is 
uncertain if the abnormalities described are pathological or reflect the 
damage caused by local steroid injections and other therapy. 
The lesion was initially thought to be a 'traumatic periostitis' (123, 239, 
266, 276), but Carter (1925) (38) could not verify this and Hansson and 
Horwich (1930) (109) demonstrated experimentally that periosteal avulsion 
was more likely. Extra-articular bursitis was described by Osgood (1922) 
(209) and others (67, 213, 255) sometimes with calcification (35), but 
Goldie (1964) (94) in an extensive surgical study found no evidence of a 
bursa or inflammation or soft tissue calcification at this site. He found 
granulation tissue both deep to and involving the CET. Hyaline 
degeneration (20) or tears (182) of the orbicular ligament and 
chondromalacia (21) or fibrillation (202) of the radial head have been 
reported. Radio-humeral synovitis with pinching of synovial fringes (3, 
184, 265) and radio-ulnar arthritis (80, 236) have also been thought 
important in some cases. 
Cyriax (1936) (57) reviewed over 30 suggested sites of pathology and 
favoured degeneration in the CET close to its origin. Meherin and Cooper 
(1950) (178) and Sinclair (1965) (250) found definate evidence of 
tendinitis at this site and Spencer and Herndon (1953) (254) declared the 
tendon to be the only site of pathology in 93 operations over 10 years. 
Tears of the lower end of the CET have often been noted (50, 91, 121, 122) 
and Sarkar and Uhthoff (1980) (242) reported ultra-structural evidence of 
degeneration, tears and healing of the tendon at this site. Calcification 
has also been reported at this site (128, 173, 178, 268), but Cowan and 
Stone (1952) (54) found no relationship between the extent of calcification 
in the tendon and the severity of symptoms. Niepal and Sitaj (1979) (203) 
proposed enthesopathy as the underlying pathology. Lesions affecting the 
extensor carpi radialis brevis (36, 57, 90, 204, 260), pronator teres (185) 
and supinator tendons (236) have been suggested and surgical treatment 
directed at these sites. 
Nerve entrapment has been considered as a common cause of resistant tennis 
elbow (33, 65, 92, 146, 210, 235, 253, 285), with the posterior 
interosseous branch of the radial nerve being singled out for particular 
mention. Carpener (1966) (34) reported good results in 8 out of 10 chronic 
tennis elbow lesions treated by nerve decompression. Werner (1979) (275) 
in an extensive study concluded that 5% of resistant lesions could be 
attributed to nerve entrapment. Van Rossum et al (1978) (269) could not 
substantiate entrapment as a cause and Hagert et al (1977) (104) considered 
the 2 diseases as separate entities. Case reports of idiopathic posterior 
interosseous nerve compression (27, 120, 190) have stressed weakness and 
not pain. Kaplan (1959) (137) proposed radial neuritis as a cause, but 
this has not been substantiated. The association between tennis elbow and 
cervical spondylosis with radiculopathy (102, 134, 195, 247, 259) has been 
mentioned previously. 
PATHOGENESIS 
The excessive use of specific muscles was proposed by Runge (1873) (239). 
Edgar (1929) (76) felt this diverted blood away from the tendon to the 
active muscle predisposing to tendon degeneration. Forced gripping (76, 
183, 250) and repeated pronation and supination (57, 91, 184, 186, 271) 
have been considered important. Trauma has been considered as the main 
cause by some early workers (20, 38, 163, 236), but is not a common cause 
(89, 90, 121, 193) in most series. Hohl (1961) (121) felt that repeated 
minor trauma led to attrition of the tendon. Uhthoff and Sarkar (1980) 
(242) considered the lesion to be multifactorial with age-related 
degeneration and repetitive movements being important. 
While overuse or repetitive activities during manual labour, housework and 
hobbies are often mentioned as precipitating factors, many cases remain 
unexplained. 
DISCUSSION 
A historical review of the pathology and pathogenesis of lateral 
epicondylitis seems to high-light the marked disagreement expressed by 
different workers. While many of these hypotheses have not been subjected 
to critical analysis, the predominant view at the present time is that 
tennis elbow constitutes a degenerative process affecting the common 
extensor tendon at or close to its insertion. Niepal and Sitaj (203) 
considered the lesion to be an enthesopathy which was very similar to the 
rotator cuff lesions of the shoulder. The pathogenesis of the lesion is 
probably multifactorial with age-dependant tendon degeneration and 
repetitive rotatory movements playing an important role. 
CHAPTER 17 
CLINICAL FEATURES OF LATERAL EPICONDYLITIS; PATIENTS INCLUDED 
IN THE PROSPECTIVE AND RETROSPECTIVE STUDIES 
Runge (239) considered the disease to be occupational and Hohl (121), 
Goldie (94), Sinclair (250) and Kivi (143) documented its preponderance in 
some occupational groups. Morris (186), Nirschl (205), Gruchow and 
Pelletier (100) and Carroll (37) assessed the incidence of the lesion in 
tennis players and found it to be common. However, most series assessing 
the lesion in the general population show tennis to be an uncommon cause of 
symptoms (90). While toolwork, sport, hobbies or trauma often (94) 
precipitate symptoms, nearly half the patients in most series are not aware 
of any causative factors (121, 250). 
A review of the literature suggests that females are affected as frequently 
as males (50), with onset occurring from 30 - 65 years with a mean of 42 -
44 years in most series (50, 90, 94, 121, 235). Onset is rare before 20 or 
after 70 years of age. The marked dominant arm preponderance is documented 
in all reports (50, 94, 121, 235), although the condition can be bilateral 
(50, 205). Symptoms usually arise insidiously but can begin suddenly. 
SYMPTOMS 
Patients with tennis elbow experience pain around the lateral aspect of the 
elbow which is worse when the forearm extensors contract against 
resistance. Weakness of grip strength is often noted (94). The pain may 
radiate down the forearm and night pain and morning stiffness of the elbow 
sometimes occurs. 
SIGNS 
Severe local tenderness near the lateral epicondyle is the most striking 
feature. While this tenderness is usually anterior to the lateral 
epicondyle, the site of maximum tenderness can vary (61, 90, 94). The 
elbow pain is exacerbated by forced wrist dorsiflexion and sometimes by 
supination and pronation against resistance. Grip strength is always 
reduced due to pain. The active and passive range of elbow movement is 
usually normal, but is severe cases a few degree of elbow extension can be 
lost. 
PATIENT GROUPS 
141 patients with lateral epicondylitis were studied:-
A. The 'Prospective Group' 
Seventy-six patients suffering from lateral epicondylitis (Table 17:1) of 
at least one month's duration were included in the study. Criteria for 
inclusion were pain and localised tenderness near the lateral epicondyle of 
the humerus with exacerbation of pain on resisted wrist dorsiflexion and 
reduction in grip strength. Local arthritis of the elbow (clinical or 
radiological), generalised polyarthritis or neurological abnormality in the 
upper limbs resulted in patient exclusion. Patients who had a single 
steroid injection were included if symptoms persisted for at least one 
month. However, more than one injection resulted in patient exclusion. 
B. The 'Retrospective Group' 
Seventy-seven patients treated in the rheumatology outpatient department in 
Cambridge from 1 - 5 years previously were sent questionnaires with regard 
to therapy, side-effects, initial outcome and subsequent course. Where 
possible the information was verified from the case records. Sixty-five of 
the 77 patients completed the questionnaires - 3 had died and 9 could not 
be traced. Mean follow-up was 39.5 (range 12 - 60) months. 
PATIENT DETAILS 
Patients: Of 141 patients included in the 2 groups, 79 were female and 62 
male. Age range at presentation was 29 - 65 (mean 43.5) years. Treatment 
was to the dominant arm in 106, non-dominant in 31 and both arms in 4 
cases. The duration of symptoms at presentation varied from 1 - 12 (mean 
4.5) months in the prospective group. This information was not available 
from the retrospective group. The clinical details are summarised in Table 
17:1. 
Aetiology: Seventy-four patients (52%) attributed symptoms to specific 
activities especially housework, toolwork, lifting or sports (Table 17:2). 
Trauma to the elbow was an uncommon cause. The other 67 patients (48%) 
could not recall any causative factors. 
Occupation: The occupations of the patients at the time of presentation 
are shown (Table 17:3). The majority were housewives, domestic workers, 
sedentary workers or were unemployed and only 30 (21%) did manual labour. 
Hobbies: Gardening, home decoration (do it yourself) and racket sports 
were the most common hobbies undertaken by the tennis elbow patients before 
the onset of symptoms (Table 17:4). 
Therapy Before Presentation: This information was only recorded for the 
prospective group (Table 17:5). Non-steroidal anti-inflammatory agents and 
simple analgesics were frequently prescribed, but were rarely considered 
beneficial by the patients. 
CLINICAL PARAMETERS 
No accepted clinical parameters have been described for the routine 
prospective study of tennis elbow. Tests used for serial clinical 
assessment of the prospective group were:-
1. A pain score using 10 cm horizontal visual analogue scales. 
2. Pain (0-3) induced by resisted wrist dorsiflexion (O = no pain; 1 = 
mild pain but normal power; 2 = moderate pain and reduced power; 3 = severe 
pain and absent power). 
3. A weight test (250) (0-3) which assessed the ability to lift weights of 
4, 2 and 1 pounds (1.8, 0.90 and 0.45 kg) with the elbow extended and 
forearm pronated. 
4. Grip strength (204) was performed using a 300 mm Hg spring-coil gauge 
attached to a rubber bag pre-set to 30 mm Hg. An average of 3 estimations 
was taken and recordings taken both with the elbow (a) in a position of 
flexion (and supination) and (b) extension (and pronation). 
Inter-observer Assessment of Clinical Parameters 
Twenty-five patients with tennis elbow lesions were examined by 2 
independent observers (A & B), at the same time and using an identical 
examination technique. As the position of the elbow seemed to influence 
the result, it was carefully standardised for the assessments. Pain on 
resisted wrist dorsiflexion and the weight test were performed with the 
forearm pronated and the elbow extended as far as possible. The severity 
of local tenderness was assessed with the elbow flexed and forearm 
pronated. A 4-point scale of severity was used (0 = no tenderness; 1 = 
slight/diffuse tenderness; 2 = moderate tenderness; 4 = severe tenderness). 
Grip strength was assessed both inflexion (with the forearm supinated) and 
extension (with the forearm pronated). 
As the inter-observer differences for pain on resisted wrist dorsiflexion, 
weight test and tenderness take in very limited values - the maximum scale 
being -2, -1, 0, 1 and 2, the paired t-test was not applicable. 
Comparision of the results of the individual parameters using the 'sign 
test', showed no difference between observers A and B for pain on wrist 
dorsiflexion or the weight test, but did show a significant difference 
(p<0.05) for tenderness. The latter parameter was therefore not used in 
serial assessments. Comparison of grip strength using paired t-tests 
showed no difference between the observers when the arm was assessed in a 
similar position (Table 17:6). When assessments were compared by the same 
observer inflexion and extension, using paired t-tests, a significant 
difference (p<0.001) was found (Table 17:7). Although the effect of the 
position of the arm was not studied in a similar way with the other 
clinical parameters, care was taken to carefully standardise this factor in 
the routine assessments. 
The site of maximum tenderness was assessed in the Prospective patients and 
was not always the same. In 58 (76%) it was anterior to the lateral 
epicondyle and in 18 cases (24%) posterior. This feature was documented at 
each follow-up visit to determine its prognostic significance. 
DISCUSSION 
The clinical features in the patients were similar to those in the medical 
literature in all aspects except the sex of the patients, with females 
outnumbering males in this study. Previous studies have shown no 
difference or a male preponderance (121, 143, 193), possibly due to patient 
selection on the basis of occupation (143), sport (37, 100, 205) or a need 
for surgery (94, 267). 
The clinical parameters chosen for serial assessment were based on tests 
used in previous studies, but the inter-observer error was also evaluated 
for each parameter. 
While non-steroidal anti-inflammatory agents were commonly prescribed to 
patients with tennis elbow, they were of little value. Simple analgesics 
were helpful in some patients. 
TABLE 17: 1 
CLINICAL DETAILS OF TENNIS ELBOW PATIENTS 
Sex Female Male 
Age (Years) Mean 
Range 
Arm Dominant Non- Dominant 















Group (N = 65) 
31 : 34 
45.1 
29 - 62 
50 11 
TABLE 17 :2 
AETIOLOGY OF TENNIS ELBOW LESIONS IN THE PROSPECTIVE 
AND RETROSPECTIVE STUDY GROUPS 
Prospective Retrospective 
Group (N = 76) Group (N = 65) 
Housework / Domestic Work 11 16 
Toolwork 9 8 
Lifting/Carrying 8 4 
Sport/Hobbies 7 5 
Trauma 4 2 
No Cause 37 27 
Can't Remember 3 
TABLE 17:3 
OCCUPATIONS OF TENNIS ELBOW PATIENTS AT THE TIME OF PRESENTATION 
Occupation Prospective Retrospective 
Group (N = 76) Group (N = 65) 
Sed~ntary/Unemployed 25 25 
Housework/Domestic 30 18 
Manual/Toolwork 13 17 
Secretarial 8 5 
TABLE 17:4 
HOBBIES UNDERTAKEN BY THE TENNIS ELBOW PATIENTS 
AT THE TIME OF PRESENTATION 
Gardening 

























THERAPY (AND ITS EFFICACY) GIVEN TO THE PROSPECTIVE TENNIS ELBOW 
PATIENTS BEFORE PRESENTATION (N = 76) 
N 
Non-steroidal Anti-
Inflammatory Agents 60 
Analgesic Tablets 38 
Immobilisation 4 
Single Steroid Injection 10 











TABLE 17: 6 
COMPARISON OF GRIP STRENGTH BY TWO INDEPENDENT OBSERVERS 
Observers Paired T-test 
'A' 'B' T24 p< 
Grip Strength in 
Flexion (mmHg) 192.6 191. 9 0.424 N/S 
Grip Strength in 
Extension (mmHg) 133.1 131.3 0.748 N/S 
N/S = Not Significant 
TABLE 17:7 
COMPARISON OF GRIP STRENGTH INFLEXION AND EXTENSION BY 

















A CLINICAL AND THERMOGRAPHIC STUDY OF LATERAL EPICONDYLITIS 
The investigation of most soft tissue lesions has been hampered by a lack 
of objective reproducible parameters which permit serial assessment. As a 
pilot study of tennis elbow suggested that thermography may produce a 
consistent abnormality, this lesion was chosen for further study. Whilst 
the clincal diagnosis is usually simple, some differences in the site of 
localized tenderness have been noted (57, 61). 
The aim of this study was to examine the clinical and thermographic 
features of tennis elbow with regard to their diagnostic and prognostic 
significance and the possible application of thermography to the 
investigat~on of other soft tissue lesions. 
PATIENTS 
Fifty-six of the patients from the prospective tennis elbow study were 
studied. 39 were female and 17 male. The dominant arm was involved in 50 
and the non-dominant arm in 6 cases. Mean age was 43 years and mean 
duration at presentation was 4.5 months (range 1-12 months). Trauma 
initiated symptoms in three cases. Eight were attributed to sport, seven 
to manual work and the other 38 had a spontaneous onset. 
METHODS 
Clinical: The clinical assessment of severity was based on the 5 
parameters used in the prospective study (see Chapter 17), each judged from 
0-3. The pain score, pain induced by resisted wrist dorsiflexion and the 
weight test were judged as previously described. Grip strength inflexion 
and extension was measured in mmHg and the range divided to fit the 4-point 
scale shown (O = )280; 1 = 205-275; 2 = 105-200; 3 = <100 mmHg). 
Summation of the score for the individual parameters gave an overall 
'clinical score'. The exact site of tenderness and presence or absence of 
pain on resisted pronation and supination were recorded. 
Infrared Thermography: AGA 680M thermographs were taken of the lateral 
aspect of both elbows after 15 minutes stabilization at 20°c. All 
----------~--~ 
thermographs were taken at 1 meter using a 0.5°c sensitivity setting. Data 
was then analysed via an OSCAR interface and recorded on tape, allowing 
numerical analysis of the grey areas in an area of interest (of constant 
size) using an Apple II microcomputer. The box centred over the abnormal 
area (position A) permitted mean and maximum temperature and peak frequency 
of isotherms to be measured. Moving the box medially (position B) 
permitted the slope of the thermal gradient with distance to be calculated 
(Figure 18:1). Patients were reviewed fortnightly until asymptomatic for 
at least 1 month, but thermographic analysis is based on the initial visit 
and the visit at 6 weeks (or on discharge if earlier). Ten patients had 
thermography performed in the morning and afternoon to assess diurnal 
variation and 60 age and sex-matched normal controls (120 elbows) were also 
studied. All 56 patients were also reviewed clinically and 
thermographically one year after their initial presentation. 
RESULTS 
A. Clinical: Tenderness was anterior to the lateral epicondyle in 39 
patients (70%), posterior in 11 (19%) and variable in six (11%), but this 
did not correlate with pain on pronation or supination or other clinical or 
thermographic features and did not influence the response to local therapy. 
B. Thermographic: Thermography of the affected elbow showed a discrete 
localized area of increased heat near the lateral epicondyle ('hot spot') 
in 53 of the 56 affected elbows, the centre being 1-3°c above the 
background isotherm (Figure 18:2). A similar abnormality was found in only 
three of the 120 control elbows, the lesion never being more than 1°c above 
the background. Contingency table analysis showed the difference to be 
significant (X2 with Yates correction= 145.0, p<0.0001). The normal 
thermographic pattern showed no specific features near the lateral 
epicondyle, although a negative thermal gradient was often present from the 
elbow joint towards the olecranon (Figure 18:3). 
A clear diurnal variation was detected in all 10 patients - the temperature 
tending to rise through the day (Table 18:1). Both mean temperature and 
peak frequency of isotherms showed a significant increase in the afternoon 
compared with the morning temperature. Maximum temperature also increased 
through the day, but this increase did not reach significance (p<0.1). 
Gradient slope analysis, however, showed minimal diurnal change (p)0.5) and 
also correlated well with the severity of the condition and reflected 
recovery (Figure 18:4, r=0.49, p(0.02). Mean and maximum temperature and 
peak frequency of isotherms did not show this correlation. 
Sixteen patients (39%) with unilateral tennis elbow also had a hot spot 
near the lateral epicondyle on the unaffected side, two later developing 
pain. The morphology of the hot spot was always similar to the unaffected 
side, but the peak temperature and gradient slopes were less. 
C. Clinical/Thermographic Outcome: Mild ache and/or tenderness often 
persisted for weeks or months after full functional recovery (that is 
normal grip strength, weight test and painless resisted wrist 
dorsiflexion). Thermography reflected the clinical improvement with a fall 
in the peak temperature; the localized lesion often increasing in size 
before merging with muscle heat. The thermographic lesion persisted on 
discharge in 18 patients - nine still having clinical tennis elbow and the 
others having continuing ache and/or tenderness (Table 18:2). Seven 
contralateral elbows were also still abnormal on discharge. The three 
patients with consistently negative thermography failed to respond to local 
therapy - two later complaining of neck pain. 
When the patients were reviewed 1 year after initial presentation, 9 were 
still symptomatic and 7 had a persistent thermographic abnormality. Two 
patients who never showed a local thermographic change were still 
symptomatic but with normal thermography of the lateral elbow. All the 
other patients had normal elbow thermography even when an intermittent ache 
in the elbow persisted following use. The 5 patients with tennis elbow in 
the opposite side also developed hot spots at the lateral elbow and 3 with 
medial epicondylitis, hot spots at the medial aspect of the elbow. 
DISCUSSION 
Lateral epicondylitis produces some variability in the site of local 
tenderness and severity of pain on resisted supination and pronation. 
Whilst these differences may reflect different underlying pathology, they 
did not seem to influence the response to therapy nor affect the prognosis. 
The thermographic abnormality described was present in over 98% of painful 
elbows (irrespective of the site of tenderness), and analysis of the 
gradient across the abnormal area showed good correlation with clinical 
severity. The gradient slope showed far less diurnal fluctuation than the 
temperature-based parameters. 
Similar thermographic changes were found in over 30% of the asymptomatic 
contralateral elbows and only 3% of the normal controls and may indicate an 
underlying susceptibility in these patients, or more likely reflect the 
stress placed on the asymptomatic elbow in order to protect the painful 
arm. 
Cervical spine radiographs were no different from age and sex-matched 
controls, but a persistently normal thermograph in patients with clinical 
tennis elbow may reflect an undetected cervical root lesion. While the 
pathology of tennis elbow remains controversial, thermography mirrors 
clinical severity and offers definite possibilities for prospective study 
of this and other soft tissue lesions and their noted associations. 
TABLE 18:1 
DIURNAL VARIATION IN THERMOGRAPHIC PARAMETERS OF TEN 
TENNIS ELBOW LESIONS 
A.M. P.M. Paired 
T-test 
Mean SD Mean SD p< 
Box Position A 
Mean Temperature 30.84 0.94 31.88 0.69 o.os 
Maximum Temperature 31.29 0.93 31.80 0.72 0 .1 
Peak Frequency 30. 83 o. 92 31.49 o. 83 0.02 
Box Position B 
Gradient Slope 0.41 0 .14 0.46 0.14 )0. 5 
TABLE 18:2 
CLINICAL AND THERMOGRAPHIC FEATURES ON DISCHARGE 
Thermography 
Clinical Features No. Abnormal Normal 
* Persistent Tennis Elbow 12 9 3 
Ache After Use 17 2 15 
Localised Tenderness 7 5 2 
Asymptomatic 20 2 18 
* All Three Remained Persistently Normal. 
Position 'A' Position 'B' 
FIGURE 18: I. Position of the 'Regions of Interest• for analysis 
of the thennographic data in the lateral epicondylitis study. 
FIGURE 18: 2. Thennographic 
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CHAPTER 19 
LATERAL EPICONDYLITIS AN EVALUATION OF THERAPEUTIC ULTRASOUND 
Since Wood and Loomis (289) first investigated the interaction between 
ultrasound and living tissue, biological effects of the radiation have been 
recognised. These include enhanced blood flow, increased membrane 
permeability and altered connective tissue extensibility and nerve 
conduction (156). Stimulation of protein synthesis with fibroblast 
activation has also been reported (111). All these sequelae were initially 
attributed to the deep thermal effects, but introduction of pulsed 
ultrasound largely eliminated the rise in temperature within tissues, 
showing non-thermal effects also to be present (75). 
The effectiveness of ultrasound remains unproven. Reports have claimed its 
value in treating tennis elbow (1), painful shoulder (155, 192) and other 
conditions (156) but the failure to randomise treatment and lack of 
controls has cast doubt on their conclusions. In the few studies to 
include a control group (83, 189), beneficial results were less pronounced. 
However, Dyson et al using control groups showed enhanced tissue 
regeneration in an animal model (75), and improved varicose ulcer healing 
in man (74). 
Tennis elbow (lateral epicondylitis) was chosen as an ideal soft tissue 
lesion for study as it is common, clinical diagnosis simple, and the lesion 
discrete, localised and superficial. Ultrasound by its ability to cross 
myofascial planes and concentrate near bone (154), offers further 
theoretical advantages. 
PATIENTS 
The seventy-six patients in the Prospective Group suffering from lateral 
epicondylitis of at least one month's duration were included in the study 
(Table 19:1). 
METHODS 
The Electro-medical Supplies Therasonic ultrasound machine which was 
employed in the study continued to be used for routine physiotherapy. The 
machine was standardised initially and then every month thereafter on a 
master balance. Output was also checked before each treatment session on a 
simple underwater radiation balance (Figure 19:1) constructed (169) for 
this purpose. An on/off key introduced into the transducer circuit 
permitted mock-insonation to be given to a placebo group, without affecting 
the normal ultrasonic output when the key was turned to on. 
Therapy Regime: Therapy was 'pulsed' with an on to off ratio of 1 to 4 and 
a frequency of 1.0 megahertz. Treatment was given in contact, using 
Electro-medical Supplies ultrasonic coupling medium. The space-averaged 
intensity was increased from 1 to 2 watts per cm
2 
and therapy time from 5 
to 10 minutes during the course of therapy. Twelve treatments were given 
(2-3 per week) over a 4-6 week period. 
A therapist not taking part in giving the therapy, randomly allocated 
patients to the ultrasound or placebo groups according to a prearranged 
schedule. She also set the transducer switch accordingly before each 
treatment session, so the patient, medical assessor and primary therapist 
were unaware of the treatment groups. 
Patients were reviewed fortnightly while receiving therapy. Follow-up 
continued for at least one further month before patients were discharged or 
if symptomatic, offered alternative therapy. 
At each visit, clinical assessment included the pain score, pain on 
resisted wrist dorsiflexion, weight test and grip strength inflexion and 
extension as previously described. The patient's assessment protocol is 
shown in Appendix II. 
After completing therapy and during further follow-up, patients were asked 
to assess the results of treatment. The medical assessor also judged the 
outcome. A satisfactory outcome on examination was judged as full 
functional recovery with no more than a minor ache and/or slight tenderness 
remaining. The 'end point' of the study was discharge, withdrawal, or 
alternative therapy. All patients were, however, re-examined or completed 
a postal questionnaire at 1 year after inclusion in the study as part of a 
larger assessment of natural history of lateral epicondylitis (see Chapter 
20). 
RESULTS 
Objective Outcome: Twenty-four patients treated with ultrasound (63%) and 
11 who had received placebo (29%) showed a satisfactory outcome on 
objective testing both at the termination of therapy and during further 
follo-w-up. Contingency table analysis (Table 19:2) showed that the 
difference between the groups was significant (X2 with Yates' correction= 
7.63, p(0.01). 
Subjective Outcome: Six patients (2 given ultrasound treatment and 4 given 
placebo) reported the outcome innnediately after completing therapy, to be 
satisfactory despite persistent disability on objective assessment. Review 
one month later confirmed an unsatisfactory result in 5 of the 6 patients. 
Parameter Analysis: The two treatment groups showed no significant 
differences in the mean severity of any of the clinical parameters at 
presentation. Comparisons of the rate of recovery from time Oto each 
follo-w-up visit (Wilcoxon rank sum tests) however, confirmed a significant 
advantage for the ultrasound over the placebo group. The reduction in the 
pain score, pain on resisted wrist dorsiflexion, pain on weight test and 
the improvement in grip strength inflexion and extension in the 2 groups 
is shown (Figure 19:2). 
The mean grip strength in all the patients at presentation was 58 mmHg 
better with the elbow flexed (GF) than with it extended (GE). By the end 
of the controlled study the advantage for GF was still 28 mmHg in the 
ultrasound and 39 mmHg in the placebo groups. 
The duration of symptoms at presentation, dominance of the affected arm and 
therapy given before referral did not influence the outcome, but patients 
who responded to mock-insonation had less severe symptoms at presentation 
than those responding to ultrasound. 
Reliability of the Ultrasound Machine: Fluctuation in the ultrasonic 
output was detected in the study machine when subjected to checks on the 
underwater radiation balance prior to treatment. Therapy had to be delayed 
for repairs to the ultrasound machine on 2 occasions when there was no 
output and on a further 4 occasions when the radiation was considerably 
reduced. 
Further Therapy Given: Forty-one patients (14 given ultrasound and 27 
given placebo) still had an unsatisfactory outcome at the end of the 
controlled study and were offered ultrasound (some placebo group patients) 
and/or steroid injections (Table 19:3). Eight patients either withdrew 
still complaining of severe disability or required surgery to the elbow; Of 
these, 4 were housewives, 2 domestic workers and 2 manual labourers. 
Review at 1 Year: All the patients were re-examined or completed a postal 
questionnaire at 1 year. A much lower incidence of recurrence of severe 
pain (Table 19:4) was noted in the patients who responded to ultrasound 
than those who required steroid injections. Minor or intermittent pain in 
the elbow was still present in over 50% of patients. 
DISCUSSION 
This study has shown that ultrasound enhances recovery in patients with 
lateral epicondylitis (1), but only in 63% of cases. Serial assessment of 
clinical parameters has confirmed that the treated patients had a 
significantly better rate of recovery than the placebo group, and later 
review suggested a lower incidence of recurrence in the patients who 
responded to ultrasound. Eleven of the patients (29%) in the placebo group 
recovered without any other therapy. This may reflect the benefits of 
careful supervision, increased rest and natural remission, but may also 
result from the massage effect of the transducer head over the affected 
area during mock-insonation. 
Subjective patient assessment immediately after the completion of therapy 
has usually been used to determine the efficacy of treatment. However, a 
definite discrepancy between the subjective and objective assessments was 
found. Review 4-6 weeks later showed better agreement. Repetitive 
activity especially housework often precipitated the onset of symptoms, and 
failure to rest from this activity resulted in a poor response. Although 
Dyson et al using an animal model (75) suggested that maximum benefit could 
be obtained from starting therapy as early as possible, no advantage was 
detected in patients who did present early. 
Clarke and Stenner (43) and Allen and Battye (4) noted considerable 
alterations of ultrasonic output with time. Using a simple underwater 
balance this was confirmed, emphasising the need for frequent assessment. 
Ultrasound is time consuming to patient and therapist and further 
controlled studies in other conditions are necessary. 
TABLE 19: 1 
CLINICAL DETAILS OF TENNIS ELBOW PATIENTS 
Ultrasound Group Placebo Group 
(N = 38) (N = 38) 
Sex Female Male 25 13 23 15 
Age (Years) Mean 44.1 42.4 
Range 29 - 59 29 - 65 
Arm Dominant Non-Dominant 29 9 27 11 
Duration of symptoms (Months) 
Mean 4.8 4.3 
Range 1 - 12 1 - 12 
TABLE 19:2 











TABLE 19: 3 
OUTCOME IN PATIENTS WITH AN UNSATISFACTORY INITIAL RESULT 
Outcome 
Healed with Ultrasound 
Healed with Injections 
Healed with U/S and 
Injection 
Placebo Group 




Withdrew while Symptomatic 3 
Referred for Surgery to 
Elbow 2 
TABLE 19: 4 
Ultrasound Group 










(+ placebo) 32 
Steroid injection 
(+ U/S + placebo) 25 
Unresolved/refused 
further therapy 8 
* 1 Patient after Surgery 
+ 2 Patients after Surgery 
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FIGURE I9 I. Simple underwater radiation balance. 
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CHAPTER 20 
LATERAL EPICONDYLITIS : AN ASSESSMENT OF NATURAL HISTORY AND 
THE EFFECT OF CONSERVATIVE THERAPY 
Many of the conservative therapeutic measures advocated for the treatment 
of tennis elbow have fallen into disuse. Marlin (172) and Mills (183) 
considered manipulation therapy to be the treatment of choice, but this was 
never widely accepted. Stoddard (257) and Wadsworth (270) have more 
recently advocated it for persistent lesions which have not responded to 
repeated local steroid injections. Immobilisation (36, SO, 109, 213), 
shortwave diathermy (57, 109, 250), deep massage (236, 266) and deep X-ray 
therapy (54, 117, 178) have been used but not subjected to controlled 
study. Therapeutic ultrasound has been discussed in detail (see Chapter 
19). 
Local steroid injection therapy has been shown to enhance recovery (8, 40, 
59, 61, 121, 129) and remains the treatment of first choice. However, even 
after repeated injections, some patients remain symptomatic or show a rapid 
recurrence of symptoms (193, 222, 250, 293). Cyriax (57) regarded tennis 
elbow as a self-limiting condition, improving with or without treatment 
within 8 - 12 months. He felt recurrence was unusual. However, symptoms 
do persist in some patients. Clarke and Woodland (40) reviewed patients 
after 6 months and found recurrence in 54% of cases, although few were 
receiving further treatment. Nevelos (198) reported recurrence in 18% of 
his patients after a similar period. During the therapeutic study of 
ultrasound (see Chapter 19), persistent or recurrent symptoms were common. 
As no long-term studies of conservative therapy in tennis elbow have been 
reported, follow-up of the prospective group was extended and the outcome 
in a retrospective group of patients treated in the out-patients department 
in the previous 5 years was assessed. 
PATIENTS AND METHODS 
Clinical details of the patients have been given in Chapter 17 and 19 and 
will only be briefly summarised. 
The Prospective Group consisted of the 76 patients included in the study of 
therapeutic ultrasound (Chapter 19). 'Discharge' was at 3-4 months and 
irrespective of the outcome all the patients were recalled for 'review' one 
year later. 
The Retrospective Group. 77 patients treated 1-5 years previously in the 
out-patients department for tennis elbow were sent questionnaires with 
regard to therapy and outcome (see Appendix III). Where possible 
information was verified from the case records. 65 patients completed the 
questionnaires. 3 had died and 9 could not be traced. Mean follow-up was 
39.5 (range 12-60) months. 12 of the 65 patients (18%), had defaulted from 
the clinic - 4 because acute symptoms had resolved; 6 because treatment was 
ineffective and 2 because the steroid injections had been unacceptably 
painful. 'Discharge' refers to symptoms at the time of discharge or 
default. 
RESULTS 
Clinical Data: The details relating to the 141 patients in the 2 groups is 
shown in Table 17:1. 
Hospital Treatment: Therapy given in the two groups (Table 20:1) differed 
in that most prospective patients were initially treated with ultrasound 
and were only given steroid injections if the former was ineffective. 
Steroid injection was the preferred treatment in the retrospective group. 
90% of patients (both groups) were improved by the injections, but some 
patients in the retrospective group had up to 8 injections. 70% of the 
injected patients reported marked exacerbation of pain lasting 24-72 hours 
after the injections. 8 prospective and 12 retrospective patients 
defaulted or refused further injections. Ultrasound produced improvement 
in 60% of cases without any initial exacerbation of symptoms. Only 4 of 34 
patients who received both ultrasound and injections considered ultrasound 
more effective. 
Prospective Group: The results of therapy (Table 20:2) at 3-4 months 
('discharge') showed 10% of patients still to be symptomatic. On review 
after one year, 22% had severe pain. Steroid injection improved 90% of 
patients even when the symptoms persisted after ultrasound. Recurrence of 
severe symptoms (Table 20:3) occurred almost exclusively in the patients 
treated with injections. Only 3 patients who improved with ultrasound had 
a recurrence within 4 months. More than 50% of all patients had persisting 
or intermittent discomfort (Table 20:2) which was never considered severe 
enough to warrant further treatment, but did cause them to stop or limit 
some activities. 5 patients (3 domestic workers and 2 manual labourers) 
had changed occupations; 10 stopped or had not fully resumed sport and 15 
other hobbies, because of the elbow pain. Few patients sought further 
medical aid even when they had severe persisting or recurrent symptoms 
(Table 20:4). 4 patients attended 'fringe' medical practitioners without 
benefit and 4 after further medical treatment, were referred for surgery to 
the elbow. Most resigned themselves to prolonged disability. 
Retrospective Group: Results of therapy at 'discharge' and on review 
(Table 20:2) and interim recurrences (Table 20:3) are shown. With the 
longer follow-up in this group, some increase in late recurrence (after 6 
months) was noted, but fewer patients at review had severe disability. 
Despite the longer follow-up - 42% of patients still had intermittent 
symptoms which prevented full resumption of normal activities. 6 patients 
had changed occupations (4 manual and 2 domestic workers) and 20 
permanently stopped a hobby or sport because of persisting pain or fear of 
further recurrence. 10 of the patients had been symptomatic for over 2 
years - 5 for longer than 5 years. Only 7 patients (Table 20:4) had sought 
further medical care, 6 turning unsuccessfully to 'fringe' medicine to 
obtain relief. 2 patients were awaiting surgery to the elbow. 
Other Soft Tissue Lesions: Two patients in the prospective group had 
bilateral tennis elbow lesions at presentation and 10 others developed 
bilateral symptoms during the follow-up period. 5 patients also developed 
medial epicondylitis (2 bilateral) and 6 tendinitis of the shoulder. In 
addition to the 3 retrospective patients with bilateral tennis elbow at 
presentation - 12 others developed bilateral elbow pain and 15 shoulder 
pain during the follow-up period. 
DISCUSSION 
Tennis elbow is of common occurrence and is generally regarded as a trivial 
condition which is self-limiting or responsive to steroid injection. Most 
studies have evaluated the efficacy of different surgical procedures in the 
small proportion of chronic lesions coming to surgery (22, SO, 88, 94, 
204). Studies of conservative therapy especially steroid injection have 
concentrated on the immediate results. Clarke and Woodland (40) and 
Nevelos (198) extended follow-up to 6 months and noted a high recurrence of 
symptoms, but did not define the severity of these symptoms. This study 
has confirmed the large number of patients who do not respond to treatment 
or who show recurrence of severe symptoms sometimes associated with 
resumption of the activity which induced the initial pain. Manual workers, 
especially mechanics and builders and domestic workers were most 
susceptible to recurrence and tended to seek medical or fringe medical care 
to permit continuation of their occupations. More surprising was the large 
number of patients who had persisting or recurrent discomfort following use 
which induced some modification in their normal activities. This minor 
disability was not considered severe enough to require therapy, but lasted 
for far longer than is generally recognised. The absence of suitable 
controls and the use of retrospective patients makes comparison of steroid 
injection and ultrasound therapy difficult. The lower recurrence rate 
noted in ultrasound-responsive patients may reflect the milder condition in 
these patients or a true enhancement of healing, but as only 60% the 
patients responded, this therapy cannot be regarded as the treatment of 
choice. Steroid injections though more effective (90% improved) were often 
followed by recurrence. The pain induced by the injections can also be 
considerable and was the reason a number of patients did not seek further 
treatment. 
The development of bilateral tennis elbow may be due to increased stress 
placed on the unaffected arm but the high incidence of medial 
epicondylitis, shoulder tendinitis and other soft tissue lesions observed 
in this and other studies (22, 61, 204) remains as yet unexplained. 
Tennis elbow has been shown to be a common cause of prolonged disability 
and even when responsive to conservative therapy, mild or even severe 
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CLINICAL STATUS AT DISCHARGE AND ON REVIEW 
ProsEective GrouE Retrospective Group 
Clinical Status At On At On 
Discharge Review Discharge Review 
N % N % N % N % 
No Symptoms 25 (33%) 21 (28%) 19 (29%) 30 (46%) 
Intermittent Discomfort 43 (57%) 38 (50%) 39 (60%) 27 (42%) 
Severe Pain 8 (10%) 17 (22%) 7 (11%) 8 (12%) 
TABLE 20:3 




Within 3 Months 9 (12%) 
3 - 6 Months 6 ( 8%) 
After 6 months 2 ( 3%) 
TABLE 20:4 
TREA1MENT AFTER DISCHARGE 
Treatment Prospective 
Group 















DISCUSSION OF SOFT TISSUE RHEUMATISM IN THE CONTEXT OF THE PRESENT STUDIES 
The lack of definition, understanding and research into soft tissue 
rheumatism is widely recognised (68, 151). The investigation into these 
conditions has been hampered by a paucity of clinical features or 
abnormalities in blood tests or other special investigations which permit 
classification of these lesions. This lack of an accepted classification 
has also resulted in differences in terminology and interpretation of data 
from existing studies. Soft tissue lesions never cause death and rarely 
come to surgery, so there is little material for study at the tissue level. 
Even those patients who come to surgery have usually received repeated 
steroid injections and other conservative measures over a prolonged period, 
making it difficult to determine if the histological abnormalities reflect 
the primary pathology or are secondary to healing and the therapeutic 
endeavours. 
The special "shoulder clinic" set up in Cambridge fulfilled an important 
role in the study of conditions causing pain in the shoulder region. The 
initial response by local general practitioners to a request for patients 
with shoulder symptoms suggested that many lesions are inadequately 
diagnosed and treated. The frequency and severity of the different 
shoulder syndromes was assessed and the lesions causing the greatest 
difficulty in clinical practice were chosen for further study. 
The complexity of normal shoulder function has presented particular 
problems in the study of conditions in this region and most methods 
advocated for the measurement of the range of movement have been cumbersome 
and unreliable (2,71,87,152). Information relating to the range of 
movement in health and disease and the factors which influence this have 
therefore been lacking. Clarke et al (41) used a hydro-goniometer in 
healthy controls and patients with painful stiff shoulders and found the 
instrument simple to use with satisfactory reproducibility of results. 
However, they only measured a few variables and published limited data. A 
modification of this goniometer was therefore used to define the range of 
movement in the normal population and the factors which might influence 
this range. In the Painful Stiff Shoulder (PSS), the passive range was 
reproducible and was used for serial study. Like Lee et al (153), a 
consistent relationship was found between individual movement variables in 
the PSS, permitting simplification of the analysis of the recovery in range 
by the use of multivariate or principal component analysis. As a 
consistent reduction in the passive range was not found in the Rotator Cuff 
Tendinitis (RCT) syndrome, this was not useful for serial study. The 
active range of movement was usually reduced due to pain and was used 
instead. Pain on resisted movement (58) and the severity of the painful 
arc on abduction could also be quantified for serial study of the RCT 
lesions. A reduction in the range of elbow extension was not a consistent 
finding in the Lateral Epicondylitis (L/E) lesions and could not be used to 
follow the progress of these lesions. Pain on resisted wrist dorsiflexion, 
grip strength and the weight test reflected the clinical severity of these 
lesions, were reproducible and were used for serial study. The importance 
of careful standardisation of the position of the elbow when performing the 
clinical assessment of L/E was indicated by the significant difference 
between the grip strength when performed with the elbow held inflexion and 
extension. 
Many patients reported difficulty in transcribing the severity of pain to 
visual analogue scales (VAS), but no more satisfactory method of 
quantifying pain was found. The ability to sleep on the affected shoulder 
and the duration before pain was much improved provided an end-point for 
determination of recovery in the shoulder conditions studied, but could not 
be used to assess serial change in the severity of the pain. The use of 
simple analgesic agents was also thought to be dependent on the personality 
of the patient rather than the severity of the pain. 
Thermography produced a consistent abnormality in L/E lesions which 
correlated with clinical severity and altered with clinical improvement. 
Similar changes were not evident in the shoulder lesions as the rich 
vasculature in the region of the shoulder distorted the thermographic 
image. Nevertheless, thermography is an objective and non-invasive 
technique which may be of value in the study of other soft tissue lesions. 
Arthroscopy of the shoulder (103, 279) has been reported in the PSS and 
other shoulder syndromes and may be a useful method of obtaining tissue in 
these and other lesions close to large joints at a much earlier stage in 
their natural history and before local steroid injections and other therapy 
has distorted the histological picture. 
As the pathogenesis and pathology of the soft tissue lesions remains poorly 
understood, treatment is largely empirical. Local steroid injections are 
the treatment of choice in many of these conditions, but some patients fail 
to respond or show no more than a transient response. Most other therapies 
advocated to treat these lesions have not been subjected to controlled 
study. To assess efficacy, the condition chosen for study needs to be 
clearly defined with suitable parameters for serial analysis. As many of 
the lesions are self-limiting and the natural history uncertain, large 
groups of patients, a suitable control group and randomisation procedures 
are essential. The study of therapeutic ultrasound in L/E was carried out 
along these lines; 63% of L/E patients were improved by ultrasound and 29% 
by placebo. The subjective outcome at the end of treatment was an 
unreliable guide to the eventual outcome and should not be used in 
isolation to determine efficacy. The high recurrence rate of tennis elbow 
lesions following steroid injection therapy also suggests that the 
follow-up period needs to be prolonged to determine the true value of 
treatment. Many patients also fail to return for further treatment if 
symptoms recur. The ultrasound study also indicated that the ultrasound 
machines are often unreliable and the reduced radiation output can be 
missed by the physiotherapist in her routine pre-treatment checks. This 
has important implications both for the routine use and study of this and 
other therapeutic modalities. An improvement in the quality of 
pre-treatment checks and increase in the frequency of professional 
equipment maintenance may reduce problems from this source with a more 
consistent therapeutic response. 
Pulsed electro-magnetic field (PEMF) therapy has not previously been used 
to treat soft tissue lesions. The study was based on the clinical and 
experimental evidence that it stimulates growth and regeneration of 
connective tissue structures and bone. This therapy was safe and useful in 
patients with severe persistent RCT lesions and warrants study in other 
chronic tendon and soft tissue lesions. 
Treatment of the PSS remains unsatisfactory. These studies have suggested 
that steroids given by mouth or by local injection do decrease pain, but 
have little effect on the recovery in the range of movement. The maximum 
improvement in pain occurred within 4 - 6 weeks of presentation and active 
treatment is most effective during this period. Ice packs were of no value 
and mobilisation physiotherapy possibly harmful if given in the acute 
stage. Little justification for the referral of PSS patients to the 
physiotherapist was found. The role of home pendular exercise in the 
prevention and treatment of this condition is still unclear, as all the 
patients were encouraged to perform this activity. The recovery in the 
patients who only performed home pendular exercise was similar to those who 
also recevied active treatment, suggesting either that therapy does not 
influence the rate of recovery or that the pendular exercise was the 
important factor in their recovery. A comparison of the progress before 
and after the inclusion in the studies suggests that the latter explanation 
may be correct. 
Non-steroidal anti-inflammatory agents are the mainstay of general 
practitioner treatment of most soft tissue lesions, but was reported to be 
of little value by a majority of the patients who received this therapy. 
Simple analgesics were of some value in the shoulder patients as they 
facilitated sleep. Few patients received advice from their general 
practitioners on the need to rest or exercise the affected limb. The 
retrospective L/E study suggested that patients do not regard the therapy 
given by their general practitioner or rheumatologist as being of prolonged 
benefit, so many defaulted or failed to return when symptoms recurred. 
The natural history of these conditions has not been documented previously; 
50% of the L/E patients had a persistent or recurrent ache in the elbow 
which limited some activities. This lasted for 6 months or longer usually 
without severe relapse. 10% of patients had severe and prolonged 
disability which markedly affected work and other activities. The PSS also 
produced prolonged reduction in range, but as this was usually without 
pain, most patients adapted to this minor disability and were unaware that 
it was present. 
The patients included in all the groups studied had an increased incidence 
of other soft tissue lesions and the presenting complaint was often 
bilateral. While this supports the hypothesis of individual susceptibility 
to these lesions, no explanation for this was found. HLA-B27 was no more 
common in the patients than the controls and no other antigen associations 
were evident. However, only the A and B loci antigens were analysed. 
Whether the lesions arise from pathology at the enthesis (enthesopathies) 
was not assessed, but thermography of the elbow did suggest a localised 
lesion at this site in most L/E patients. Why the enthesis should be 
unusually susceptible to injury is unclear. Clinical cervical spondylosis 
was not common, but 3 of the patients with symptoms of L/E but with 
persistently normal thermography developed neck pain. It was not possible 
to ascertain if these factors were causally related (195). Painful 
'trigger' points in the classical areas described by Smythe et al (252) 
were not demonstrated and there was no evidence of the 'fibrositis' 
syndrome in these patients. 
Whether the RCT lesions precede the PSS remains uncertain. RCT which 
persisted for at least 3 months was studied, but only 2 patients developed 
a loss in the passive range during the follow-up period. Neither was 
severe enough to fulfill the criteria of the PSS. This lack of progression 
may have been due to therapy, pendular exercise or a lack of relationship 
between the 2 conditions. Few of the PSS patients could recall symptoms of 
a RCT lesion in the months before the onset of the PSS. The importance of 
immobilisation in the prevention of the PSS needs further study. The PSS 
was more common in females aged from 40 - 75 years (mean 54.4), and 
involved the non-dominant arm. RCT was slightly more common in males with 
a similar mean age but a much wider age range (20 - 80 years). The 
dominant arm was also more often involved. This does not support a causal 
relationship, but as tendon degeneration is usually bilateral the 
differences may be due to chance. There was also no strong association 
between manual labour and any of the lesions studied. The immunological 
studies showed some abnormalities in the PSS and with the increased uptake 
of technetium would support an inflammatory reaction, but were not specific 
or consistent enough to prove Macnab's hypothesis of a type IV 
immunological reaction to damaged collagen (170). Further more specific 
immunological studied are needed. The concept of connective tissue failure 
also needs to be explored. 
In summary 3 common soft tissue lesions in the upper limb have been studied 
in a prospective manner evaluating clinical, laboratory and other factors 
of possible relevance. The natural history of these lesions and the 
possible influence of therapy has been considered. An attempt has been 
made to explore the previously documented association between a variety of 
soft tissue lesions which may shart a common pathology and pathogenesis. 
Useful principles for the further study of Soft Tissue (Non-Articular) 
Rheumatism has also been presented. 
PART VII 
CONCLUSIONS 
A. THE SHOULDER STUDIES 
1. Many patients with shoulder pain do not receive any specific therapy. 
The shoulder clinic was useful for studying these patients and confirmed 
that most lesions can be diagnosed by careful clinical examination. 
2. Non-steroidal anti-inflammatory agents are the mainstay of treatment of 
all shoulder conditions in the community, but were considered ineffective 
by most patients studied. Few patients received any advice from their 
general practitioners with regard to use of the shoulder after symptoms 
developed. 
3. Detailed analysis of shoulder movement in the normal population showed 
that females of all ages have a better range than males and that the 
decrease in range with age was more marked in the males. Arm dominance did 
not influence the range. 
4. Frozen shoulder using the strict criteria in these studies is not 
common, recruitment of patients took 18 months in the Major Study and 12 
months in the Supplementary study. 
5. A modified spirit goniometer was easy to use and gave reproducible 
results for the serial measurement of shoulder range. The passive range 
of movement was more useful than the active range in the assessment of the 
painful stiff shoulder (PSS) and component analysis was a convenient method 
of simplifying analysis of the recovery in range, accurately reflecting the 
change in individual movement parameters. The active range was useful in 
the assessment of rotator cuff tendinitis (RCT) lesions. 
6. Patients experienced difficulty in transcribing the severity of pain to 
visual analogue scales, but no better method of serial assessment of this 
parameter was found. 
7. The frozen shoulder patients were generally in good health and few of 
the associated illnesses suggested in the literature were found. This 
possibly reflected the strict entrance criteria used in the studies. 
8. The rate at which pain and range of movement improved was similar in 
the two Frozen Shoulder Studies, suggesting that therapy did not markedly 
influence the natural history of this condition. A slight advantage in the 
rate of recovery was found in older patient ()56 years), early presentation 
(<3 months), and dominant arm involvement, but these benefits never reached 
significance and were only short-lived. 
9. Eight months after presentation, 40% of the PSS patients still had some 
pain, although it was severe in only a quarter of the cases. Whilst 89% of 
patients had a range less than the minimum for age and sex-matched controls, 
only 55% regarded their range restricted at this time. The PSS patients 
(both studies) had a highly significant range deficit at 8 months for all 
movements, glenohumeral and total, when compared to the matched controls. 
Only the resumption of manual labour in the convalescent phase was 
associated with a significantly worse outcome at this time. 
10. Review of the Major Frozen Shoulder Study patients after 40-48 months 
also showed a marked discrepancy between the patients subjective opinion of 
a full recovery and the finding of objective restriction in many cases. 
While glenohumeral movement was not significantly different from the 
control group, all the other movement parameters still showed significant 
restriction. One patient had severe pain and restriction and 4 others 
severe restriction at this time. The discrepancy between the patient and 
observer assessement of recovery indicates either the excellent adaptation 
many patients make to the minor disability which often follows the frozen 
shoulder or the low expectations and ignorance of many of the patients. 
11. Patients with PSS who resumed manual labour in the convalescent phase 
continued to show a worse range at review (40-48 months follow-up). 
Patients with dominant arm involvement also had a worse range at this time, 
but this was a later development. 
12. Immunological abnormalities at presentation were not sufficiently 
consistent features to support an immunological hypothesis for the PSS. 
13. The contention that all patients with painful stiff shoulders have 
evidence of capsulitis at arthrography was disputed. Only half the 
patients showed these features; the others showed rotator cuff rupture or 
no abnormality. The capsulitis group had the least restriction at 
presentation but the other groups soon caught up and there was no further 
difference in outcome between the groups. 
14. The increase in technetium diphosphonate uptake by the PSS was 
confirmed, but this did not influence the outcome. 
15. Paired steroid injection therapy was more effective than the other 
treatment regimes in terms of reduction in pain and improvement in range of 
the PSS, but the difference from the other groups was not significant and 
the benefits were only short-lived. Oral steroids were also effective at 
reducing pain, but did not influence the recovery in range. Steroid 
therapy by either route is justified only in those patients in whom pain is 
particularly severe. As the pain usually improved within 4 - 6 weeks 
irrespective of therapy, active therapy should possibly be confined to this 
time. Ice therapy was of no value, and mobilisation physiotherapy possibly 
harmful. Like dominant arm involvement and a resumption of manual labour 
in the convalescent phase, active physiotherapy in the acute stage was 
associated with a worse range at late follow-up of the PSS. 
16. The progression from persistent rotator cuff tendinitis to the frozen 
shoulder was not shown, but this course may have been prevented by pendular 
exercise performed by all the patients. The assocation between RCT and 
frozen shoulder, the importance of immobility in triggering the frozen 
shoulder and the role of pendular exercise in the prevention and treatment 
of the latter condition requires further study. 
17. Pulsed electro-magnetic field therapy, enhanced the recovery of 
persistent RCT lesions and may have a value in the treatment of other 
chronic tendon lesions. 
B. THE LATERAL EPICONDYLITIS STUDIES 
1. The clinical diagnosis of lateral epicondylitis is easy, but the site 
of local tenderness can vary. The condition usually affects the dominant 
arm. The lesion was more common in females and non-manual workers which is 
at variance with some studies in the literature based on occupation, sport 
or a need for surgery. 
2. Non-steroidal anti-inflammatory agents are the mainstay of general 
practitioner treatment of tennis elbow, but few patients found them 
beneficial. 
3. Clinical parameters which are reliable and reproducible and reflected 
severity have been described. The importance of standardising the position 
of the arm when performing these assessments has been noted. 
4. Thermography demonstrates a consistent abnormality in this condition 
which reflects severity. This is one of the first examples of the use of 
an objective test in the assessment of severity of a soft tissue lesion. 
5. A double-blind controlled study of therapeutic ultrasound has shown the 
use of lateral epicondylitis as a model for the assessment of 
physiotherapeutic measures. The ultrasound machine was unreliable and as 
this was not detected by the therapist, it may contribute to the poor 
results of this therapy in some patients. 
6. Therapeutic ultrasound has been shown to promote recovery of tennis 
elbow lesions. No untoward reactions occured and the recurrence rate was 
low. On the other hand steroid injection therapy was more effective - 90% 
of lesions were improved - but recurrence of symptoms was frequent and 
unacceptable side-effects occurred in some patients. 
7. There was a discrepancy between the subjective and objective outcome at 
the end of the treatment period and the subjective outcome at this time 
cannot be used in isolation to determine the efficacy of therapy. Studies 
of conservative treatment need to include more objective measurements in 
the assessments and also need to prolong the period of follow-up. 
8. Few patients who have a recurrence of symptoms return for further 
treatment. 
9. The natural history of tennis elbow was found to be longer than is 
generally recognised. 50% of the patients had minor disability which 
limited some activities. Over 10% of patients had severe and prolonged 
pain. 
10. This study had confirmed the high incidence of soft tissue lesions in 
patients presenting with lateral epicondylitis. A few patients with 
persistently normal elbow thermography and a poor response to therapy to 
the elbow developed neck pain and this may suggest that lesions of the 
cervical spine can manifest themselves as soft tissue lesions of the upper 
limb. 
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APPENDIX I 
PROTOCOL FOR ASSESSMENT OF PATIENTS IN THE SHOULDER STUDIES 
A. ASSESSMENT ONLY AT THE INITIAL VISIT: 
GENERAL 
PAIN INQUIRY 
Date; Patient No. 
Age; Sex; Arm - affected, dominant. 
Cause. 
Duration since onset of symptoms. 
Distribution and radiation. 
Present (yes/no) at night, on movement, at rest. 
Can you lie on the affected shoulder? 
RANGE RESTRICTION Duration since onset. 
INQUIRY (if Severity - Mild/Moderate/Severe. 
present) Progress from onset - Inc./Same/Dec. 
NECK INQUIRY Pain; Restriction; Paraesthesia/weakness in hands. 
PREVIOUS THERAPY NSAID'S, analgesics, injections, physiotherapy, 
AND EFFICACY other 
GP ADVICE ON USE ON THE SHOULDER. 
PRESENT MEDICATION. 
PAST HISTORY Shoulder pain; Musculoskeletal disorders; Medical and 
surgical conditions. 







At onset of symptoms; During convalescence; In 
past; Time lost from each. 
General; Systematic; Musculoskeletal 
Neck - flexion, extension, lateral flexion and rotation. 
Arms - power, sensation, reflexes. 
X-RAY SHOULDER+ ACROMIOCLAVICULAR JOINTS. 
BLOOD TESTS - ESR (Westergren), Rheumatoid factor. 
DIAGNOSIS BY GP AT REFERRAL. 
DIAGNOSIS AT CLINIC. 
SUITABILITY FOR STUDY. 
CONSENT (if applicable). 
ARRANGE SPECIAL TESTS (if applicable). 
B. ASSESSMENT AT THE INITIAL AND EACH FOLLOW-UP VISIT: 
GENERAL Date; Week No., Patient No. 
THERAPY SINCE LAST VISIT 
PATIENT ASSESSMENT 
PAIN 





Paracetamol, diazepam, other. 
Change since last visit. 
Much/Abit better/Same/Worse 




Can you lie on the affected shoulder? 
Distribution - Same/Changed. 
ACJ, Other 
PAINFUL ARC ON ABDUCTION (0-3) 









Int. Rot. (cm.) 
CHANGE IN THERAPY 
COMMENTS 
DATE OF NEXT VISIT. 
RIGHT 




PROTOCOL FOR ASSESSMENT OF PATIENTS WITH LATERAL 
EPICONDYLITIS IN THE PROSPECTIVE STUDY 






Date; Patient No. 
Age; Sex; Arm - affected, dominant. 
Cause. 
Duration since onset of symptoms. 
Distribution and radiation. 
Present (yes/no) - night pain, sleep disturbance. 
Actions causing pain (yes/no) - housework; carrying; 
lifting; writing/typing; sport; hobbies; other. 
Severity - Mild/Moderate/Severe. 






Pain; Restriction; Paraesthesia/weakness in hands. 
PREVIOUS THERAPY AND EFFICACY 
PRESENT MEDICATION. 
PAST HISTORY. 
NSAID'S, Analgesics, Injections (and/no.), 
Ultrasound, Other. 
Date of last injection. Was it of benefit? 
Shoulder pain; Musculoskeletal disorders; Medical and 
surgical conditions. 
SYSTEMATIC INQUIRY Opposite shoulder; Musculoskeletal disorders; Gener~l 
health. 
FAMILY HISTORY Musculoskeletal; Other. 
OCCUPATION AND HOBBIES 
EXAMINATION 
X-RAY ELBOW 
At onset of symptoms; Duration unable to do these. 
General; Systematic; Musculoskeletal. 
Neck - flexion, extension, lateral flexion and rotation. 
Arms - power, sensation, reflexes. 
Shoulders; Other elbow. 
BLOOD TESTS - ESR (Westergren); Rheumatoid factor. 
DIAGNOSIS BY GP AT REFERRAL 
DIAGNOSIS AT CLINIC. 
SUITABILITY FOR STUDY. 
B. ASSESSMENT AT THE INITIAL AND EACH FOLLOW-UP VISIT: 
GENERAL Date; Week No., Patient No. 
THERAPY SINCE LAST VISIT 
Paracetamol, Other. 
Change since last visit. 
PATIENT ASSESSMENT Much/Abit better/Same/Worse. 
PAIN 
(10 cm scale) 
'No pain' 'Severe as possible' 
I--------------------------------- I 
Site of maximum pain; Radiation. 
Distribution - Same/Changed. 
TENDERNESS On L.E./Ant./Post./Diffuse/Absent/Other. 
PASSIVE RANGE Elbow extension; Pronation; Supination. 
PAIN (0 - 3) ON RESISTED WRIST DORSIFLEXION. 
ON RESISTED MIDDLE FINGER EXTENSION. 
GRIP STRENGTH (mm Hg). INFLEXION. 
IN EXTENSION. 
WEIGHT TEST (O - 3 ). 
ACTIONS INDUCING PAIN - Housework; Carrying; Lifting; Writing/typing; 
Sport; Hobbies; Other (state). 
OTHER JOINTS Elbow; Shoulders; Neck. 
DIAGNOSIS 
CHANGE IN THERAPY 
DATE OF NEXT VISIT. 
APPENDIX III 
QUESTIONNAIRE FOR THE RETROSPECTIVE ASSESSMENT OF LATERAL EPICONDYLITIS 
TREATED AT A RHEUMATOLOGY CLINIC 1 - 5 YEARS PREVIOUSLY 
A. GENERAL QUESTIONS 
Name; Sex; Age at onset of symptoms. 
Date of tennis elbow; Arm affected; Dominant arm. 
Occupation and hobbies at onset. 
Cause of symptoms. 
B. BEFORE HOSPITAL REFERRAL 
Did the tennis elbow interfere (yes/no) with Work; Hobbies; Sport; Sleep? 
What treatment did your GP give? - Tablets; Injections; Other (state). 
C. HOSPITAL THERAPY 
Duration before referral. 
Treatment given (1) Injections (if yes) - How many? Were they 
painful? Did they help? Did the pain recur? If yes - after how 
long? 
(2) Ultrasound (if yes) - Did it help? Did the pain 
recur? If yes - after how long? 
(3) Other treatment (if yes) What? Did it help? 
If more than 1 treatment - Which was first? Which was more effective? 
D. AFTER DISCHARGE 
Was elbow (choose one only) completely healed/need to protect arm/ache 
after extreme use/pain as bad as ever? 
How long did symptoms persist? 
Has pain recurred? How long after 'improved'? 
If pain recurred - did you (choose 1) seek further help from GP or 
hospital/learn to live with pain/give up or limit work or hobbies/seek 
alternative therapy? 
Is elbow still painful? 
Has the other elbow been affected? 
Have you ever had tennis elbow before? 
Have you ever suffered from shoulder pain? 
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